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Atherosclerosis is the leading cause of death in the Western world. 
Although mitochondrial DNA (mtDNA) damage has been implicated in 
atherosclerosis, it is unclear whether the damage is sufficient to impair 
mitochondrial respiration, and mitochondrial dysfunction has not been 
demonstrated. Treatment of vascular smooth muscle cells (VSMCs) with an 
atherogenic lipid, oxidised low-density lipoprotein (OxLDL), dose dependently 
decreased basal and maximal respiration and fat-feeding of apolipoprotein E 
deficient (ApoE-/-) mice reduced mitochondrial DNA copy number relative to 
nuclear DNA in aortas. Mitochondrial respiration of ApoE-/- mouse aortas, 
assessed through a 24-well Seahorse extracellular flux analyser, was not 
affected prior to the development of atherosclerotic plaques. Developed 
human carotid atherosclerotic plaques were dissected into defined regions 
including healthy media, shoulder region, fibrous cap and core and their 
respiration was investigated. The respiratory reserve capacity (RRC) of the 
shoulder region was similar to the media. However, the cap RRC was 
significantly reduced compared to healthy media. In contrast, the extracellular 
acidification rates (ECAR) of the media, shoulder, cap and core regions were 
 IV 
similar. In addition, mtDNA copy number was significantly reduced in tissues 
derived from human plaques compared to healthy arteries and expression of 
complexes I and II of the electron transfer chain (ETC) were significantly 
reduced in plaque VSMCs. OxLDL induced mitophagy in human VSMCs and 
plaque VSMCs demonstrated increased levels of mitophagy without 
compensatory upregulation of proteins involved in mitochondrial biogenesis. 
Understanding the role of mitochondrial metabolism and signalling is 
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Atherosclerosis causing myocardial infarction and stroke is the leading 
cause of morbidity and mortality in the developed world (Krishnamurthi et al., 
2013; Murray et al., 2012). With an ageing population, the burden of 
atherosclerosis is set to increase unless the disease trajectory is modified 
(Roth et al., 2015). Although classical risk factors such as a positive family 
history, smoking, hypertension, obesity, hypercholesterolaemia / 
hyperlipidaemia, diabetes, aging and male sex are well known (Dawber, 
Moore, & Mann, 1957), not all of these risk factors are modifiable. 
Nevertheless, significant improvements can be achieved through alteration of 
these risk factors, as exemplified by the clinical effectiveness of the 
Hydroxymethylglutaryl Coenzyme A (HMGCoA) reductase inhibitor drugs 
(statins) (M. A.-A. S. Group, 1994; S. S. S. S. Group, 1994). Understanding 
the mechanisms of atherosclerosis may in future open new therapeutic 
strategies to address this debilitating disease. 
Atherosclerosis is a chronic inflammatory disease affecting the 
medium-sized and large arteries. It has been described as a stage-wise 
process consisting of 1) endothelial dysfunction, 2) fatty streak formation, 3) 
formation of an advanced complicated lesion and 4) unstable fibrous plaques 
(Ross, 1999) (Figure 1-1). Although simplifying the disease process, this 
framework highlights that in different stages of the disease various 




Figure 1-1 Stages of atherosclerosis 
Adapted from Ross (1999). A) Endothelial Dysfunction. Permeability of endothelial layer to 
lipoproteins increases. Endothelial cells express adhesion molecules facilitating adhesion of leukocytes 
and their migration to the intima. B) Fatty streak formation. Fatty streaks are formed by lipid-laden 
foam cells (monocytes, macrophages and T-lymphocytes) and later in the disease process VSMCs. C) 
Advanced, complicated atherosclerotic lesion. A fibrous cap, made up of VSMCs covers the necrotic 
core. D) Unstable atherosclerotic plaque. Thinning of the fibrous cap can lead to plaque rupture or 
ulceration with thrombus formation. 
 
Endothelial dysfunction is considered to be an early stage of 
atherosclerosis. The endothelial layer becomes permeable to lipoproteins and 
other plasma constituents and expresses endothelial adhesion molecules 
such as intercellular adhesion molecule 1 (ICAM1), vascular-cell adhesion 
molecule 1 (VCAM1), and selectins, facilitating the recruitment of leukocytes 



















crease peripheral resistance. Thus, free-radical forma-





Several reports have shown a correlation between
the incidence of atherosclerosis and the presence of








have been identified in atheromatous lesions in cor-










organisms have been used as a predictor of further





 Nonetheless, there is no direct evi-





 Although these organisms are
ubiquitous in many tissues and organs, the fact that
lesions cannot be induced experimentally in animals
by injection of the organisms leaves their role as eti-
ologic agents in question. It is nevertheless possible
that infection, combined with other factors, may be
responsible for the genesis of the lesions of athero-




THE NATURE OF THE INFLAMMATORY 
RESPONSE
 
Interactions among Endothelial Cells, Monocytes, 
and T Cells
 
Specific arterial sites, such as branches, bifurca-
tions, and curvatures, cause characteristic alterations





 At these sites, specific
molecules form on the endothelium that are respon-
sible for the adherence, migration, and accumulation
of monocytes and T cells. Such adhesion molecules,
which act as receptors for glycoconjugates and inte-
grins present on monocytes and T cells, include sever-






with the migration of leukocytes across the endothe-





 act in conjunction with chemoattractant mol-
ecules generated by the endothelium, smooth muscle,





 and modified LDL — to at-




The nature of the flow — that is, whether shear




 Endothelial Dysfunction in Atherosclerosis.
The earliest changes that precede the formation of lesions of atherosclerosis take place in the endo-
thelium. These changes include increased endothelial permeability to lipoproteins and other plasma
constituents, which is mediated by nitric oxide, prostacyclin, platelet-derived growth factor, angioten-
sin II, and endothelin; up-regulation of leukocyte adhesion molecules, including L-selectin, integrins, and
platelet–endothelial-cell adhesion molecule 1, and the up-regulation of endothelial adhesion molecules,
which include E-selectin, P-selectin, intercellular adhesion molecule 1, and vascular-cell adhesion mol-
ecule 1; and migration of leukocytes into the artery wall, which is mediated by oxidized low-density
lipoprotein, monocyte chemotactic protein 1, interleukin-8, platelet-derived growth factor, macrophage
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important in determining whether lesions occur at
these vascular sites. Changes in flow alter the expres-
sion of genes that have elements in their promoter
regions that respond to shear stress. For example, the













in endothelial cells have these elements, and their ex-





alterations in blood flow appear to be critical in de-





 Rolling and adherence of monocytes and
T cells occur at these sites as a result of the up-reg-
ulation of adhesion molecules on both the endothe-
lium and the leukocytes.
Chemokines may be responsible for the chemo-





 Activation of monocytes and T cells
leads to up-regulation of receptors on their surfaces,
such as the mucin-like molecules that bind selectins,
integrins that bind adhesion molecules of the im-






tor interactions further activate mononuclear cells,
induce cell proliferation, and help define and lo-
calize the inflammatory response at the sites of le-
sions (Fig. 1).
In genetically modified mice that are deficient in
apolipoprotein E (and have hypercholesterolemia),
intercellular adhesion molecule 1 is constitutively in-




 In fact, it is present on
the surface of the endothelium at these sites in normal
mice and is increased in mice with apolipoprotein E
deficiency. In contrast, vascular-cell adhesion mole-
cule 1 is absent in normal mice but is present at the
same sites as intercellular adhesion molecule 1 in mice





of monocytes and T cells may occur after an increase
in one or more of the adhesion molecules, which
may act in concert with chemotactic molecules such
as monocyte chemotactic protein 1, interleukin-8, or
modified LDL. Would interference with only one of
the several adhesion molecules be sufficient to de-
crease inflammation and thus slow or counteract the
process of atherogenesis? In mice that are completely
deficient in intercellular adhesion molecule 1, P-selec-




 Fatty-Streak Formation in Atherosclerosis.
Fatty streaks initially consist of lipid-laden monocytes and macrophages (foam cells) together with
T lymphocytes. Later they are joined by various numbers of smooth-muscle cells. The steps involved
in this process include smooth-muscle migration, which is stimulated by platelet-derived growth factor,




; T-cell activation, which is mediated by




, interleukin-2, and granulocyte–macrophage colony-stimulating factor; foam-
cell formation, which is mediated by oxidized low-density lipoprotein, macrophage colony-stimulating




, and interleukin-1; and platelet adherence and aggregation, which are




, tissue factor, and the factors described in
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Comparison of the relative roles of these molecules
in inflammation in the arteries and the microvascu-
lature may provide clues to the relative feasibility of
modifying the inflammatory process at these sites,
and thus of modifying atherosclerosis.
A recently discovered class of molecules, the disin-
tegrins, sometimes called metalloproteinase-like, dis-
integrin-like, cysteine-rich proteins (MDCs), has been





 These transmembrane proteins, which





tain a metalloproteinase sequence in their extracellu-
lar segment that permits them to activate molecules








 They are not
found in normal arteries, but one of them, MDC15,





molecules such as L-selectin can be cleaved from the
surface of leukocytes by a metalloproteinase (L-selec-
tin sheddase), which suggests that in situations of
chronic inflammation it may be possible to measure
the “shed” molecules, such as the different adhesion





 Disintegrins may partici-
pate in these shedding processes. If shedding occurs,
it may be detectable in different types of inflamma-
tory responses. Increased plasma concentrations of
shed molecules might then be used to identify pa-





The ubiquitous monocyte, the precursor of macro-
phages in all tissues, is present in every phase of ather-
ogenesis. Monocyte-derived macrophages are scav-
enging and antigen-presenting cells, and they secrete
cytokines, chemokines, growth-regulating molecules,
and metalloproteinases and other hydrolytic enzymes.
The continuing entry, survival, and replication of
mononuclear cells in lesions depend in part on factors
such as macrophage colony-stimulating factor and
granulocyte–macrophage colony-stimulating factor
for monocytes and interleukin-2 for lymphocytes.
Continued exposure to macrophage colony-stimulat-
ing factor permits macrophages to survive in vitro




 Formation of an Advanced, Complicated Lesion of Atherosclerosis.
As fatty streaks progress to intermediate and advanced lesions, they tend to form a fibrous cap that
walls off the lesion from the lumen. This represents a type of healing or fibrous response to the injury.
The fibrous cap covers  mixture of leukocytes, lipid, and debri , which may form a necrotic core.
These lesions expand at their shoulders by means of ontinued leukocyte adhesion and entry caused
by the same factors as those listed in Figures 1 and 2. The principal factors associated with macro-
phage accumulation include macrophage colony-stimulating factor, monocyte chemotactic protein 1,
and oxidized low-density lipoprotein. The necrotic core represents the results of apoptosis and necrosis,
increased proteolytic activity, and lipid accumulation. The fibrous cap forms as a result of increased









, and osteopontin and of decreased connective-tissue degradation.
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brosis, granulocytes initially appear in the alveolar
spaces; however, the lung parenchyma, where fibrosis
ultimately occurs, is infiltrated by macrophages and
lymphocytes. Thus, there are parallels between ath-
erosclerosis and these other inflammatory diseases.
Are there art cular aspects of the chronic inflam-
matory response in atherosclerosis that can be used
to adva tage? At least three different types of mac-
rophages, each regulated by different T-cell cyto-
kines (interferon-g, interleukin-2, interleukin-4, and
interleukin-10) have been identified.122 These differ-
ences raise the question whether there are subgroups
of monocytes that “home” to a specific tissue or or-
gan. Are there differences in arterial endothelium
and microvascular endothelium such that different
types of monocytes are attracted to each, and could
one take advantage of such differences?123 One might
try to use such differences to modify the inflamma-
tory response s  as to emphasize its protective rather
than its destructive characteristics.
If the injurious agent or agents are not removed
or nullified by the inflammatory response and the
nflammation progresses, the re pons  chang s from
a protective to an injurious response. Such constant
or repetitive injury can stimulate each tissue to re-
pair or wall off the damage by means of a fibropro-
liferative response, which, when excessive, diminish-
es the functional capacity of the tissue or organ and
becomes part of the disease process (Table 1).
Instability and Rupture of Plaque
Chronic inflammatory responses are often associ-
ated with specific types of injurious or granuloma-
inducing agents. In most patients myocardial infarc-
tions occur as a result of erosi n or uneven thinning
and rupture of the fibrous cap, often at the shoulders
of the lesion where macrophages enter, accumulate,
and are activated and where apoptosis may occur.124,125
Degradation of the fibrous cap may result from elab-
oration of metalloproteinases such as collagenases,
elastases, and stromelysins (Fig. 4).126 Activated T cells
may stimulate metalloproteinase production by mac-
rophages in the lesions, which promotes plaque insta-
bility and further implicates an immune response.103
These changes may also be accompanied by the pro-
duction of tissue-factor procoagulant and other he-
mostatic factors,102,127 further increasing the possibil-
ity of thrombosis.
Stable advanced lesions usually have uniformly
dense fibrous caps. The potentially dangerous lesions
are often nonocclusive and thus difficult to diagnose
by angiography, yet at autopsy active inflammation is
evident in the accumulation of macrophages at sites
of plaque rupture.107 Macrophage accumulation may
Figure 4. Unstable Fibrous Plaques in Atherosclerosis.
Rupture of the fibrous cap or ulceration of the fibrous plaque can rapidly lead to thrombosis and usually
occurs at sites of thinning of the fibrous cap that covers the advanced lesion. Thinning of the fibrous
cap is apparently due to the continuing influx and activation of macrophages, which release metallo-
proteinases and other proteolytic enzymes at these sites. These enzymes cause degradation of the ma-
trix, which can lea  to hemorrhage from the vasa vasorum or from the lumen of the artery and can
result in thrombus formation and occlusion of the artery.
Plaque rupture Thinning of fibrous cap Hemorrhage from plaque!
microvessels
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macrophages, as well as VSMCs recruited to these sites phagocytose lipids 
and oxidised lipids [Oxidised low-density lipoprotein (LDL) (OxLDL)] and 
become so-called lipid-laden foam cells and early fatty streaks are formed 
(Jonasson, Holm, Skalli, Bondjers, & Hansson, 1986; Ross, 1999). During the 
formation of the advanced, complicated lesion a fibrous cap, made up largely 
from VSMCs and extracellular matrix, separates the lipid-laden atherosclerotic 
core from the lumen. It is the thinning and rupture of this protective cap that is 
responsible for a large proportion of unstable coronary artery disease (Burke 
et al., 1997; Calvert et al., 2011).  
 
1.1.1 Atherosclerosis – inflammation and immunity 
The discovery of inflammation in atherogenesis and the involvement of 
both the innate and adaptive immune systems as main drivers of this process 
have been reviewed extensively in the past (Hansson & Libby, 2006; Libby, 
2012; Ross, 1999; Witztum & Lichtman, 2014).  
Endothelial cells are activated through a wide range of stimuli including 
injury (Ross, 1999), altered shear stress (Mondy et al., 1997) or modified 
lipids (see 1.1.3) causing up-regulation of cytokines and chemokines 
(Hansson & Libby, 2006). Adhesion molecules, cytokines and their receptors 
involved in the recruitment of inflammatory cells during atherogenesis include 
intercellular adhesion molecule 1 (ICAM-1) (Nakashima, Raines, Plump, 
Breslow, & Ross, 1998), C-C motif chemokine (CC) ligand 2 (CCL2) also 
known as monocyte chemoattractant protein 1 (MCP1) (Gu et al., 1998; 
Papadopoulou, Corrigall, Taylor, & Poston, 2008) and its corresponding 
receptor CC receptor 2 (CCR2) (Boring, Gosling, Cleary, & Charo, 1998), CC 
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ligand 5 (CCL5, also known as regulated on activation, normal T cell 
expressed and secreted [RANTES]), CCL11, C-X-C motif chemokine (CXC) 
ligand (CXCL) 10 (CXCL10), CXCL11, CXCL16, and C-X3-C motif chemokine 
ligand 1 (CX3CL1) (Hansson & Libby, 2006), highlighting the active process of 
inflammatory cell recruitment during this disease process. Monocytes, binding 
to endothelial VCAM-1 through very late antigen-4 (VLA-4), migrate into the 
intima as a response to locally formed chemokines and differentiate into 
macrophages after macrophage colony-stimulating factor (M-CSF) stimulation 
(Hansson & Libby, 2006).  
We now know that innate immunity in atherosclerosis involves a huge 
array of soluble factors and their receptors and different cell types including 
monocytes or macrophages, granulocytes, mast cells, dendritic cells (DCs) 
natural killer (NK) cells and B1 lymphocytes (Bobryshev & Lord, 1995; 
Chistiakov, Orekhov, & Bobryshev, 2016; Jonasson et al., 1986; Kovanen, 
Kaartinen, & Paavonen, 1995). The innate immune system is also required for 
activation of the adaptive immune system. Dendritic cells mediate the juncture 
from innate immunity to adaptive immunity in atherosclerosis through uptake 
of foreign antigens and their presentation to T-lymphocytes. T-lymphocytes 
release cytokines, thus further activating leukocytes and inducing humoral 
immunity through activation of B-lymphocytes (Chistiakov et al., 2016). A full 
discussion of the role of the adaptive immunity in atherosclerosis is beyond 
the scope of this introduction, but has been reviewed elsewhere (Chistiakov et 
al., 2016; Witztum & Lichtman, 2014). 
The innate immune system is normally activated through foreign 
materials or patterns such as exogenous pathogens. As the first line of 
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defence, the role of the innate immune system is to recognise such material, 
neutralise it through phagocytosis and also induce tissue repair (Witztum & 
Lichtman, 2014). An important principle of the innate immune system is the 
recognition of foreign and self to avoid damage to the organism’s cells and 
tissues. Such pathogen-associated molecular patterns (PAMPs) are specific 
structures shared by a wide range of pathogens, including teichoic acids 
(gram-positive bacteria), lipopolysaccharide (LPS) (gram-negative bacteria), 
double-stranded RNA (certain viruses), and mannans (yeast) (Medzhitov & 
Janeway, 1997). 
As there is evidence that infections are not the primary cause of 
atherogenesis (Wright et al., 2000), it has been hypothesised that the 
recognition of damage-associated molecular patterns (DAMPs) trigger the 
innate immune response in atherosclerosis. Similar to PAMPs, DAMPs are 
specific structures that are not recognised as endogenous but instead treated 
as foreign material. They are structures that are not normally accessible to the 
immune system, including heat shock proteins (HSPs), high-mobility group 
protein 1, and chemically-modified molecules such as advanced glycation 
end-products (Witztum & Lichtman, 2014), cholesterol crystals (Duewell et al., 
2010), and mitochondrial DNA (section 1.3). For example, immunization of 
normocholesterolaemic rabbits with HSP such as recombinant HSP65 
induced atherosclerosis (Xu et al., 1992). 
DAMPs are ligands for scavenger receptors expressed on the surface 
of immune cells, of which ten classes have been identified so far (Prabhudas 
et al., 2014). Although several molecules can act as DAMPs, much of our 
knowledge stems from the study of OxLDL due to its major effects on 
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atherogenesis. For example, three of the most commonly studied scavenger 
receptors are scavenger receptor (SR)-A1 (SR-A1), SR-B2 [also known as 
cluster of differentiation 36 (CD36)], and SR-E1 [(lectin-like OxLDL 
receptor-1 (LOX-1)], each of which binds OxLDL (Zani et al., 2015). DAMPs 
are also recognised by toll-like receptors (TLRs) (Levitan, Volkov, & 
Subbaiah, 2010). The role of scavenger receptors and TLRs is discussed in 
section 1.1.3 in the context of OxLDL. 
Inflammasomes are protein complexes that recognise a wide range of 
inflammation inducing stimuli including PAMPs and DAMPs controlling the 
production of cytokines such as interleukin (IL)-1β (IL1β) and IL18 (Strowig, 
Henao-Mejia, Elinav, & Flavell, 2012). Recognition of DAMPs by the innate 
immune system can lead to the activation of the NLRP3 inflammasome. The 
NLRP3 inflammasome then activates caspase-1, which in turn cleaves pro-
IL1β to IL1β. NLRP3 expression needs to be induced by a priming signal 
followed by activation through a second signal. The signals priming the 
NLRP3 inflammasome are diverse and include ROS, proteases, monosodium 
urate crystals and ATP (Strowig et al., 2012; Wen, Ting, & O'Neill, 2012). For 
example, cholesterol crystals activate the NLRP3 inflammasome in peripheral 
blood mononuclear cells (PBMC) in vitro and also cause NLRP3-dependent 
inflammation in vivo. NLRP3 activation can regulate the inflammatory 
response and atherogenesis in LDL receptor-/- (LDLR-/-) mice through 
interleukin-1 (IL1) signalling. For example, irradiated LDLR-/- mice 
reconstituted with NLRP3-, apoptosis-associated speck-like protein containing 
a caspase activation and recruitment domain (ASC)-, or IL1α/β-deficient bone 
marrow have significantly reduced atherosclerotic plaque and IL18 serum 
 7 
concentrations (Duewell et al., 2010). Similar results were observed after 
siRNA-mediated silencing of NLRP3 in ApoE-/- mice and such silencing also 
improved markers of plaque stability by increasing VSMC content and 
decreasing macrophage and lipid content (Zheng, Xing, Gong, Mu, & Xing, 
2014). However, a study by a different group using ApoE-/- mice with 
additional knockout of the Nlrp3 inflammasome pathway, i.e, ApoE-/- Nlrp3-/-, 
ApoE-/- Asc-/-, or ApoE-/- caspase-1-/-, found no effects on atherogenesis 
after fat-feeding (Menu et al., 2011). 
Nlrp3 inflammasome activation may also be relevant in human 
atherosclerosis. mRNA levels of Nlrp3, ASC, caspase-1, IL1β and IL18 were 
all increased in atherosclerotic carotid endarterectomy samples compared to 
healthy aortas and iliac arteries (Paramel Varghese et al., 2016). The same 
study found an association of single nucleotide polymorphisms (SNPs) in the 
downstream regulatory unit of Nlrp3 to mRNA levels in PBMCs, although 
there was no association between SNPs and risk of myocardial infarction.   
1.1.2 Oxidative stress in atherosclerosis 
It is well established that a variety of ROS, produced in vivo, have the 
capacity to oxidatively modify target biological molecules. Major reactive 
oxidants in vivo are: superoxide, hydroxyl radical, alkoxyl radical, and peroxyl 
radical, hydrogen peroxide, peroxynitrous acid, hypochlorous acid, and singlet 
oxygen (Niki, 2018). Their reaction with target molecules in turn leads to the 
production of hydroperoxides, hydroxyl fatty acids, isoprostane and 
neuroprostane, epoxides, oysterols, chlorohydrins and chlorinated 
compounds, nitro-compounds and importantly the oxidation of antioxidant 
scavengers (Niki, 2018). 
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There is ample evidence that oxidative damage occurs in 
atherosclerosis and it is thought that such modifications perpetuate the 
disease process. For example, the degree of lipid peroxidation correlates with 
the stage of the atherosclerotic lesion in human atherosclerosis (Kuhn et al., 
1992). Similarly, tyrosine-nitrates (Sucu et al., 2003), and chlorinated 
compounds (Messner, Albert, McHowat, & Ford, 2008) are increased in 
human atherosclerotic plaque compared to healthy arteries. Antioxidative 
components such as peroxiredoxins in turn have been found to be more 
oxidated in murine atherosclerotic aortas compared to healthy aortas (Mayr et 
al., 2005). 
Key players in the initiation and propagation of atherosclerosis are 
oxidised lipids such as OxLDL as discussed in section 1.1.3. Oxidative stress 
can also lead to DNA damage and may therefore facilitate atherosclerosis, 
which is further discussed in section 1.1.5.  
Not surprisingly, the use of antioxidants in the prevention or treatment 
of atherosclerosis has therefore been studied extensively. However, the use 
of Vitamin C, Vitamin E or antioxidant cocktails, has not demonstrated any 
effects on cardiovascular outcomes in larger studies (Kris-Etherton et al., 
2004). Sections 1.2.2 and 1.3.3 explore the role of mitochondria in the 
production of ROS and may offer an explanation to the lack of effect of 
antioxidants in the prevention of atherosclerosis.  
1.1.3 Oxidised lipids and their receptors in atherosclerosis 
It is widely accepted that LDL can be modified through oxidation in vivo 
resulting in increased proinflammatory and proatherogenic properties (Levitan 
et al., 2010). Modified LDL is often referred to as OxLDL, however, there is 
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great heterogeneity of ex vivo-derived OxLDL preparations and no clear 
definition of OxLDL exists. Modified LDL preparations have been arbitrarily 
divided into “minimally modified LDL” (mmLDL) and “extensively oxidized 
LDL” (OxLDL), the former being recognised by the LDL receptor but not by 
most of the scavenger receptors, and the latter being recognised by the 
scavenger receptors but not by the native LDL receptor (LDLR) (Levitan et al., 
2010). To complicate matters further, the preparation of LDL forms varies 
between different laboratories and even with identical protocols the end-
products vary considerably due to initial fatty acid composition and even 
antioxidant status of the original LDL (Levitan et al., 2010). The extent of 
oxidation of LDL is frequently reported as nmol of thiobarbituric acid-reactive 
substances (TBARS), determined by measurement of malondialdehyde 
(MDA). However, only certain lipid peroxidation products generate MDA and 
MDA can be generated through other mechanisms (Janero, 1990). Therefore 
results need to be interpreted with caution particularly when comparing 
TBARS levels from different laboratories.  
It should be noted that despite the general acceptance of the important 
role of OxLDL on atherogenesis, it is not entirely clear where and to what 
extent LDL is oxidised in vivo. In addition, at least seven major compound 
groups in OxLDL exert biological effects on target cells and tissues, namely: 
phospholipid products, sphingolipid products, free fatty acid products, 
oxysterols, cholesteryl ester products, short-chain aldehydes (hydroxynonenal 
and MDA), and apo B modifications (Levitan et al., 2010). As OxLDL 
preparations contain many active compounds it is often unclear which of the 
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compounds mediate certain effects, and the effects observed can vary 
between groups (Levitan et al., 2010).  
Macrophages express various scavenger receptors, which allow for the 
recognition of ligands, their uptake and subsequent degradation. Following a 
recent expert consensus the nomenclature of human scavenger receptors has 
been updated and now includes 10 classes (A-J) of scavenger receptors 
(Prabhudas et al., 2014). The most widely studied scavenger receptors in 
atherosclerosis are SR-A1, SR-B2 (formally known as CD36), and SR-E1 
(LOX-1) (Zani et al., 2015). These three Scavenger receptors are all involved 
in the recognition and uptake of OxLDL. Binding of ligands such as modified 
lipids to SR-A1 can lead to either clathrin-dependent or clathrin-independent 
uptake and activation of p38 MAPK, JNK2 and ERK signalling, facilitating 
foam cell formation and apoptosis of macrophages (Ricci et al., 2004; X. D. 
Zhu et al., 2011). ApoE-/- mice deficient in SR-A1 have decreased 
atherosclerotic lesions (Suzuki et al., 1997).  
Lack of SR-B2 (CD36) in human macrophages leads to reduced 
inflammatory signalling and nuclear factor kappa B (NFκB) activation upon 
OxLDL stimulation (Janabi et al., 2000). Binding to SR-B2 leads to lipid raft-
mediated uptake of the ligand and also activation of p38, JNK, Fak, and Vav, 
affecting a wide range of responses including foam cell formation, platelet 
activation, apoptosis, angiogenesis, inflammation and cell adhesion and 
migration (Zani et al., 2015). LDLR-/- mice that are also deficient in SR-E1 
(LOX-1) have reduced atherosclerosis and inflammatory NFκB signalling 
(Mehta et al., 2007). The effects of this scavenger receptor are mediated 
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through clathrin-independent uptake of Ox-LDL, which in turn activates 
p42/p44 MAPK, p38 MAPK and NFκB. (Zani et al., 2015).  
OxLDL can also be recognised by TLRs to induce uptake. For 
example, mmLDL induces macropinocytosis through the TLR4 signalling 
complex, leading to TLR4 phosphorylation and ultimately activation of 
ERK1/2, Rac, Cdc42 and Rho (Choi et al., 2009). TLR2, TLR4 and TLR9 all 
have been implicated in the development of atherosclerosis through 
inflammatory signalling after binding of DAMPs such as OxLDL (Roshan, 
Tambo, & Pace, 2016). Interestingly, there is also interdependency of 
scavenger receptor and TLR signalling. For example, binding of OxLDL or 
beta-amyloid to SR-B2 facilitates assembly of TLR 4 and -6 heterodimers and 
subsequent NFκB and IL1β inflammatory signalling (Stewart et al., 2010).  
Whilst the minimally modified LDL species tend to be recognised by 
TLR and LDL-R, the extensively oxidised LDL forms are recognised primarily 
by SR-A1, SR-B2 (CD36), and SR-E1 (LOX-1) (Levitan et al., 2010). There 
are also multiple other mechanisms of OxLDL uptake that can induce 
inflammatory signalling, but a review of them is beyond the scope of this 
report (Levitan et al., 2010).  
The interaction between oxidised lipids and mitochondrial function and 




1.1.4 The Importance of vascular smooth muscle cell viability to 
determine plaque stability 
VSMCs play an important role in all phases of atherosclerosis. Early 
hypotheses of atherogenesis suggested that in response to injury VSMCs 
migrate from the arterial media to the intima [reviewed in Ross (1999)]. Intimal 
thickening could then lead to progressive blood flow obstruction through 
proliferation and production of extracellular matrix. This theory is supported by 
observations in animal models and humans where injury through inflation of 
balloons or by wire leads to restenosis through neo-intimal VSMC 
accumulation (W. McBride, Lange, & Hillis, 1988; Steele et al., 1985). VSMCs 
also play a key role in inflammation and foam cell formation in atherosclerosis. 
For example, during early atherosclerosis VSMCs can express adhesion 
molecules and chemokines, which facilitate recruitment of inflammatory cells 
derived from the immune system to the atherosclerotic plaque (Mach et al., 
1999). Furthermore, through their scavenger receptors VSMCs take up 
modified lipoproteins (see section 1.1.3). However, a number of studies have 
questioned the dogma that VSMCs are detrimental for disease progression, 
and instead suggest that the stability of the atherosclerotic plaque, which in 
turn is predominantly determined by the extracellular matrix produced by 
VSMCs in the fibrous cap, determines disease morbidity and mortality. This 
theory is supported by observations that statins, which only exert limited 
effects on atherosclerotic plaque size, have substantial effects on clinical 
outcome (M. A.-A. S. Group, 1994; S. S. S. S. Group, 1994; Weissberg, 
Clesham, & Bennett, 1996). Bennett’s group has also shown that survival of 
VSMCs is crucial for fibrous cap stability (Clarke et al., 2006). In this study, 
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selective induction of VSMC apoptosis in ApoE-/- mice via the diphtheria toxin 
receptor, caused thinning of the fibrous cap, loss of extracellular matrix, 
accumulation of cell debris and significant intimal inflammation (Clarke et al., 
2006).  
We have recently shown that premature senescence of VSMCs 
promotes atherosclerosis (J. Wang et al., 2015). Overexpression of telomeric 
repeat binding factor 2 (TRF2), an important shelterin protein protecting 
telomere structure, decreases VSMCs senescence, reduces DNA damage, 
facilitates DNA repair, and is protective in ApoE-/- fat-fed mice. In contrast, a 
point mutation in TRF2, causing a substitution of threonine residue 188 to 
alanine (T188A) in the protein, results in constitutively inactive TRF2, 
promotes atherosclerosis and leads to multiple features typical of vulnerable 
lesions.  
These observations support the theory that exacerbated cell death and 
senescence of VSMCs determines clinical disease. The mechanisms leading 
to VSMC senescence and apoptosis are numerous and beyond the scope of 
this introduction. However, one of the mechanisms that may be particular 
relevant is ROS-mediated accumulation of DNA damage in the progression of 
atherosclerosis as discussed in section 1.1.5.  
The precursor lesion for plaque rupture is the ‘thin-cap fibroatheroma’ 
where a fibrous cap of less than 65 µm comprising VSMCs and matrix 
separates a relatively large necrotic core from the arterial lumen (Burke et al., 
1997; Calvert et al., 2011). Such thin-cap fibroatheromata might not only be 
caused by excessive VSMC apoptosis but also by limited proliferation or 
senescence. Identifying targets to improve VSMC survival and function and 
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thereby improving atherosclerotic plaque stability may offer future therapeutic 
strategies. It is therefore important to better understand the biology of 
atherosclerotic plaques, particularly the cap region, to help identify pathways 
that determine VSMC health. 
 
1.1.5 DNA damage in atherosclerosis 
DNA damage is present in atherosclerotic plaques as well as in 
circulating cells from patients with coronary artery disease. For example, 
genetic instability correlates with coronary artery disease severity and there is 
also evidence of chromosome abnormalities including loss of the Y-
chromosome, XXY karyotype and trisomy 7, 10 and 18 in atherosclerotic 
plaques (Botto et al., 2001; Casalone et al., 1991; J. Mercer, Mahmoudi, & 
Bennett, 2007). VSMCs derived from atherosclerotic plaques have increased 
levels of double-stranded DNA breaks compared to VSMCs from healthy 
arteries, and increased accumulation of γH2AX and ataxia telangiectasia–
mutated (ATM) proteins, markers of DNA damage and repair, respectively 
(Mahmoudi et al., 2008), while statins increase DNA repair in VSMCs 
mediated through Nijmegen breakage syndrome (NBS)-1 and the human 
double minute protein (Hdm2) (Mahmoudi et al., 2008). In addition, ApoE-/- 
mice heterozygous for ATM (ApoE-/- ATM+/-) have accelerated 
atherosclerosis as well as metabolic changes and mitochondrial dysfunction 
(J. R. Mercer et al., 2010), and VSMCs derived from human atherosclerotic 
plaques not only have increased ATM and γH2AX, but also decreased 
telomeric repeat-binding factor-2 (TRF2) expression (J. Wang et al., 2015). 
Upon irradiation, TRF2 is rapidly phosphorylated in an ATM-dependent 
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manner and localises to sites of DNA damage (H. Tanaka et al., 2005). 
Overexpression of TRF2 in mouse VSMCs in turn reduces DNA damage and 
decreases senescence with beneficial effects on measures of atherosclerotic 
plaque stability such as the cap/core ratio (J. Wang et al., 2015). There are 
also reports of loss of heterozygosity and microsatellite instability in 
atherosclerotic plaques, prompting comparisons with neoplastic diseases 
(Hatzistamou, Kiaris, Ergazaki, & Spandidos, 1996). Indeed, clonal expansion 
of a low proportion of VSMC determines accumulation after vascular injury 
and in murine atherosclerosis (Chappell et al., 2016). However, although 
somatic mutations are present in VSMC forming plaques (Casalone et al., 
1991), it is currently unclear whether this is the cause of proliferation 
(Chappell et al., 2016) and atherosclerotic lesions do not become cancerous.  
Thus there is compelling evidence that DNA damage occurs in 
atherosclerosis and that this can perpetuate disease progression at least in 
mouse models of atherosclerosis. As DNA mutations occur more frequently in 
mtDNA compared to nuclear DNA (see also 1.2.1) various groups have 
investigated the role of mtDNA mutations in atherosclerosis. This is further 
discussed in section 1.3.2.  
 
1.1.6 Animal models of atherosclerosis 
The study of atherosclerosis has been greatly facilitated by the use of 
animal models. In humans the disease process takes many decades and one 
of the challenges has therefore been to accelerate the progression of 
atherogenesis in any animal model. As hypercholesterolaemia and 
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hyperlipidaemia are considered main risk factors for atherosclerosis, 
strategies frequently revolve around increasing plasma lipid levels in animals.  
The most commonly used animal models for atherosclerosis are in 
decreasing order: genetically manipulated mice with or without additional fat-
feeding, hypercholesterolaemic rabbits, pigs and non-human primates (Getz & 
Reardon, 2012). The advantages of larger animals, particularly pigs and 
primates, are that the lipoprotein profile has more similarities with humans, 
there is greater tissue availability and non-invasive measurements can be 
taken. Furthermore, larger animals are also more appropriate to study 
atherosclerosis affecting the coronary arteries. However, such animal models 
are expensive and are generally less suitable for genetic modification limiting 
their use in the study of atherosclerosis (Getz & Reardon, 2012). 
Currently, mice remain the most widely studied animals in 
atherogenesis, particularly apolipoprotein E-/- (ApoE-/-) and LDL receptor-/- 
(LDLR-/-) mice. 
 
1.1.6.1 ApoE-/- mouse model 
Apolipoprotein E (ApoE), produced primarily by the liver, is a major 
constituent of lipoproteins, and plays an important role in their clearance. Two 
groups simultaneously developed ApoE-/- mice demonstrating 
hypercholesterolaemia and atherosclerosis (Plump et al., 1992; S. H. Zhang, 
Reddick, Piedrahita, & Maeda, 1992). These mice are characterised by 
increased hypercholesterolaemia (494 mg/dl) compared to control animals (60 
mg/dl), which can be further increased through a high-fat diet (1821 mg/dl) 
(Plump et al., 1992). Although human atherosclerosis is largely mediated 
 17 
through LDL, the hypercholesterolaemia in these mice is largely due to 
intermediate density lipoproteins (IDL) and very low-density lipoproteins 
(VLDL). ApoE-/- mice develop atherosclerosis throughout the arterial tree but 
there is a predilection for the aortic root and the lesser curvature of the aortic 
arch as well as certain areas of the more distal aorta primarily at arterial 
branch points (Nakashima, Plump, Raines, Breslow, & Ross, 1994). There 
are, however, limitations to this model. ApoE also influences macrophage 
biology, immune function and adipose tissue biology therefore affecting 
atherosclerosis through mechanisms other than hypercholesterolaemia (Getz 
& Reardon, 2012). 
 
1.1.6.2 LDLR-/- mice 
Knockout of the LDL receptor (LDLR) leads to significantly increased 
plasma cholesterol levels in mice (Ishibashi et al., 1993). LDLR-/- mice need 
to be aged considerably (>1 year) to develop atherosclerosis if fed a normal 
chow or alternatively need to be kept on a high-fat diet (Getz & Reardon, 
2012). As LDLR knock-out has fewer off-target effects, this model may be 
more appropriate in certain situations, particularly when bone marrow 
transplantation models are used.  
Thus, different animal models of atherosclerosis have their limitations. 
Caution in the interpretation of results is needed, particularly when trying to 




Mitochondria are thought to have evolved through symbiosis between 
prokaryotes and primitive eukaryotic cells (Sagan, 1967). Mitochondria have 
long been regarded as the “powerhouses” of cells, providing energy in the 
form of ATP for cellular function. However, a more nuanced view of 
mitochondrial function has developed, suggesting that mitochondria are 
important for a variety of cellular processes, including regulation of cellular 
metabolism, cell cycle regulation, cellular signalling, regulation of cell survival, 
and cell death (H. M. McBride, Neuspiel, & Wasiak, 2006; Murphy, 2009).  
 
1.2.1 Mitochondrial DNA and its maintenance 
The human mitochondrial genome is a circular double strand DNA 
molecule of 16,569 base pairs encoding for some but not all of the proteins of 
the electron transfer chain (ETC) and ATP synthase as well as rRNAs and 
tRNAs required for mitochondrial translation. The proteins for both replication 
and transcription of mtDNA are encoded in nuclear DNA and imported into the 
mitochondrial matrix via specialised transport mechanisms. Importantly, 
mtDNA is not packaged by histones, instead mammalian cells can contain 
thousands of mtDNA molecules distributed over several hundred nucleoids 
(Falkenberg, Larsson, & Gustafsson, 2007). 
mtDNA is prone to mutations causing maternally-inherited 
mitochondrial myopathies (Holt, Harding, & Morgan-Hughes, 1988; Wallace et 
al., 1988). However, even healthy tissue from human adults contains mtDNA 
mutations (Cortopassi & Arnheim, 1990). The susceptibility of mtDNA to 
mutations has been explained by its close proximity to the inner mitochondrial 
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membrane and therefore potentially high exposure to ROS, due to lack of 
protective histones, and the lack of some DNA damage repair mechanisms 
(Graziewicz, Longley, & Copeland, 2006). For example, oxidative modification 
is not limited to nuclear DNA but also affects mtDNA forming 8-
hydroxydeoxyguanosine (8-OH-dG) (Hayakawa, Torii, Sugiyama, Tanaka, & 
Ozawa, 1991). Such modifications are associated with ageing and induction 
of ROS-mediated oxidative DNA damage with doxorubicin exacerbates the 
age-related decline in electron transfer chain activity (Yamada, Sugiyama, 
Kosaka, Hayakawa, & Ozawa, 1995). Furthermore, not only oxidative damage 
can be detected in ageing tissue, but also deletions, as exemplified in studies 
on human heart and brain tissues (Cortopassi & Arnheim, 1990). It is well 
established that there is heteroplasmy, i.e. the coexistence of mutated and 
normal mtDNA, within tissues and it is thought that certain thresholds of 
pathogenic mtDNA are required to cause dysfunction of the electron transfer 
chain (Corral-Debrinski, Horton, et al., 1992; Hayashi et al., 1991; Larsson, 
2010).   
Several pathways have evolved that preserve the integrity of mtDNA 
and therefore mitochondrial function: 1) relatively faithful DNA replication, 
transcription and translation; 2) mtDNA damage repair mechanisms; 3) redox 
homeostasis limiting the damaging effects of ROS (see also section 1.2.2); 4) 
mitochondrial fission and fusion and mitochondrial autophagy or mitophagy of 
damaged mitochondria (see also section 1.2.3.1) (Scheibye-Knudsen, Fang, 
Croteau, Wilson, & Bohr, 2015).  
Faithful replication of mtDNA requires the assembly of the minimal 
replisome consisting of the mtDNA polymerase γ (PolG) with both its subunits, 
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PolGA and PolGB (Carrodeguas, Theis, Bogenhagen, & Kisker, 2001), as 
well as the Twinkle helicase (Twinkle) and mitochondrial single-stranded 
binding protein (mtSSB) (Korhonen, Pham, Pellegrini, & Falkenberg, 2004). 
Mutations in the proof-reading domain of PolG (D257A) in PolG-/- or “mutator 
mice” lead to accumulation of mtDNA mutations, and increased hydrogen 
peroxide (H2O2) production at later time points (Logan et al., 2014). PolG-/- 
mice have shorter life spans and are more prone to atherosclerosis (Trifunovic 
et al., 2004; E. Yu et al., 2013). 
Twinkle is essential for mouse embryonic development but conditional 
knockout of Twinkle has been achieved causing severe mtDNA loss in heart 
and skeletal muscle (Milenkovic et al., 2013). In contrast, transgenic 
overexpression of Twinkle in mice (Tw+) leads to increased mtDNA copy 
number in various tissues that does not affect mouse development, at least 
until 16 months of age (Tyynismaa et al., 2004). Twinkle overexpression can 
ameliorate pathological remodelling after myocardial infarction (MI) in mice (A. 
Tanaka et al., 2013) and protects superoxide dismutase-deficient mouse 
cardiomyocytes from increased levels of ROS (Pohjoismaki et al., 2013). 
Increased mtDNA copy number is also protective against volume overload-
induced heart failure independently of the function of the electron transfer 
chain (ETC) (Ikeda et al., 2015). The authors of this study demonstrate that 
Twinkle overexpression reduces mitochondrial-derived ROS production and 
activation of matrix metalloproteinases 2 and 9 (MMP2, MMP9), all of which 
are known to facilitate heart failure. However, the mechanisms by which 
Twinkle overexpression protects from damaging ROS production are not 
completely understood.  
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Although initial evidence suggested that mitochondria lack mtDNA 
repair capacity (Clayton, Doda, & Friedberg, 1974) it is now commonly 
accepted that mitochondria have a functioning base-excision repair 
mechanism, but are deficient in nucleotide excision-repair and mismatch 
repair (Bogenhagen, 1999). Other repair mechanisms such as homologous 
recombination and non-homologous end joining have so far not been 
described in mitochondria (Larsson, 2010). The paucity of mtDNA repair 
mechanisms combined with the frequency of mtDNA mutations underscores 
the importance of other mechanisms to maintain mtDNA integrity. These 
mechanisms include tight regulation of ROS through buffering as discussed in 
1.2.2 and mitochondrial homeostasis as discussed in 1.2.3. 
 
1.2.2 The electron transport chain, reactive oxygen species and redox 
signalling 
Reactive oxygen species have long been considered as a damaging 
side product of oxidative phosphorylation, however a more nuanced view of 
the biological significance of ROS has evolved (Collins et al., 2012). 
Mitochondria are an important source of cellular ROS, although other cellular 
oxidoreductases are also able to produce ROS (Murphy, 2009). Superoxide 
(O2•−) is the proximal ROS generated within mitochondria through a one-
electron reduction of O2 (Murphy, 2009). In mammalian cells mitochondrial 
complexes I and III are thought to be the main sources of O2•− but there are 
also others (Chouchani, Methner, et al., 2014; Murphy, 2009). Figure 1-2 





Figure 1-2 The electron transport chain and sources of mitochondrial ROS 
Reproduced from Pelletier, Lepow, Billingham, Murphy, and Siegel (2012): In the electron transport 
chain, complex I (NADH dehydrogenase) and complex III (coenzyme Q: cytochrome c – 
oxidoreductase) are the main sources of superoxide. Glycerol-3-phosphate dehydrogenase (GPDH) and 
the electron transferring flavoprotein ubiquinone oxidoreductase (ETF-QOR) can also produce 
superoxide. G3P - Glycerol-3-phosphate; DHAP - dihydroxyacetone phosphate; cyt C - cytochrome C; 
I-IV - electron transfer complexes I-IV; V - ATPase; Q - coenzyme Q/ubiquinone. 
 
 
O2•− is rapidly converted to hydrogen peroxide (H2O2) by manganese 
superoxide dismutase (MnSOD), which is highly expressed in the 
mitochondrial matrix (Balaban, Nemoto, & Finkel, 2005). H2O2 can readily 
pass through mitochondrial membranes and although it is not the most 
reactive ROS, it is considered to be the main ROS involved in redox signalling 
by mitochondria. O2•− can also form the highly reactive peroxynitrite 
(ONOO−) through reaction with nitric oxide (NO•) (Collins et al., 2012).  
Within the mitochondrial matrix there is a high concentration of 
peroxiredoxins (Prxs) which effectively scavenge H2O2, and it has been 
calculated that around 90% of H2O2 generated in the mitochondrial matrix 
Figure 1. Mitochondrial sources of reactive oxygen species
In the respiratory chain, complex I (NADH dehydrogenase) and co plex III (coenzyme Q:
cytochrome c – oxidoreductase) can both produce ROS. ROS produced by complex I are
released in the mitochondrial matrix while those of complex III are generated in both the
matrix and the intermembrane space. The mitochondrial inner membrane enzyme
glycerol-3-phosphate dehydrogenase (GPDH) is also capable of superoxide production
during the conversion of glycerol-3-phosphate (G3P) to form dihydroxyacetone phosphate
(DHAP). During β-oxidation of fatty acids, the electron transferring flavoprotein ubiquinone
oxidoreductase (ETF-QOR) catalyzes the oxidation of electron transferring protein (ETF).
During this process, ROS can be released in the matrix.
Pelletier et al. Page 18























targets Prx3, the most prominent mitochondrial isoform (Cox, Winterbourn, & 
Hampton, 2010). Other regulators of H2O2 include glutathione peroxidase 1 
(Gpx1), which uses mitochondrial glutathione (GSH) as a means of recycling 
the enzyme (Collins et al., 2012).  
Redox processes can cause reversible alterations of critical cysteine 
residues on signalling proteins, including sulphenylation, S-nitrosation/S-
nitrosylation, glutathionylation and formation of disulphide bonds (Chouchani, 
James, Fearnley, Lilley, & Murphy, 2011; Collins et al., 2012; Hurd, James, 
Lilley, & Murphy, 2009; Murphy, 2012), altering their activity within 
mitochondria and cells. For example, redox modification of complex I of the 
electron transport chain through reversible nitrosation can reduce its activity in 
vivo (Chouchani et al., 2013). Redox signalling by mitochondria has been 
implicated in a variety of biological processes including oxygen sensing, 
differentiation, immunity, mitochondrial function, hormone signalling and 
regulation of life span [reviewed in Collins et al. (2012)]. 
 
1.2.3 Mitochondrial homeostasis 
Mitochondria (and mtDNA) are prone to oxidative damage and 
therefore need mechanisms to maintain homeostasis to avoid dysfunction. 
mtDNA repair mechanisms have already been discussed in section 1.2.1. 
Here I will focus on mitochondrial dynamics and particularly autophagy of 
mitochondria (mitophagy) (section 1.2.3.1) and mitochondrial biogenesis 
(section 1.2.3.2).  
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1.2.3.1 Mitochondrial dynamics and mitophagy  
Through fission and autophagy dysfunctional mitochondria can be 
degraded to preserve a pool of functioning mitochondria. Fusion of 
mitochondria is thought to facilitate communication between mitochondria and 
thereby access to proteins only encoded in the mitochondrion, and to buffer 
transient mitochondrial defects. In contrast, fission leads to fragmentation of 
mitochondria, which can segregate dysfunctional mitochondria, which then 
undergo mitochondrial autophagy or mitophagy (Friedman & Nunnari, 2014).  
If mitochondrial fusion is disrupted this leads to mitochondrial 
segregation and dysfunction probably due to loss of functional mtDNA (H. 
Chen, Chomyn, & Chan, 2005). Thus mitochondrial dynamics need to be 
highly regulated to avoid dysfunctional mitochondria. Mitochondrial fission and 
fusion are controlled by the dynamin-related proteins (DRPs). Whilst fission is 
mediated by DRP1 and FIS1 in mammals (Smirnova, Shurland, Ryazantsev, 
& van der Bliek, 1998; Twig et al., 2008), fusion requires the coordinated 
action of the DRPs MFN1/MFN2 and OPA1 (H. Chen et al., 2005). 
Mitochondrial membrane potential controls the cleavage of OPA1 mediated by 
the zinc metalloprotease OMA1 (Head, Griparic, Amiri, Gandre-Babbe, & van 
der Bliek, 2009). The presence of the long and short forms of OPA1 in turn 
are important to determine mitochondrial shape as illustrated in Figure 1-3, 




Figure 1-3 Mitochondrial stress responses [reproduced from Friedman and 
Nunnari (2014)] 
Stress or damage to mitochondria can lead to a loss of mitochondrial membrane potential (blue) 
activating the unfolded protein stress response pathway (UPRmt) through accumulation of the 
activating transcription factor associated with stress (ATFS1). This in turn activates mitochondrial 
repair pathways and facilitates metabolic adaptation. Loss of mitochondrial membrane potential can 
also cause OPA1 –short accumulation leading to attenuated mitochondrial fusion, ER-mediated 
mitochondrial division (ERMD), fragmentation and mitophagy or cell death. Mitochondrial damage 
leading to OPA1-short and OPA1-long dependent hyperfusion is thought to transiently buffer 
mitochondrial dysfunction (Friedman & Nunnari, 2014).  
 
Autophagy has been divided into non-selective autophagy, for example 
during energy deprivation to preserve nutrient and building blocks, and cargo-
specific autophagy. The latter allows for removal of redundant or damaged 
organelles and depending on the organelle involved has been termed 
pexophagy (peroxisomes), ribophagy (ribosomes) or, when mitochondria are 
the target, mitophagy (Youle & Narendra, 2011). Much of our knowledge 
about mitophagy is derived from investigations in yeast. One of the key 
proteins mediating mitophagy in yeast is Atg32, located on the outer 
mitochondrial membrane and interacting with Atg8 and Atg11 (Okamoto, 
Kondo-Okamoto, & Ohsumi, 2009). Atg32 can directly bind to Atg8 or 
indirectly through binding to Atg11 leading to recruitment into the 
 26 
autophagosome which then fuses with lysosomes to form the 
autophagolysosome (Youle & Narendra, 2011).   
In mammalian cells, fission and fusion are key steps prior to 
mitophagy. Using a photolabeling strategy of individual mitochondria, Twig et 
al. (2008) demonstrated frequent cycles of fission and fusion in mammalian 
cells. However, fission produced daughter mitochondria, with differing 
membrane potential. One of the daughter mitochondria became 
hyperpolarised, whilst the other became depolarised after the fission event. 
Interestingly, daughter mitochondria with a normal membrane potential had a 
higher probability of subsequent fusion then those with a depolarised 
membrane potential, which also have reduced expression of OPA1. Inhibition 
of fission (DRP1 and FIS1) also decreases mitophagy and results in the 
accumulation of damaged mitochondrial proteins. In reverse, overexpression 
of OPA1 reduces mitophagy, suggesting that mitochondrial fission is required 
for mitophagy (Twig et al., 2008). 
Following fission dysfunctional mitochondria need to be targeted for 
degradation. The mammalian orthologue of Atg8 is LC3, of which two forms 
exist, LC3-I, the cytosolic form, and LC3-II, the membrane-bound form. LC3 
mediates transfer of cargo to the autophagosome after starvation (Kabeya et 
al., 2000), but although the LC3 pathway is involved in the degradation of 
mitochondria, this form of autophagy is not specific to this organelle (Youle & 
Narendra, 2011).  
The most extensively studied pathway for mitophagy is mediated by 
PTEN-induced putative kinase protein 1 (PINK1) and the E3 ubiquitin ligase 
parkin. Interestingly, mutations in either of the corresponding genes lead to 
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early-onset Parkinson’s disease (Kitada et al., 1998; Valente et al., 2004). 
Removal of the Drosophila melanogaster PINK1 homologue (CG4523) leads 
to male sterility, apoptosis in the muscle, dopaminergic neuronal 
degeneration, locomotive defects and abnormal mitochondrial morphology as 
well as increased sensitivity to oxidative stress (Clark et al., 2006; Park et al., 
2006). Similar phenotypes are observed after parkin loss, but the phenotype 
of double mutants is identical to single gene mutants, suggesting that PINK1 
and parkin act in the same pathway. Transgenic parkin overexpression 
rescues parts of the effect of PINK1 loss indicating that parkin acts 
downstream of PINK1.  
In functional mitochondria, PINK1 is degraded by the mitochondrial 
protease preselin-associated rhomboid-like protein (PARL). When the 
mitochondrial inner membrane becomes depolarised, this degradation is 
inhibited and PINK1 accumulates on the mitochondrial outer membrane 
(MOM) where it can recruit parkin (Jin et al., 2010). Subsequently further 
proteases have been identified that mediate PINK1 degradation in polarised 
mitochondria such as mitochondrial processing peptidase (MPP), m-AAA and 
ClpXP (Greene et al., 2012). A cleavage product of PINK1, if not degraded by 
the cytosolic proteasome, binds to parkin thereby inhibiting its translocation to 
mitochondria (Fedorowicz et al., 2014). Depolarisation of the mitochondrial 
inner membrane (MIM) leads to PINK1 autophosphorylation at Ser228 and 
Ser402 and mutations of these sites inhibits parkin recruitment (Okatsu et al., 
2012). Activated PINK1 also phosphorylates parkin at Ser65 (Kondapalli et 
al., 2012) and ubiquitin at Ser65 (Koyano et al., 2014) thereby activating 
parkin activity. Activated parkin ubiquitinates several MOM proteins leading to 
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the recruitment of autophagy receptors such as Nucleoporin 
62/sequestosome 1 (p62/SQSTM1), the neighbour of BRCA 1 (NBR1), and 
optineurin (Ploumi, Daskalaki, & Tavernarakis, 2017) 
Activation of the PINK1/parkin pathway also activates mitochondrial 
fission involving mitofusins (Poole et al., 2008; Ziviani, Tao, & Whitworth, 
2010), indicating reciprocal interaction between mitochondrial morphology and 
mitophagy. 
 
1.2.3.2 Mitochondrial biogenesis 
Mitochondrial biogenesis is closely linked to mitochondrial clearance 
allowing maintenance of mitochondrial homeostasis. Since approximately 
90% of mitochondrial proteins are nuclear-encoded, coordinated transcription 
and translation of both nuclear and mitochondrial genes are important for 
mitochondrial function (Picca & Lezza, 2015; Ploumi et al., 2017). For that 
purpose mitochondria employ protein import systems formed by the 
translocase of the outer mitochondrial membrane protein complex (TOM), 
sorting and assembly machinery (SAM) complex, and translocase of the inner 
mitochondrial membrane protein complex (TIM) (Ploumi et al., 2017). 
Imbalance in electron transport complex composition in turn leads to 
activation of mitochondrial degradation processes such as mitophagy, 
described in section 1.2.3.1. 
One of the key signalling pathways in energy metabolism is cAMP 
response element-binding protein (CREB) activation leading to peroxisome 
proliferator-activated receptor-γ coactivator-1α (PGC-1α) -mediated signalling 
(Herzig et al., 2001). It is thus not surprising that PGC-1α affects transcription 
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of both nuclear and mitochondrial DNA to allow co-ordinated mitochondrial 
biogenesis. Some of the main factors involved in mitochondrial biogenesis 
and regulators of mitochondrial integrity are discussed below. 
 
1.2.3.2.1 PGC-1α 
Energy demand in cells and tissues can vary substantially and 
mitochondria need to be able to adapt to changing ATP requirements. A 
master regulator of metabolic programmes is the family of peroxisome 
proliferator-activated receptor γ coactivator 1 (PGC-1) and these proteins are 
highly expressed in tissues that are metabolically active such as brown 
adipose tissue (BAT), heart, skeletal muscle, kidney, and brain (Handschin & 
Spiegelman, 2006). Ectopic expression of PGC-1α in C2C12 myotubes 
increases oxygen consumption through upregulation of the expression of 
genes involved in oxidative phosphorylation, and mtDNA content was 
increased approximately two-fold (Wu et al., 1999). Mechanistically, PGC-1α 
expression upregulates nuclear respiratory factor 1 (NRF-1) and mitochondrial 
transcription factor A (TFAM), two important transcription factors for 
mitochondrial function (Wu et al., 1999). PGC-1α also signals through NRF-2 
and oestrogen-related receptor α (ERRα). Other members of the PGC-1 
family sharing a similar modular structure include PGC-1β and PGC-1-related 
coactivator (PRC), however currently PGC-1α remains the most thoroughly 
studied member (Handschin & Spiegelman, 2006).  PGC-1α transcription 
itself is regulated by a wide array of stimuli including AMPK, activity levels, 
calorie restriction, NO, diabetes, and hypoxia (Handschin & Spiegelman, 
2006; L. Zhu et al., 2010). 
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1.2.3.2.2 Sirtuin-1  
Sirtuins are highly conserved NAD(+)-dependent deacetylases that 
regulate lifespan in lower organisms and have been connected to cellular 
stress resistance, genomic stability, tumourigenesis and energy metabolism in 
mammalian cells (Finkel, Deng, & Mostoslavsky, 2009). Sirtuin-1, the best 
studied of the sirtuin family members, acts as an intracellular energy sensor 
and is activated by an increased AMP/ATP ratio through AMPK and 
NAD+/NADH signalling (Canto et al., 2009). The most frequently studied 
targets of sirtuins are histones (Triolo & Sternglanz, 1996), p53 (Vaziri et al., 
2001), forkhead proteins (Brunet et al., 2004), E2F (C. Wang et al., 2006) and 
PGC-1 (Nemoto, Fergusson, & Finkel, 2005) (Figure 1-4). Importantly, PGC-
1α is a major deacetylation target of sirtuin-1, regulating the mitochondrial 
response to nutrient deprivation, and sirtuin-1 may also affect mitochondrial 
function through modulation of autophagy (I. H. Lee et al., 2008).  
Work from our laboratory has shown that sirtuin-1 expression is 
reduced in human atherosclerotic plaques compared to healthy aortas or 
internal mammary arteries (Gorenne et al., 2013). Furthermore, inhibition of 
sirtuin-1 in VSMCs reduced DNA repair and induced apoptosis through 
reduced activation of the Nijmegen Breakage Syndrome-1 repair protein, and 
VSMC-specific deletion of sirtuin-1 increased atherosclerosis in ApoE-/- mice 
(Gorenne et al., 2013). However, the effects of sirtuin-1 on human 
atherosclerosis are less clear. Resveratrol, a small molecule activator or 
sirtuin-1, can prolong life-span in yeast (Howitz et al., 2003), but clinical 
studies have so far failed to show convincing beneficial effects on 





Figure 1-4 Schematic of sirtuin-1 regulation and signalling 
The nicotinamide adenine dinucleotide (NAD+/NADH) dependent histone deacetylase sirtuin-1 has 
many targets other than histones. Adenosine triphosphate (ATP), adenosine monophosphate (AMP), 
Forkhead box O3 (FOXO3), tumour protein p53 (p53), acetylation (ac). 
 
1.2.3.2.3 Mitochondrial transcription factor A 
PGC-1α activation leads to the expression of mitochondrial proteins 
including TFAM and the mitochondrial transcription factors B1 and B2 
(TFB1M and TFB2M) (Picca & Lezza, 2015). TFAM has not only been 
implicated in mtDNA transcription but is also an important regulator of mtDNA 
copy number (M. I. Ekstrand et al., 2004). Nils-Göran Larsson’s group has 
overexpressed human TFAM in mice and demonstrated a direct 
proportionality between TFAM levels and mtDNA copy number without 
affecting respiratory enzyme activity or mitochondrial volume density (M. I. 
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Ekstrand et al., 2004). Overexpression of TFAM decreases mitochondrial-
derived ROS and leads to upregulation of matrix metalloproteinases -2 and -9, 
thereby attenuating volume overload-induced concentric cardiac hypertrophy 
(Ikeda et al., 2015). Furthermore, TFAM has also been implicated in 
mitochondrial base-excision repair (Canugovi et al., 2010) highlighting the 
importance of this protein in mtDNA regulation. 
 
1.2.3.2.4 Twinkle helicase 
Twinkle helicase (Twinkle) and DNA polymerase γ (PolG) as well as 
mtSSB form the minimal replisome required for replication of mammalian 
mtDNA. Twinkle is essential for mouse embryonic development and is thought 
to be the only mammalian mtDNA helicase as conditional knockout leads to 
significant mtDNA depletion in the heart and skeletal muscle of mice 
(Milenkovic et al., 2013).  
Transgenic mice overexpressing Twinkle have increased mtDNA copy 
number (Tyynismaa et al., 2004) and Twinkle overexpression protects 
Sod2+/- mice against superoxide-induced cardiomyopathy (Pohjoismaki et al., 
2013). Interestingly the mtDNA mutation load is significantly reduced in 
transgenic Twinkle/Sod2+/- mice compared to Sod2+/- mice suggesting that 
increased Twinkle availability improves mtDNA integrity (Pohjoismaki et al., 
2013). The exact mechanism of reduced mtDNA mutation load however is not 
understood. Nevertheless, since mtDNA integrity is perturbed in many 
diseases, manipulation of mtDNA homeostasis could provide interesting 
therapeutic targets for such diseases.  
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1.2.3.2.5 DNA polymerase γ 
As described above, PolG forms part of the minimal replisome required 
for mammalian mtDNA replication. The 3’-5’ exonuclease activity of PolG, 
necessary for proof-reading newly synthesised mtDNA, has been ablated by a 
mutation (D257A) (Trifunovic et al., 2004). “Mutator mice” or “PolG-/- mice” 
were generated that have increased mitochondrial point mutations and 
deletions and are characterised by reduced lifespan and evidence of 
premature aging such as osteoporosis, increased kyphosis, weight loss, 
anaemia, reduced subcutaneous fat and cardiomegaly. Interestingly, during 
aging these mice have increased levels of mitochondrial H2O2 as measured 
by the MitoP/MitoB ratio (Logan et al., 2014).  
 
1.3 Evidence for mitochondrial involvement in atherosclerosis 
Despite the increasing interest in the role of mitochondria in 
atherosclerosis, much of the data available to date is correlative and a 
causative role of mitochondrial dysfunction in atherogenesis remains elusive. 
Because ROS cause modifications of LDL forming OxLDL, it is frequently 
assumed that dysfunctional mitochondria influence this disease process. The 
paucity of data may in part be explained by a lack of tools to manipulate 
mitochondrial biology in vivo and specifically in certain tissues or cell types. In 
the following section I will review the data supporting a link between 
mitochondrial dysfunction and atherosclerosis. 
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1.3.1 Mitochondria and endothelial dysfunction 
Endothelial dysfunction is considered an early event in the 
pathogenesis of atherosclerosis (Ross, 1999) (section 1.1). Many 
atherosclerotic triggers such as fatty acids (Du et al., 2006), hyperglycaemia 
(T. Yu, Robotham, & Yoon, 2006) and tobacco smoke (Vayssier-Taussat et 
al., 2001) cause altered mitochondrial physiology or production of ROS in 
endothelial cells (ECs) [reviewed in (Dromparis & Michelakis, 2013)].  
ROS derived from mitochondria in turn lead to oxidation of LDL at least 
in vitro (Mabile et al., 1997). There is further evidence that electrophilic lipids 
but not non-electrophilic lipids accumulate in mitochondria and that this 
accumulation correlates with increased ROS production (Landar et al., 2006). 
This in turn could fuel a vicious circle of OxLDL formation and mitochondrial 
dysfunction (Dromparis & Michelakis, 2013). 
OxLDL can stimulate adhesion of monocytes to endothelial cells 
(Berliner et al., 1990) through upregulation of adhesion molecules on both 
monocytes and ECs (Levitan et al., 2010; Schwartz et al., 1994). OxLDL 
binding to the lectin-like OxLDL receptor 1 (LOX-1, SR-E1) of endothelial cells 
induces dose-dependent intracellular ROS and subsequent NFκB activation 
(Cominacini et al., 2000). Interestingly, decreasing mitochondrial ROS through 
inhibition of complex II, uncoupling of mitochondria, or by scavenging through 
the MnSOD system, reverses hyperglycaemia-induced activation of protein 
kinase C, formation of advanced glycation end-products and activation of 
NFκB in ECs (Nishikawa et al., 2000). 
Endothelial dysfunction is at least in part determined by the reduced 
bioavailability of NO. Interestingly, administration of MitoQ, an antioxidant 
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targeted to mitochondria through the lipophilic cation triphenylphosphonium 
(TPP), restores the ex vivo endothelium-dependent dilatation in aged mice 
through improving NO bioavailability by decreasing superoxide production 
(Gioscia-Ryan et al., 2014).  
 
1.3.2 Mitochondrial DNA damage and atherosclerosis 
Although they were not directly studying the vasculature, but instead 
heart tissues from individuals with coronary artery disease, Corral-Debrinski, 
Shoffner, Lott, and Wallace (1992) found that mtDNA damage correlates with 
age and atherosclerosis. Interestingly, increased mtDNA damage was present 
in the left ventricle but not the right. Energy expenditure of the left ventricle 
may be more susceptible to nutrient depletion from ischaemic heart disease, 
which as the authors suggest could lead to reactive oxygen species 
production during reperfusion. This theory is plausible and supported by work 
in the Murphy laboratory demonstrating that succinate, accumulates during 
ischaemia, is rapidly consumed upon reperfusion through retrograde electron 
transport (RET) at complex I, generating large quantities of ROS (Chouchani, 
Pell, et al., 2014).  
However, these studies have examined cardiac tissue rather than 
vascular tissue. The first studies investigating the relationship between 
reactive oxygen- and nitrogen species and mtDNA damage and function in 
vascular cells were in Marschall Runge’s laboratory. Cultured human aortic 
VSMCs and human umbilical vein endothelial cells (HUVEC) were treated 
with H2O2 or ONOO- and mtDNA and nuclear DNA damage assessed by 
qPCR. The assay used compares the relative efficiency of replication of a 
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long DNA segment compared to a short DNA segment, based on the principle 
that oxidative damage to DNA will stall the replication fork. Damage in the 
long segment normalised to the short segment, which statistically has a much 
smaller chance of oxidative DNA damage, allows for quantification of either 
mitochondrial or nuclear DNA damage. The authors show that both H2O2 and 
ONOO- induce more damage in mtDNA compared to nuclear DNA, and that 
damage occurs in both endothelial cells and VSMCs (Ballinger et al., 2000). 
Furthermore, mtDNA damage was reflected in reduced mitochondrial RNA 
and mitochondrial protein synthesis, as well as reduced ATP content 
(Ballinger et al., 2000). Subsequently this group demonstrated that mtDNA 
damage precedes atherosclerosis in ApoE-/- mice, that mtDNA damage at 
later time points correlates with the degree of atherosclerosis, and mice 
lacking mitochondrial MnSOD have increased levels of ROS and increased 
atherosclerosis (Ballinger et al., 2002). Our group has demonstrated that 
ApoE-/- mice heterozygous for the protein kinase ataxia telangiectasia 
mutated (ATM) (ApoE-/- ATM+/-) have increased nuclear DNA damage but 
also increased mtDNA damage, as well as reduced oxidative phosphorylation 
and altered metabolism similar to that occurring during the metabolic 
syndrome in humans. This phenotype was also associated with increased 
atherosclerosis (J. R. Mercer et al., 2010). Treatment with MitoQ rescued 
features of the metabolic syndrome and reduced the monocyte content of 
plaques in these mice (J. R. Mercer et al., 2012). Similarly, PolG-/- mice 
crossed with ApoE-/- mice (PolG-/- ApoE-/-) have increased mtDNA damage, 
mitochondrial dysfunction, and accelerated atherosclerosis compared to 
ApoE-/- mice (E. Yu et al., 2013). Similar to the study by Ballinger et al. 
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(2002), this work showed that mtDNA damage occurs before the development 
of atherosclerotic plaques, suggesting that mtDNA damage promotes 
atherosclerosis. To investigate whether the effect of mtDNA damage on 
atherosclerosis is mediated through increased mitochondrial ROS the 
MitoP/MitoB ratio was calculated. Mitochondrial ROS levels were not different 
in PolG-/- ApoE-/- vs. ApoE-/- mice, suggesting that mtDNA damage 
promotes atherosclerosis independently of ROS (E. Yu et al., 2013). 
However, the study was not powered to identify possible subtle differences in 
ROS between these groups (E. Yu et al., 2013). mtDNA damage has also 
been found in human atherosclerotic plaques (E. Yu et al., 2013) suggesting a 
role in human atherogenesis.  
The mechanisms by which mtDNA damage promotes atherosclerosis 
are not completely understood. However, potential mechanisms include 
activation of inflammation through mtDNA released from the cell (section 
1.3.3) and effects on cell survival mediated either directly or indirectly through 
ROS as discussed in section 1.3.4. 
 
1.3.3 The role of mitochondria in inflammation 
Section 1.2.2 has introduced the concept that mitochondria produce 
ROS that contribute to intracellular redox signalling via modification of thiol 
residues. ROS produced by the cellular NADPH oxidases have long been 
known to be important for creating the respiratory burst of phagocytic cells 
(Pelletier et al., 2012). However more recently, ROS derived from 
mitochondria have been implicated in the immune response, particularly in 
innate immunity. For example, ROS mediate the response to 
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lipopolysaccharide (LPS) -driven MAPK activation and cytokine production 
(Bulua et al., 2011). Using N-acetylcysteine (NAC) as a scavenger for ROS 
the authors demonstrated reduced JNK and p38 phosphorylation as well as 
IL-6 production by fibroblasts following stimulation with LPS. Mitochondria-
derived ROS can also cause inflammation in the absence of external 
inflammatory stimuli. For example, Tschopp’s group showed that by inhibiting 
mitophagy cells accumulate dysfunctional mitochondria, which produce higher 
levels of ROS, which in turn promote inflammation through NLRP3 
inflammasome activation (R. Zhou, Yazdi, Menu, & Tschopp, 2011). There is 
further evidence that ROS generated through RET at complex I may be a 
driver of inflammation. Macrophages stimulated with LPS switch metabolism 
from oxidative phosphorylation to glycolysis and accumulate large quantities 
of succinate (Tannahill et al., 2013), which in turn stabilises HIF-1α and 
increases IL-1β production. Succinate may exert its effects in part through 
RET (Chouchani, Pell, et al., 2014). Indeed, more recently it has been shown 
that the effects of LPS are greatly enhanced by succinate and that inhibition of 
RET by various means can reduce IL-1β production (Mills et al., 2016). HIF-
1α may also be stabilised by ROS generated through complex III (Chandel et 
al., 2000). The mechanisms by which HIF-1α is stabilised under aerobic 
conditions are not completely understood. HIF-1α stabilisation may be 
afforded through reversible redox modification of target proteins. For example, 
hydroxylation of HIF-1α by prolyl hydroxylase (PHD) leads to ubiquitination of 
HIF-1α and subsequent proteosomal degradation (Bruick & McKnight, 2001; 
Epstein et al., 2001). PHD is inhibited by 2-hydroxyglutarate derived from the 
tricarboxylic acid (TCA) cycle intermediate 2-oxoglutarate (Burr et al., 2016). 
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HIF-1α is an important mediator of inflammation and immunity suggesting that 
mitochondria could integrate various stimuli to direct cell responses including 
metabolism, immune function and differentiation (Palazon, Goldrath, Nizet, & 
Johnson, 2014). 
Although it is compelling to think of ROS as mediators of inflammation 
in atherosclerosis, targeting ROS in clinical trials has largely been 
unsuccessful. Several studies have been conducted investigating Vitamin C, 
Vitamin E or antioxidant cocktails, but the larger studies have not 
demonstrated any effects on cardiovascular outcomes (Kris-Etherton et al., 
2004). However, none of these strategies directly target mitochondrial ROS. 
Targeting antioxidants such as ascorbate (MitoC) (Finichiu et al., 2015) or 
ubiquinone (MitoQ) (Kelso et al., 2001) directly to mitochondria may be more 
promising. Indeed as already discussed in section 1.3.2 MitoQ can 
significantly affect atherosclerotic plaque composition in mice (J. R. Mercer et 
al., 2012) suggesting that altering mitochondrial redox signalling may be a 
treatment strategy for atherosclerosis or indeed other chronic inflammatory 
diseases.   
Mitochondria can also mediate inflammation through mechanisms 
independent of ROS signalling. Mitochondria, as evolutionary endosymbionts 
(Sagan, 1967) contain mostly non-methylated CpG motifs (B. Liu et al., 2016). 
These immunogenic motifs activate innate immune cells similarly to bacterial 
DNA. For example, injury in trauma patients leads to release of mtDNA into 
the circulation (Q. Zhang et al., 2010). Such mitochondrial damage-associated 
molecular patterns (DAMPs) in turn activate inflammatory cascades in human 
peripheral blood mononuclear cells (PMNCs) through binding to TLR9 
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resulting in systemic inflammation and organ injury (Q. Zhang et al., 2010). 
During apoptosis, oxidised mtDNA can directly bind to and activate the 
NLRP3 inflammasome increasing the production of IL1β (Shimada et al., 
2012). Endogenous danger signals arising from mitochondria and the 
activation of the NLRP3 inflammasome may thus be important steps in the 
development of atherosclerosis as discussed in section 1.1.1.  
In addition, succinate can not only lead to RET as described above but 
also bind to the G protein-coupled receptor GPR91 and trigger an 
inflammatory response, at least in dendritic cells. Through binding to GPR91 
succinate greatly amplifies the effects induced by polyinosinic-polycytidylic 
acid [poly(I:C)] such as Erk1/2 phosphorylation (Rubic et al., 2008). 
Interestingly, this receptor is also expressed on activated monocytes, but its 
role in atherosclerosis has not been studied, yet.  
Previously, Otsu’s group has demonstrated that autophagy is an 
adaptive response in the failing heart upon haemodynamic stress (Nakai et 
al., 2007), and that cardiac specific deletion of lysosomal deoxyribonuclease 
(DNase) II, an enzyme digesting mtDNA in the lysosome, increases mortality, 
inflammation and dilated cardiomyopathy in pressure overload treated mice 
(Oka et al., 2012). These effects are abolished by either ODN2088, a 
synthetic oligodeoxynucleotide ‘GCGGG’ which blocks the unmethylated 
CpG/TLR9 interaction, or by ablation of Tlr9 suggesting that mtDNA, which 
has not been degraded, activates inflammation through activation of the TLR9 
pathway (Oka et al., 2012). Synthetic CpG motifs, which activate the TLR9 
pathway (ODN2006, TCGTCGTTTTGTCGTTTTGTCGT) also increase IFNα 
secretion in atherosclerotic plaques (Niessner et al., 2006), indicating that 
 41 
such a pathway is also important in atherogenesis. The role of TLRs in 
atherosclerosis is further discussed in section 1.1.3. 
Thus mitochondrial dysfunction may perpetuate inflammation in 
atherosclerosis directly and indirectly through production of ROS and through 
DAMPs activating two important inflammatory cascades, the NLRP3 pathway 
and the TLR9 pathway. Succinate, an important TCA intermediate could also 
act through binding to GPR91, although the latter pathway is currently not 
researched in atherosclerosis.  
 
1.3.4 Mitochondria as regulators of cell survival and cell death 
Cell death has traditionally been divided into apoptosis, the planned 
and coordinated death of cells, necrosis or accidental cell death which is 
frequently associated with extensive inflammation, autophagic cell death, and 
mitotic catastrophe resulting from deficient cell cycle checkpoints and cellular 
damage (Kroemer, Galluzzi, & Brenner, 2007). Mitochondria are crucial to 
integrate a variety of signals ultimately determining cell fate. For example, 
mitochondrial outer membrane permeabilisation is the terminal process 
leading to cell death via the release of cytochrome c and activation of 
caspases, as well as cessation of bioenergetics and redox function of 
mitochondria (Kroemer et al., 2007). 
It is thus not surprising that mitochondria regulate cell fate in numerous 
organs and disease processes including in the cardiovascular, neurological, 
and renal systems. For example, ischaemia/reperfusion injury shares 
common pathways across different organs and tissues and mitochondria are 
crucial in this process. Ischaemia/reperfusion injury can be greatly diminished 
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through nitrosylation of cysteine residue 39 (Cys39) of complex I of the ETC 
using the mitochondrially targeted probe MitoSNO. This posttranslational 
protein modification locks complex I into a de-active state preventing 
excessive ROS production during reperfusion (Chouchani et al., 2013). We 
now have evidence that it is the accumulation of succinate during ischaemia 
that drives RET during reperfusion thereby generating large amounts of 
superoxide (Chouchani, Pell, et al., 2014). This mechanism appears not to be 
limited to the heart as administration of MitoQ to scavenge mitochondrial ROS 
also diminishes kidney reperfusion injury (Dare et al., 2015). However, the 
theory of succinate mediated RET and ROS production during 
ischaemia/reperfusion injury has been controversial not least because loss of 
succinate during reperfusion may also be explained by efflux rather than RET 
and because pre-conditioning does not prevent succinate accumulation during 
ischaemia despite its protective effect on reperfusion (Andrienko, Pasdois, 
Pereira, Ovens, & Halestrap, 2017).  
There is also evidence that mitochondria not only act as mediators of 
signals leading to cell death, but damage or dysfunction of mitochondria can 
cause cell death. For example, induction of mitochondrial ROS through 
proteasome inhibition leads to Bax- and caspase-mediated apoptosis that can 
be inhibited by the antioxidant N-acetyl-l-cysteine (NAC) (Papa, Gomes, & 
Rockwell, 2007). Similarly, after nerve growth factor withdrawal, MitoQ is 
more effective than MitoE2 in preventing ROS-mediated neural cell death 
compared to MitoE2 (McManus, Murphy, & Franklin, 2014). MitoE2 contains 
the α-tocopherol moiety of vitamin E linked to TPP and penetrates the MIM to 
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a lesser degree than MitoQ, suggesting that it is mitochondrial ROS rather 
than cytosolic ROS that determines cell fate (McManus et al., 2014).  
Mitochondrial ROS has also been implicated in apoptosis of VSMCs. A 
product of lipid peroxidation, 4-hydroxynonenal, induces apoptosis of VSMCs 
in a dose-dependent manner. This effect is sensitive to rotenone, suggesting 
that complex I-derived superoxide mediates this effect. In contrast, reducing 
ROS derived from other cellular sources through inhibition of NADPH oxidase, 
xanthine oxidase, or cyclooxygenase does not have similar effects (J. Y. Lee 
et al., 2006), further highlighting the importance of the cellular localisation of 
ROS to elicit signalling effects.  
 
1.4 Aims of this study 
The aims of this study are to determine: 
1. Which, if any, mediators of atherosclerosis induce mitochondrial 
dysfunction in cultured VSMCs. The main focus is on OxLDL and LPS. 
2. Whether the mtDNA damage that occurs in atherosclerosis is sufficient to 
affect mitochondrial function in human atherosclerosis. 
3. Whether mitochondrial dysfunction induced by OxLDL affects mitochondrial 
clearance (mitophagy) and mitochondrial biogenesis in cultured human 
VSMCs. 
4. Whether fat-feeding alters mitochondrial function in ApoE-/- mice prior to 
the development of atherosclerosis.  
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2 Materials and Methods 
 
2.1 Materials and general procedures 
All chemicals and reagents were obtained from Sigma-Aldrich (St. 
Louis, USA), unless otherwise stated. Milli-Q ultrapure water (Merck Millipore, 
MA, USA) was used unless stated otherwise.  
 
2.1.1 Animal husbandry and mouse strains used 
All animal studies were performed under UK Home Office licenses and 
following ethical review by the University of Cambridge Animal Welfare and 
Ethical Review Body (AWERB). Trained animal technicians performed 
husbandry. Colonies of ApoE-/- mice on a C57BL/6 background (Jackson 
Laboratory) were maintained in-house, overseen by Alison Finigan from 
Professor Bennett’s laboratory. Initial experiments on the optimisation of 
extracellular flux analysis in tissues were done on various mouse strains, 
ages and sex that were being sacrificed for other reasons and tissues that 
would otherwise have been discarded were used for these experiments. 
 
2.1.2 LDL preparations 
LDL (BT-903) and OxLDL (BT-910) were obtained from Bioquote 
limited and stored at 4oC. According to the manufacturer OxLDL was 
prepared by using 20 µM CuSO4 (oxidant) in PBS at 37oC for 24 hours. 
Oxidation was terminated by addition of excess EDTA. Oxidised LDL was 
membrane filtered and aseptically packaged in a solution containing PBS at 
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pH 7.4 and 0.3 mM EDTA. Each lot was analysed on agarose gel 
electrophoresis for migration versus LDL and a TBARS assay was used 
(typical value of 27.4 nmoles of MDA/mg Protein) to confirm oxidation. The 
manufacturer also tested samples for receptor binding to peritoneal 
macrophages in conjuction with DiIOxLDL. The manufacturer detected no 
endotoxins.  
2.1.3 Mitochondrial inhibitor stock solutions 
The oligomycin supplied (Sigma O4876) contains ≥ 60% oligomycin A 
but also oligomycin B and C. A stock solution of 2 mg/ml was prepared in 
sterile DMSO and stored at -20oC. Likewise, 2.5 mM stock solutions of 
carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) (Sigma 
C2920), rotenone (Sigma R8875) and antimycin A (A8674 Sigma) were 
prepared in DMSO and stored at -20oC. 
 
2.1.4 MitoB 
MitoB was synthesised by Professor Richard Hartley’s laboratory and 
stored in Dr. Michael Murphy’s laboratory at -20oC. A 0.5 mM stock solution in 
0.9% sterile sodium chloride was prepared and stored in aliquots at -20oC for 
use in in-vivo studies. 
 
2.1.5 Human tissue acquisition 
Human aortas were obtained from patients undergoing cardiac 
transplantation or valve replacement at Papworth Hospital, Papworth Everard, 
UK, after written informed consent has been obtained. The cardiothoracic 
 46 
surgical teams performed the procedures and samples were stored in DMEM 
at 4oC until transfer to the Cardiovascular Division at Addenbrooke’s Hospital 
by courier after a maximum of 24 hours. Tissues were processed on the day 
of transfer and consisted of snap freezing a tissue sample in liquid nitrogen for 
storage and diverting a section to fixation in neutral-buffered formalin for later 
processing. The remainder of the sample was used for isolation of VSMCs. 
Human atherosclerotic plaque samples were obtained from patients 
undergoing carotid endarterectomies under the surgical teams at 
Addenbrooke’s Hospital after written informed consent has been obtained. 
Samples were transferred to the Cardiovascular Division and processed as 
described above for aortic samples. Alternatively, a portion of the sample was 
used directly in Seahorse extracellular flux analysis experiments as described 
in section 2.3.2.2.  
 
2.2 Cell culture 
 
2.2.1 Culture medium and incubation 
Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
containing 4.5 g/L glucose supplemented with 10% foetal calf serum (FCS), 
100 U/ml penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine (culture 
medium in the following) in a tissue culture incubator at 37oC under an 
atmosphere of humidified air supplemented with 5% CO2. Tissue explants 




2.2.2 Cell passaging and plating 
Cells were passaged and seeded after trypsinisation. In brief, cells 
were washed twice with pre-warmed PBS and incubated in Trypsin-EDTA 
(Sigma, T3924) for approximately 1-5 minutes. Detached cells were 
resuspended in culture medium, counted using a Neubauer chamber, and 
placed into new culture ware (Corning, New York, USA). Cells were passaged 
at ratios of approximately 1:10 (RVSMCs), 1:3 (HEK-293T and HeLa) or 1:2 
(HVSMCs and plaque VSMCs). 
 
2.2.3 Cell freezing and thawing 
Cells were trypsinised and counted as above, centrifuged at 400 x g for 
5 minutes, and re-suspended in DMEM supplemented with 50% FCS and 
10% DMSO at a density of 1x106 cells/ml. Aliquots of cells were frozen using 
a Mr. Frosty™ Freezing Container (Thermo Fisher Scientific) as directed by 
the manufacturer and transferred to liquid N2 for long term storage. When 
required, cells were rapidly thawed in a water bath (37oC), transferred to 
culture medium and seeded into culture ware.  
 
2.2.4 Rat aortic vascular smooth muscle cell culture and infection 
Rat aortic vascular smooth muscle cells (RVSMCs) used in this study 
have previously been isolated from aortas of Wistar rats by Dr Isabelle 
Gorenne (Professor Bennett’s laboratory) and infected with a retrovirus vector 
containing human sirtuin-1 or a deacetylase-deficient sirtuin-1, sirtuin-1H365Y 
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(Gorenne et al., 2013). In brief, PhoenixTM packaging cells (Orbigen, San 
Diego, CA) were transfected with pBabe-puro vectors encoding human sirtuin-
1, sirtuin-1H365Y (gift from Dr Anthony Kouzarides, Gurdon Institute, 
Cambridge, UK) or empty vector using SuperFect (Qiagen). The transfected 
cells are referred to as SIRT+, SIRT- and EV in the following text, 
respectively. The vector contained a selection cassette for hygromycin B that 
allowed selection of virus-producing cells. RVSMCs were infected with the 
virus suspension facilitated by 8 µg/ml hexadimethrine bromide (Polybrene) 
and selected with 5 µg/ml puromycin. Aliquots of 1x106 cells were frozen in 
DMEM supplemented with 50% FCS and 10% dimethyl sulfoxide (DMSO) and 
have been used for the present study. 
2.2.5 HEK-293T  
HEK-293T cells were used for pseudo-lentiviral particle production as 
described below. Cells were obtained from Dr Anna Uryga and propagated in 
culture medium before use.  
 
2.2.6 HeLa cells 
HeLa cells were used in preliminary experiments of lentiviral infection. 
Cells were obtained from frozen lab stocks and grown under culture 
conditions as described for other cell types above.   
 
2.2.7 Human vascular smooth muscle cell isolation and culture 
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2.2.7.1 Aortic vascular smooth muscle cells 
Human aortic VSMCs were isolated from aortic specimens obtained 
from Papworth Hospital as described above (section 2.1.5). The specimens 
were kept sterile in a tissue culture flow hood, adventitial tissue was removed, 
and tissue pieces of approximately 2 mm x 2 mm were dissected and placed 
into six-well plates. Tissue specimens were then incubated (37oC, humidified 
air with 5% CO2) in culture medium with 20% FCS. After outgrowth of cells, 
the tissue pieces were removed, cells were trypsinised and cultured in 
medium containing 10% FCS. Although the cells cultured with this technique 
had the morphological appearance of VSMCs, the cell type has not been 
formally assessed through the expression of cell type specific markers. 
Subsequently cells were passaged in ratios of 1:2 or 1:3. For this study both 
freshly isolated HVSMCs as well as frozen lab stocks were used.  
 
2.2.7.2 Atherosclerotic plaque vascular smooth muscle cells 
Human atherosclerotic plaque VSMCs (plaque VSMCs in the following) 
were isolated from carotid endarterectomy samples obtained from patients 
undergoing carotid endarterectomy at Addenbrooke’s Hospital (see section 
2.1.5.) Plaque VSMCs were cultured as described above for healthy 
HVSMCs. For this study both freshly isolated plaque VSMCs as well as frozen 
lab stocks were used. 
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2.3 Extracellular flux analysis 
The metabolism of cultured VSMCs, mouse aortas and carotid 
endarterectomy-derived human atherosclerotic tissues was investigated using 
Seahorse Bioscience extracellular flux analysers. The Seahorse extracellular 
flux analysis assay uses proprietary culture plates and sensor cartridges and 
through its multi-well culture plate design allows for the simultaneous 
measurement of multiple samples. This platform simultaneously measures 
oxygen tension and pH in both a custom 96-well format (Seahorse XF96), 
used for experiments with cultured cells, and a 24-well format (Seahorse 
XFe24), used for measurements in tissue samples. Four temperature control 
wells containing no cells or tissues are used to calibrate the machine to zero. 
From these measurements the oxygen consumption rate (OCR) as well as the 
extracellular acidification rate (ECAR) can be calculated. Both of these 
platforms allow for the consecutive injection of up to four inhibitors or inhibitor 
combinations during the assay to inhibit ETC complexes and uncouple 
mitochondria. This assay has been increasingly used to infer mitochondrial 
function or dysfunction in cells and more recently intact tissues (Dunham-
Snary, Sandel, Westbrook, & Ballinger, 2014; Feeley, Westbrook, Bray, & 
Ballinger, 2014; J. Liu et al., 2009). 
 
2.3.1 VSMC extracellular flux analysis 
VSMCs were cultured as described above, trypsinised, counted using a 
Neubauer chamber and seeded in 80 µl aliquots per well into Seahorse 96-
well plates (Seahorse XF96 FluxPak). Cells were allowed to adhere and grow 
for 24 hours prior to treatment with varying doses of LDL (BT-903, Bioquote 
 51 
limited), copper-oxidised LDL (OxLDL, BT-910 Bioquote limited) and 
lipopolysaccharide (LPS from Escherichia coli 0111:B4, Sigma L3012). After 
24 hours treatment, cells were washed once with sterile assay medium 
[DMEM 4.5 g/L glucose (Sigma D5648), supplemented with 1 mM sodium 
pyruvate (Sigma, S8636), 31.66 mM sodium chloride (Sigma), pH adjusted to 
7.4] and allowed to equilibrate to assay medium at 37oC and atmospheric 
pCO2 for 1 hour. Importantly, no sodium bicarbonate is added to the assay 
medium resulting in poor pH buffering capacity allowing simultaneous 
measurement of the oxygen consumption rate (OCR) and the extracellular 
acidification rate (ECAR). The glucose concentration in the medium has not 
been optimised for this assay and high concentrations of glucose may affect 
the metabolism of the cells. However, DMEM with identical glucose content 
has previously been used as the standard assay medium in the MRC 
mitochondrial biology unit (Bridges, Jones, Pollak, & Hirst, 2014). The medium 
contained phenol red, which is thought to be a significant contributor to 
antioxidant capacity of cell culture medium (Lewinska, Wnuk, Slota, & 
Bartosz, 2007). Although phenol red has previously been used in assay 
medium [manufacture’s catalogue, Bridges et al. (2014)] any anti-oxidant 
activity could potentially alleviate the effects of treatments with compounds 
such as OxLDL, and has not been controlled for in the present study. 
Oligomycin, FCCP and a combination of rotenone and antimycin A, diluted in 
sterile assay medium, were loaded into the assay ports (25 µl per port for 
XF96) to allow simultaneous injection into all wells as described for each 
experiment. The final DMSO concentration after injection of all inhibitors 
(excluding FCCP dose titration experiments) was 0.2 % v/v. Although effects 
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of DMSO on cell viability were not directly assessed in the present study, 
DMSO concentrations of < 1% v/v had no apparent effect on proliferation of 
HeLa cells in a previous study (Ben Trivedi, Kitabatake, & Doi, 1990).  
However, more subtle effects of DMSO on cellular metabolism may be 
possible and in future experiments an alternative vehicle such as ethanol 
should be considered. OCR and ECAR were calculated before and after 
injection of the inhibitors. Measurement cycles comprised 3 minutes of mixing 
followed by 3 minutes of O2 and pH measurement. Three measurements were 
obtained at baseline and then following injection of the inhibitors. Results 
were normalised to average protein concentrations per treatment group 
obtained using a bicinchoninic acid (BCA) protein assay (Pierce) on a second 
96-well culture plate treated in parallel (RVSMCs) or protein concentration per 
well determined after completion of the assay (HVSMCs and plaque VSMCs).  
 
2.3.2 Tissue extracellular flux analysis 
 
2.3.2.1 Mouse aortic tissue  
Mice were sacrificed by rising CO2 concentrations and cervical 
dislocation, exsanguinated through cardiac puncture and their aortas were 
harvested and placed into either pre-warmed DMEM assay medium or ice-
cold PBS depending on the experimental setup. This step was performed with 
Ms Alison Finigan from Professor Bennett’s laboratory, a fully trained animal 
technician, to comply with regulations, increase consistency and decrease 
experimental time therefore increasing tissue viability. Using a stereo-
microscope (Leica M80, 7.5-60x magnification) surrounding fat tissue and 
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branching arteries were removed from the aorta. The aortas were then either 
opened longitudinally as previously described (Feeley et al., 2014) or left as 
intact aortic rings. Sections (2-4 mm length) yielding comparable masses 
were prepared and placed into separate wells of an islet capture well culture 
plate (Seahorse Bioscience) pre-filled with 250 µl warmed DMEM assay 
medium (37oC). Wells A1, B4, C3 and D6 were left blank as negative control 
wells and tissues were immobilized using the capture screens provided. The 
assay medium was replaced immediately before loading the plate into the 
XFe24 analyser. Dilutions of the inhibitors oligomycin, FCCP, rotenone and 
antimycin A in 75 µl DMEM assay medium were loaded into the injection ports 
to achieve final assay concentrations as described in each experiment. 
Measurement cycles were 3 minutes of mixing followed by 2 minutes waiting 
time and then 3 minutes of O2 and pH measurement. Four measurements 
were obtained, both as baseline and following injection of the inhibitors. 
 
2.3.2.2 Human atherosclerotic plaque tissue  
Human carotid atherosclerotic plaques were obtained from patients 
undergoing carotid endarterectomy at Addenbrooke’s Hospital, Cambridge, 
UK, after informed written consent had been obtained. To avoid delay in 
sample processing and tissue degradation the samples were collected from 
the operating theatre as soon as they became available, transferred to the 
laboratory and dissected under a stereo-microscope (Leica M80, 7.5-60x 
magnification). Four distinct areas corresponding to normal carotid medial 
wall, the shoulder region of the atherosclerotic plaque as well as the cap 
region and the necrotic core were identified. Sections of approximately 1 mg 
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wet weight were dissected from each of these areas and placed into separate 
wells of a islet capture well culture plate (Seahorse Bioscience) pre-filled with 
250 µl warmed DMEM assay medium (37oC). Extracellular flux analysis was 
performed as described in section (2.3.2.1). 
 
2.3.2.3 Determination of tissue weights for quantification of extracellular 
flux analysis 
After completion of the extracellular flux analysis assay tissue samples 
were retrieved, padded on absorbing paper to remove excess fluid and 
weighed on a microbalance (Metler Toledo). Tissue pieces were then 
transferred to formalin (pH 7.4) for subsequent immunohistochemistry or to a 
heat block at 80oC for 24 hours to determine dry weights.  
 
2.4 Immunohistochemistry  
Mrs Nichola Figg performed immunohistochemistry slide preparation 
and staining according to established immunohistochemistry techniques as 
described below. 
 
2.4.1 Tissue preparation 
Tissues were fixed in 10% neutral-buffered formalin for at least 12 
hours. Tissues were rinsed in PBS, cut into appropriate sized sections, placed 
in processing cassettes and transferred to a beaker filled with PBS. Tissues 
were then processed in an automated tissue processor (Leica) and after 
completion of the processing cycle transferred to the wax bath of the 
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embedding centre. Tissues were removed from the cassette and placed into a 
base mould containing liquid paraffin wax. The mould was then placed on the 
cold plate of the embedding centre to solidify, and then removed from the 
mould. Paraffin blocks containing human tissues were stored in the block 
bank store in a designated, monitored and secure area. Blocks were 
anonymised, catalogued and details entered on the secure laboratory 
database. 
 
2.4.2 Haematoxylin and eosin stain  
Tissues were de-waxed and rehydrated through graded alcohols to 
Milli-Q H2O. Slides were placed in haematoxylin solution (Sigma HHS128) for 
5 minutes and briefly dipped in de-stain solution (250 ml 50% methanol, 250 
ml H20, 5 ml 2 M HCL) eight times. Slides were then placed into Scott’s 
solution (20 mg magnesium sulphate, 2 mg sodium bicarbonate in 1L H2O) for 
5 minutes followed by eosin solution (Sigma HT110280) for 6 minutes. Slides 
were quickly rinsed in H2O and rapidly dehydrated through graded alcohols 
and two changes of xylene. DPX mountant (Sigma 44581) and coverslips 
were applied. 
 
2.4.3 CD68 and smooth muscle actin stain of human plaque tissues 
Tissues were de-waxed and rehydrated through graded alcohols to 
Milli-Q H2O, placed in the antigen un-masking solution (Vector Laboratories, 
H-3301) and transferred to the pressurised retrieval vessel. After completion 
of the programme, the sections were retrieved and left to cool to room 
temperature before washing twice in PBS for 5 minutes each. Sections were 
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blocked with 1% hydrogen peroxide in PBS for 10 minutes and washed twice 
in PBS for 5 minutes each. Slides were then incubated with 5% horse serum 
in PBS for 30 minutes, excess was removed and slides were carefully blotted 
around the sections. Sections were then incubated in primary antibody (CD68, 
Dako M0876, diluted 1:100 in 5% horse serum/PBS; Smooth muscle actin, 
Dako M0851, diluted 1:500 in 1% BSA/PBS) overnight at 4oC. Slides were 
washed twice in PBS for 5 minutes and secondary antibody (horse anti-
mouse, 1:400 in PBS, Vector Laboratories) added for 30 minutes. Slides were 
washed twice for 5 minutes in PBS and incubated in 3,3-diaminobenzidine 
(DAB) solution (Vector Laboratories, SK-4100). Reaction was monitored 
closely under a microscope and slides were then washed twice in H2O for 5 
minutes each. Sections were counterstained as required with haematoxylin as 
above, dehydrated through graded alcohols to Histo-clear (National 
Diagnostics, USA, HS-200) and coverslips applied.  
 
2.4.4 Masson’s trichrome stain 
All reagents for this stain were from Masson’s trichrome stain kit 
(Sigma HT15). Sections were de-waxed to H2O as above and incubated in 
preheated Bouin’s solution at 56oC for 15 minutes or at room temperature 
overnight. Slides were cooled in tap water (18-26oC) in a Coplin jar before 
washing under running tap water until the yellow colour was removed from the 
sections. Sections were then stained in working Weigert’s iron haematoxylin 
solution for 5 minutes and washed under running tap water for 5 minutes. 
Sections were rinsed in Milli-Q H2O and stained with Biebrich Scarlet Acid 
Fuchsin for 5 minutes before a further rinse in Milli-Q H2O. Slides were 
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transferred to working phosphotungstic/phosphomolybdic acid solution for 5 
minutes and then aniline blue solution for 5 minutes. Sections were then 
transferred into 1% acetic acid for 1 minute, rinsed, dehydrated through 
alcohol, cleared in xylene and mounted as above.  
 
2.4.5 Mac 3 stain 
Sections were de-waxed and transferred to water as above and placed 
into antigen unmasking solution (preheated to 96-98oC) for 30 minutes. 
Sections were cooled to room temperature for 20 minutes and washed twice 
in PBS for 5 minutes each. Sections were then incubated in 3% hydrogen 
peroxide in PBS for 10 minutes, washed twice in PBS for 5 minutes each and 
blocked with avidin/biotin solution (Vector Laboratories, SP-2001) as per the 
manufacturers protocol. Slides were then washed twice in PBS for 5 minutes 
and blocked with 5% rabbit serum in PBS for 1 hour at room temperature. 
Sections were then incubated with anti-Mac 3 antibody (Pharmingen 01781D, 
1:400 in 10% rabbit serum) at 4oC overnight. After two wash steps in PBS for 
5 minutes each, sections were incubated in secondary antibody (rabbit anti-
rat, Vector Laboratories, 1:400 in PBS) for 30 minutes and washed twice in 
PBS for 5 minutes. Sections were incubated in avidin/biotin complex 
(vectastain abc kit, PK-4000, Vector Laboratories), washed twice in PBS for 5 
minutes, transferred to 3,3'-diaminobenzidine (DAB) and closely monitored 
under a microscope. Slides were washed in Milli-Q water, counterstained, 
dehydrated, cleared and mounted as described above.  
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2.4.6 Mouse smooth muscle actin stain 
A mouse-on-mouse (MOM) immunohistochemistry kit (MOM Elite 
Peroxidase kit, PK-2200, Vector Laboratories) was used for staining of mouse 
smooth muscle actin. Sections were transferred to H2O as described above 
and placed into a Coplin jar containing antigen unmasking solution preheated 
in a waterbath to 96-98oC. After 30 minutes incubation the jars were removed 
from the waterbath and allowed to cool for 20 minutes. Slides were washed 
twice in PBS for 5 minutes and blocked in 1% hydrogen peroxide in methanol 
for 15 minutes. After two further wash steps in PBS for 5 minutes the sections 
were incubated for 1 hour in MOM immunoglobulin blocking reagent as per 
the manufacturer’s protocol. After two washes in PBS for 5 minutes sections 
were incubated in working solution of MOM diluent, excess diluent was 
removed and slides were carefully blotted around the sections. Sections were 
then incubated in primary antibody (Dako anti-smooth muscle actin, clone 
1A4, 1:500 in MOM diluent) for 30 minutes. Sections were washed twice in 
PBS for 5 minutes and then incubated in MOM biotinylated anti-mouse IgG 
reagent for 10 minutes as per the manufacturer’s instructions. After two wash 
steps in PBS for 5 minutes sections were incubated in ABC reagent for 5 
minutes, washed twice and incubated in DAB solution as described above. 
Sections were counterstained (Haematoxylin) as required, dehydrated and 
cleared in two changes of histoclear and mounted using histomount (National 
Diagnostics, HS-103).  
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2.5 Normalisation of tissue extracellular flux analysis data 
Mouse aorta extracellular flux analysis data were normalised to wet 
weights (see section 2.3.2.3) to allow for variations in the size of tissue 
samples. Extracellular flux analysis data derived from human atherosclerotic 
plaque tissue samples were normalised to both wet weights and cell density 
to take account of different cellularity in the various regions of the 
atherosclerotic plaque. Cell density was determined in H&E stained slides 
from tissue pieces after completion of the extracellular flux analysis run and 
after measurement of wet weights (section 2.3.2.3). A visual field was chosen 
to contain approximately 20 nuclei in healthy wall samples and was applied to 
all tissue pieces were immunohistochemistry was available (i.e, N=5 
experiments with immunohistochemistry available and 5 tissue pieces per 
region in each experiment). OCR and ECAR values were then divided by 
tissue weight and cell count per area for normalisation and comparison across 
different regions. Cell count per area was derived by counting nuclei per area, 
irrespective of cell type. 
 
2.6 Incucyte cell-confluency assay 
EV RVSMCs were plated in 6-well plates at a density of 50,000 cells 
per well. Cells were allowed to adhere and then treated with varying doses of 
OxLDL or vehicle (PBS supplemented with 0.3 mM EDTA) and imaged using 
an Incucyte HD system (Essenbio) with a 20x objective within a conventional 
tissue culture incubator (37oC, 5% CO2). Frames were captured in four-hour 
intervals across 16 separate regions in each well. The average confluency of 
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cells in the 16 regions was generated by the software provided. The mean of 
technical duplicates was then calculated for each treatment group.  
 
2.7 FACS – uptake of 1,1'-dioctadecyl-3,3,3'3'-tetramethyl-
indocarbocyanine perchlorate (DiI) labelled OxLDL 
To confirm uptake of human OxLDL into RVSMCs, 1,1'-dioctadecyl-
3,3,3'3'-tetramethyl-indocarbocyanine perchlorate (DiI)-labelled OxLDL 
(Intracel, RP-173) was utilised. EV, SIRT- or SIRT+ RVSMCs were plated at a 
density of 25,000 cells per well in 24-well culture plates and allowed to adhere 
overnight. Culture medium was changed and cells were treated with 0-100 
µg/ml DiI-labelled OxLDL. Cells were washed twice with PBS and trypsinised 
with 100 µl Trypsin-EDTA for 1 minute at 37oC and 5% CO2. 1 ml growth 
medium was added, cells were centrifuged at 2000 rpm for 2 minutes and 
resuspended in 150 µl stain buffer (BD Biosciences, 554656). Samples were 
analysed using a C6 Accuri flow cytometer (BD Biosciences). Intact single 
cells were gated using the forward scatter (FSC) and side scatter (SSC) and 
10,000 events were counted using an FL2 optical filter (585/40). Maximum 
FL2 signal (FL2-H) was used as a measure of DiI-labelled OxLDL uptake.  
 
2.8 Western blotting 
 
2.8.1 Cell lysis 
Cells were cultured as described in section 2.2, plated into 6-well 
plates, treated as indicated in individual experiments, washed, trypsinised and 
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centrifuged. Cell pellets were then lysed in 50 µl sodium dodecyl sulphate 
(SDS) lysis buffer (1% w/v SDS, 50 mM Tris-HCL, pH adjusted to 8.0) 
supplemented with 1:100 protease inhibitor cocktail I (Merck 539131) and 
1:100 phosphatase inhibitor cocktail I (Merck 524624). Lysates were 
sonicated on ice (Sonics and Materials INC, CT, USA, Vibra Cell VCX 130) in 
two pulses of 10 seconds with pauses of 30 seconds to complete lysis and 
shear DNA. Samples were centrifuged at 15,000 rpm for 10 minutes at 4oC 
and the supernatant transferred to new reagent tubes for downstream 
applications or storage at -80oC. 
 
2.8.2 Bicinchoninic acid protein assay 
Protein concentrations of cell lysates were determined by bicinchoninic 
acid (BCA) protein assay (Pierce BCA Protein Assay Kit, Thermo Scientific, 
23227) according to the manufacturer’s instructions. A dilution curve was 
generated using the bovine serum albumin provided in the kit and both 
standards and samples were prepared in technical duplicates on 96-well 
plates. After incubation with the BCA reagent at 37oC for 30 minutes 
absorbance at 562 nm was measured using in a microplate reader (Biotek, 
Synergy HT, VT, USA). 
 
2.8.3 Sodium dodecyl sulphate gel electrophoresis 
10-20 µg of protein was heated (60oC – 95oC for 10 minutes) in 
appropriate volumes of  BOLTTM 4x LDL sample buffer (Novex, B0007) and 
10x sample reducing agent (Novex, B0009) and run on pre-cast 4-12% 
gradient gels or 10% gels (both Invitrogen, Ca, USA) using 3-(N-
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morpholino)propanesulfonic acid (MOPS) buffer (Invitrogen) at 165 V for 45 
minutes. Semi-dry transfer was performed using an iBlot 2 dry blotting system 
(Invitrogen) at 20 V for 7 minutes and membranes washed for 10 minutes in 
washing buffer [tris-buffered saline with 0.05% tween-20 (TBST) or 
phosphate-buffered saline with 0.05% tween-20 (PBST)]. Blocking and 
antibody incubation was performed as summarised in Table 2-1. Amersham 
enhanced chemiluminescent (ECL) Western blotting detection reagent or ECL 
prime Western blotting detection reagent (both GE healthcare) was applied 
before exposure to X-ray film (Fuji Film) and development. Membranes were 
washed in washing buffer and antibodies stripped from the membrane using 
Restore™ Western blot stripping buffer (Thermo Scientific). After a further 
washing step, membranes were blocked and re-probed as indicated or dried 
and stored at 4oC for future use. Dr Anna Uryga of Professor Bennett’s 
laboratory advised on antibody optimisation and helped performing Western 
blots. In particular, one membrane with samples from HVSMCs and plaque 
VSMCs that was previously run and probed by Dr Uryga was re-probed for 
ETC complex and ATPase expression in the present study. 
 
2.9 PCR analysis of mitochondrial DNA copy number 
The quantification of mtDNA copy number has previously been 
described and was adapted for this project to measure mtDNA copy number 
in human and mouse samples (Gammage, Van Haute, & Minczuk, 2016). 
MtDNA content is quantified through quantitative PCR (qPCR) using the ratio 
of amplification of short mitochondrial amplicons compared to amplification of 
a short nuclear control gene.  
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DNA was isolated from tissues using the GenElute mammalian 
genomic DNA isolation kit (Sigma, G1N70) as per the manufacturer’s 
instructions. DNA was quantified using a spectrophotometer (NanoDrop, 
Thermo Fisher). 








Monoclonal mouse anti-sirtuin-1 (Cell Signaling 
Technology, 1F3, 8469) 
5% milk in 
TBST for 1 hr 
at RT 
1:1000 in 5% BSA TBST 
at 4oC overnight 




1:5000 in 0.25% 
milk TBST for 1 
hr at RT 
Monoclonal rabbit anti-sirtuin-6 (Cell Signaling 
Technology, D8D12, 12486S) 
5% milk in 
TBST for 1 hr 
at RT 
1:1000 in 5% BSA TBST 
at 4oC overnight 
TBST Donkey HRP-linked 
anti-rabbit IgG (GE 
Healthcare NA934V) 
1:5000 in 0.25% 
milk TBST for 1 hr 
at RT 
Monoclonal mouse anti-actin (Sigma, A 3853) 5% milk in 
TBST for 1 hr 
at RT 
1:5000 in 5% BSA TBST 
(Western Blot of 
RVSMCs) or 1:10000 in 







anti-mouse IgG (GE 
Healthcare, NA931V) 
1:10000 in 0.25% 
milk TBST for 1 hr 
at RT 
Mouse monoclonal anti-Keima-Red (Amalgaam 
MBL, M182-3) 
5% BSA in 
PBST for 1 hr 
1:1000 in 5% BSA for 1 hr 
at RT 
PBST Horse anti-mouse 
HRP-linked IgG (Cell 
Signaling Technology, 
7076) 
1:5000 in 0.25% 
milk in PBST for 1 
hr at RT 
Rabbit monoclonal anti- glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) (Cell 
Signaling, 14C10, 2118) 
5% milk in 
PBST for 1 hr 
at RT 
1:1000 in 5% BSA for 1 hr PBST Goat anti-rabbit  HRP 
linked IgG (Cell 
Signaling Technology 
7074) 
1:3000 in 0.25% 
mild in PBST for 1 
hr at RT 
Polyclonal rabbit anti-twinkle (Aviva Systems 
Biology, ARP36483_P050) 
5% milk in 
PBST for 1 hr 
at RT 
1:1000 in 5% milk in 
PBST at 4oC  overnight 
PBST Goat anti-rabbit  HRP 
linked IgG (Cell 
Signaling Technology 
7074) 
1:3000 in 0.25% 
milk in PBST for 1 
hr at RT 
Polyclonal rabbit anti PGC-1 (Santa Cruz 
Biotechnology, sc-13067) 
5% milk in 
PBST for 1 hr 
at RT 
1:2000 in 5% BSA at 4oC  
overnight 
PBST Goat anti-rabbit  HRP 
linked IgG (Cell 
Signaling Technology 
7074) 
1:1000 in 0.25% 
milk in PBST for 1 
hr at RT. 
Mouse monoclonal antibody cocktail against ETC 
complexes, one each against CI subunit NDUFB8 
(MS105), CII-30kDa (MS203), CIII-Core protein 2 
5% milk in 
PBST for 1 hr 
at RT 
1:500 in 5% BSA at 4oC  
overnight 
PBST Horse anti-mouse 
HRP-linked IgG (Cell 
Signaling Technology, 
1:10000 in 0.25% 
milk in PBST for 1 
hr at RT. 
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Table 2-1 Antibodies and blocking agents used in Western blot 
TBST: tris-buffered saline supplemented with 0.05% tween; PBST: phosphate-buffered saline supplemented with 0.05% tween; hr: hour; RT: room temperature; BSA: 
bovine serum albumin; HRP: horse radish peroxidase 
 
(MS304) CIV subunit I (MS404) and CV alpha 
subunit (MS507) (Mitosciences, MS604) 
7076) 
Polyclonal rabbit anti-citrate synthase (Abcam, 
ab96600) 
5% milk in 
PBST for 1 hr 
at RT 
1:1000 in 5% BSA at RT 
for 1 hr 
PBST Goat anti-rabbit  HRP 
linked IgG (Cell 
Signaling Technology 
7074) 
1:5000 in 0.25% 
milk in PBST for 1 
hr at RT 
Polyclonal rabbit anti-DNA polymerase gamma 
(Abcam, ab128899) 
5% milk in 
PBST for 1 hr 
at RT 
1:1000 in 5% BSA at 4oC  
overnight 
PBST Goat anti-rabbit  HRP 
linked IgG (Cell 
Signaling Technology 
7074) 
1:3000 in 0.5% 
milk for 1 hr at RT 
Polyclonal rabbit anti-PINK1 (Cell Signaling 
Technology, 6946) 
5% milk in 
PBST for 1 hr 
at RT 
1:1000 in 5% BSA at 4oC  
overnight 
PBST Goat anti-rabbit  HRP 
linked IgG (Cell 
Signaling Technology 
7074) 
1:3000 in 5% BSA 
for 1 hr at RT 
Polyclonal rabbit anti-TFAM (Cell Signaling 
Technology, 7495S) 
5% milk in 
PBST for 1 hr 
at RT 
1:1000 in 5% BSA at 4oC  
overnight 
PBST Goat anti-rabbit  HRP 
linked IgG (Cell 
Signaling Technology 
7074) 
1:3000 in 0.5% 
milk for 1 hr at RT 
Human mtDNA copy number was assessed using primers (900 nmol/L, 
all from Sigma) that have previously been described (Gammage et al., 2016). 
Relative mtDNA expression was calculated as the average of two short 
segments relative to nuclear DNA expression. qPCR was perfomed on a 
Rotor-Gene 6000 QPCR thermocycler (Corbett Research) using Rotor-gene 
SYBR green PCR mastermix (Qiagen). Mitochondrial primers were: 
CACCCAAGAACAGGGTTTGT (forward) and TGGCCATGGGTATGTTGTT-
AA (reverse) (short segment “mt3211”) and CGTCATTATTGGCTCAAC 
(forward) and GATGGAGACATACAGAAATAG (reverse) (short segment 
“mt9827”). Nuclear primers (β2 microglobulin, B2M) were TGCTGTCTCC-
ATGTTTGATGTATCT (forward) and TCTCTGCTCCCCACCTCTAAGT 
(reverse). 
Before measurement of mtDNA copy number, the efficiency of the 
qPCR reaction was tested through serial dilutions of DNA. The qPCR product 
was run on a 1% agarose gel and visualised using a UV camera system 
(Alpha Innotech Corporation, Ca, USA) to confirm amplification of a specific 
amplification product for each primer pair. For the measurement of mtDNA 
copy number each qPCR was performed in triplicate using 10 ng of sample 
DNA in 20 µl reaction volumes. Cycle conditions were 50oC for 2 minutes and 
95oC for 10 minutes followed by 40 cycles of 95oC for 15 seconds and 60oC 
for 60 seconds. Melt-curve analysis was performed following the run to 
confirm amplification of a single product. Relative amplification of mtDNA was 
calculated as 2ΔCt where ΔCt=Ct (nuclear)-Ct (mitochondrial). To correct for 
the presence of two nuclear copies of B2M mtDNA copy number was 
calculated as 2 x 2ΔCt.  
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Similarly, mouse mtDNA copy number was determined through 
amplification of one short mitochondrial amplicon relative to a short segment 
of the beta-globin gene. Primers were used at 5 µmol/L. Mitochondrial primers 
were GCCAGCCTGACCCATAGCCATAAT (forward) and GCCGGCTG-
CGTATTCTACGTTA (reverse, 127 bp product) and nuclear primers (beta-
globin, 155 bp product) were TTGAGACTGTG-ATTGGCAATGCCT (forward) 
and CCAGAAATGCTGGGCGCTCACT (reverse). Cycle conditions were 95ºC 
for 5 minutes followed by 45 cycles of 95ºC for 5 seconds and 60ºC for 10 
seconds. 
Rat VSMC copy number was determined as above using primer pairs 
(500 nmol/L) that have previously been used to determine mtDNA copy 
number (Gonzalez-Hunt et al., 2016). Mitochondrial primers were 
CAAACCTTTCCTGCACCTCC (forward) and AGGCGTTCTGATGATGGGAA 
(reverse, 181 bp fragment) and nuclear primers were GTTCCCGCCTTCTTC-
CTCTG (forward) and GTTTGCTTGCCGACTCCTTG (reverse, 144 bp 
nuclear fragment from 3',5'-cyclic AMP phosphodiesterase). qPCR conditions 
were 10 minutes at 95oC followed by 40 cycles of 95oC for 15 seconds 
followed by 60oC for 60 seconds. 
 
2.10 RT-PCR genes involved in mitochondrial turnover 
 
2.10.1 Isolation and reverse transcription of RNA 
Isolation of RNA from healthy aortic VSMCs and plaque VSMCs was 
performed by Dr Aarti Shah in Professor Bennett’s laboratory using an 
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RNeasy kit (Qiagen) as per the manufacturer’s instructions. Cells were lysed 
with 350 µl RLT buffer supplemented with 3.5 µl 2-mercaptoethanol. The 
sample was passed through a blunt 20-gauge needle 5 times and 350 µl 70% 
EtOH added. The lysate was transferred to an RNeasy spin column within a 2 
ml collection tube and centrifuged for 15 seconds at 8000 x g. The flow 
through was discarded and 350 µl buffer RW1 added. After centrifugation for 
15 seconds at 8000 x g the flow-through was discarded and DNase I, diluted 
in RNA-free H20, added to 70 µl buffer RDD and transferred to the spin 
column. After incubation for 15 minutes 350 µl buffer RW1 was added and the 
column centrifuged as above and the flow-through was discarded. 500 µl 
buffer RPE was added and the column centrifuged for 2 minutes at 8000 x g. 
The column was placed into a new 2 ml collection tube and 50 µl RNase free 
H2O was added. After centrifugation for 1 minute at 8000 x g the purity and 
concentration of the eluted RNA was analysed using a spectrophotometer 
(NanoDrop, ND-1000).  
Reverse transcription of human RNA was done by Dr Aarti Shah using 
1 µg total RNA and SuperScript III reverse transcriptase (Invitrogen). Diluted 
RNA was added to 1 µl oligodT and 1 µl 10 mM dNTP mix (both Invitrogen) to 
a final volume of 13 µl. The sample was incubated for 5 minutes at 65oC and 
cooled on ice for at least 1 minute. 4 µl 5x First-Strand Buffer (Invitrogen), 1 µl 
0.1M dithiothreitol (DTT), and 1 µl SuperScript III reverse transcriptase were 
added. After incubation for 60 minutes at 50oC the reaction was inactivated by 




2.10.2 qPCR of genes involved in mitochondrial shape dynamics 
qPCR was done for five target genes involved in mitochondrial fission 
and fusion and the control gene target 18S using primer pairs (0.5 µM each) 
and cycling conditions that have previously been described for human 
samples (Sastre-Serra, Nadal-Serrano, Pons, Roca, & Oliver, 2012) (Table 
2-2, Table 2-3). A Rotor-Gene 6000 qPCR thermocycler (Corbett Research) 
and Rotor-Gene SYBR green PCR mastermix (Qiagen) were used. cDNA was 
diluted 1:30 and 5 µl of sample was run in triplicate for each target including a 
50% cDNA control sample and a no template control in 20 µl reaction volume. 
Gene expression relative to 18S was calculated as 2ΔCt. 
 
Gene Forward primer Reverse primer Annealing 
temperature 
(oC) 
18S GGACACGGACAGGATTGACA ACCCACGGAATCGAGAAAGA 61 
mfn-1 TTGGAGCGGAGACTTAGCAT TTCGATCAAGTTCCGGATTC 51 
mfn-2 AGAGGCATCAGTGAGGTGCT GCAGAACTTTGTCCCAGAGC 56 
opa-1 GGCCAGCAAGATTAGCTACG ACAATGTCAGGCACAATCCA 51 
drp-1 AAGAACCAACCACAGGCAAC GTTCACGGCATGACCTTTTT 51 
fis-1 CTTGCTGTGTCCAAGTCCAA GCTGAAGGACGAATCTCAGG 53 
 
Table 2-2 Primer pairs used for qPCR of genes involved in mitochondrial shape 
dynamics 
mfn-1: mitofusin 1; mfn-2: mitofusin 2; opa-1: optic atrophy 1; drp-1: dynamin-related protein 1; fis-1: 
mitochondrial fission 1 protein. Adapted from Sastre-Serra et al. (2012). 
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Gene Melting Annealing Extension Cycle number 
18S 10 s at 95oC 10 s at 61oC 12 s at 72oC 40 
mfn-1 10 s at 95oC 10 s at 51oC 12 s at 72oC 40 
mfn-2 10 s at 95oC 10 s at 56oC 12 s at 72oC 40 
opa-1 10 s at 95oC 10 s at 51oC 12 s at 72oC 40 
drp-1 10 s at 95oC 10 s at 51oC 12 s at 72oC 40 
fis-1 10 s at 95oC 10 s at 53oC 12 s at 72oC 40 
 
Table 2-3 Cycling conditions for qPCR of genes involved in mitochondrial shape 
dynamics 
mfn-1: mitofusin 1; mfn-2: mitofusin 2; opa-1: optic atrophy 1; drp-1: dynamin-related protein 1; fis-1: 
mitochondrial fission 1 protein. Adapted from Sastre-Serra et al. (2012). 
 
2.10.3 qPCR of genes involved in mitophagy 
A TaqMan qPCR system was used to determine expression of PINK1 
(Hs00260868_m1) and PARK2 (Hs01038322_m1, encoding parkin) genes 
and the control gene 18S (Hs03003631_g1, Thermo Fisher) on a Rotor-Gene 
6000 qPCR thermocycler (Corbett Research) using TaqMan universal PCR 
mastermix (Thermo Fisher, 4304437). cDNA was diluted 1:30 and 5 µl diluted 
sample was run in triplicate including 50% cDNA and no template controls in 
20 µl reaction volumes. PCR conditions were 95oC for 10 minutes followed by 
50 cycles of 95oC for 15 seconds and 60oC for 60 seconds. Gene expression 
relative to 18S was calculated as 2ΔCt. 
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2.10.4 qPCR of genes involved in mitochondrial DNA regulation 
A TaqMan qPCR system was used to determine expression of TFAM 
(Hs00273372_s1), C10orf2 (Twinkle, Hs00958168) and PolG 
(Hs00160298_m1) genes and the control gene 18S (Hs03003631_g1, 
Thermo Fisher) on a Rotor-Gene 6000 qPCR thermocycler (Corbett 
Research) using TaqMan universal PCR mastermix (Thermo Fisher, 
4304437). cDNA was diluted 1:30 and 5 µl diluted sample was run in triplicate 
including 50% cDNA and no template controls in 20 µl reaction volumes. PCR 
conditions were 95oC for 10 minutes followed by 45 cycles of 95oC for 15 
seconds and 60oC for 60 seconds. Gene expression relative to 18S was 
calculated as 2ΔCt. 
 
2.11 Generation of Keima-expressing primary cell cultures 
Keima is a coral-derived, acid stable fluorescent protein that 
demonstrates a pH dependent excitation spectrum (Katayama, Kogure, 
Mizushima, Yoshimori, & Miyawaki, 2011). Through a mitochondria targeting 
sequence from COX VIII, this protein allows for quantification of mitophagy 
through determination of the excitation ratio of the protein (Katayama et al., 
2011; Sun et al., 2015). In this project I used a lentiviral strategy to deliver 
mitochondrially-targeted Keima (Keima in the following) to human aortic or 
plaque VSMCs. The Keima plasmid (Keima-pLESIP, see also vector map 
Appendix 8.3) was a gift from Dr Toren Finkel (National Heart, Lung and 
Blood Institute, Bethesda, USA) and has previously been used to generate 
lentiviral particles (Sun et al., 2015). The plasmid contains a puromycin 
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selection cassette. The generation of lentiviral particles and infection of target 
cells was done with the help of Dr Anna Uryga. 
 
2.11.1 Lentivirus particle production 
The plasmids pMD2.G, psPAX (lab stock) and Keima-pLESIP were 
progagated in One Shot OmniMAXTM 2-T1R chemically-competent E. coli. 
Plasmid DNA was isolated from overnight cultures of E.coli in lysogeny broth 
(LB) supplemented with 100 µg/ml ampicillin using a Qiagen Plasmid Midi Kit 
(12143) according to the manufacturer’s instructions. Plasmid DNA was then 
precipitated with 2.5 volumes 100% EtOH and 0.1 volumes 3 M sodium 
acetate (pH 5.2) for 1 hour at room temperature, centrifuged at 14000 rpm for 
30 minutes, washed once in 70% EtOH, centrifuged, and re-suspended in tris-
EDTA buffer. DNA concentrations were determined using a 
spectrophotometer (NanoDrop).  
7 x 105 HEK-293T cells were plated into 60 mm culture dishes using 
DMEM supplemented with 10% FCS without antibiotics. After 24 hours 
subconfluent cells were co-transfected with packaging plasmids pMD2.G (250 
ng), psPAX (750 ng) and Keima-pLESIP (1 µg) using FuGENE 6 (Roche) and 
OptiMEM. The transfection medium was replaced with fresh culture medium 
after 24 hours, pseudo-lentivirus particles were harvested after 48 hours, 
concentrated using Amicon Ultra-15 centrifugal filter devices and stored at -
80oC. A small sample was used for determination of Lentivirus titers using a 




2.11.2 Infection of HeLa cells and HVSMCs 
HeLa cells plated in 6-well plates were infected with a multiplicity of 
infection (MOI) of 1 in the presence of 8 µg/ml Hexadimethrine bromide 
(Polybrene, Sigma) using spinoculation at 1500 x g for 30 minutes at room 
temperature. After an overnight incubation the medium was changed to 
culture medium or culture medium supplemented with 0.75 µg/ml puromycin. 
HeLa cells were expanded, frozen for future use or used for Western blotting 
to confirm expression of Keima and for visualisation using confocal 
microscopy.  
HVSMCs and plaque VSMCs were plated at 100,000 cells per well in 
6-well plates and infected using an MOI of 3 as described above. Cells were 
selected with 1 µg/ml puromycin, expanded, and either re-plated in 35 mm 
glass bottom culture dishes (gamma-irradiated, poly-d-lysine coated, No 1.5 
coverslip, 10 mm glass diameter, P35GC-1.5-10-C, MatTek) for confocal 
microscopy analysis or frozen and stored in liquid N2 for future use. 
 
2.12 Confocal microscopy and image analysis 
HVSMCs or plaque VSMCs were seeded in glass bottom culture 
dishes and stained with 1 µg/ml Hoechst 33342 (Thermo Scientific) for 5 
minutes and then washed in PBS immediately before analysis on a Leica SP5 
confocal microscope using 63X/1.4NA oil objective. Simon McCallum, 
manager or the flowcytometry core facility, helped with the initial set-up of the 
SP5 confocal microscope. Fluorescence of Keima was imaged in two 
channels after sequential excitation with argon laser at 458 nm (coded green) 
and yellow laser at 561 nm (coded red) using a 580nm to 690nm emission 
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range. Hoechst 33342 was imaged in a third channel (coded blue) after 
excitation with UV light. On each experimental day the laser outputs were 
optimised and then maintained across different groups. At least 20 z-stacks 
per group were acquired in at least three independent experiments from three 
different primary cell cultures per group. 
Excitation by 561 nm (red) and 458 nm (green) was calculated for each 
image using ImageJ and a plug-in designed by Dr Richard Butler, Gurdon 
Institute, Cambridge. This ratio red/green was termed mitophagy index, where 
higher values infer increased mitophagic flux (Sun et al., 2015). Quantification 
of mitochondrial shape and was based on a plug-in that has previously been 
described (Vowinckel, Hartl, Butler, & Ralser, 2015). In short, mitochondria 
were defined by Otsu thresholding and the surface area (SA) and the volume 
(V) of the mitochondrial network were calculated. The ratio SA:V allowed for 
the estimation of mitochondrial shape with lower values signifying a higher 
degree of mitochondrial fragmentation. The plug-in also calculated a measure 
of tubularity of the mitochondrial network (compactness), i.e. the variance of 
radial distance/volume, as described before (Vowinckel et al., 2015). 
 
2.13 Mouse model of atherosclerosis – fat-feeding of ApoE-/- mice 
This research has been regulated under the Animals (Scientific 
Procedures) Act 1986 (amended 2012) following ethical review by the 
University of Cambridge Animal Welfare and Ethical Review Body (AWERB). 
ApoE-/- mouse colonies on a C57BL/6 background were kept in the 
Cardiovascular Division of the University of Cambridge and maintained by 
animal technicians. All animal experiments were performed with the help of 
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the animal technician Alison Finigan. After weaning, a proportion of littermate 
female mice was started on a high-fat ‘Western’ diet (Special Diets Services 
829100, ~21% Fat, ~20% Protein) or kept on standard animal chow (Scientific 
animal food & engineering, R105-25), as indicated in the individual 
experiments. When multiple durations of fat-feeding were used in an 
experiment the start of the high-fat diet was staggered so that at sacrifice 
aged-matched littermates could also be used. 
Mice were sacrificed using rising CO2 concentrations and subsequent 
cervical translocation. Blood was collected by cardiac puncture (done by 
Alison Finigan), centrifuged and serum snap frozen in liquid N2 and stored at -
80oC until use. To increase speed and consistency, Alison Finigan helped 
with dissection of hearts, livers and aortas for snap freezing in liquid N2 or 
downstream applications as described below.  
 
2.13.1 Lipid and cytokine measurement  
Serum samples derived from ApoE-/- mice at sacrifice were analysed 
by the core biochemical assay laboratory (clinical pathology accredited) at 
Addenbrooke’s Hospital, Cambridge. Cholesterol, Triglycerides, HDL and a 
calculated LDL were determined through standard techniques. A cytokine 
panel (Mesoscale, Proinflammatory Panel 1, K15048G) was used to measure 
serum levels of ten analytes: IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-
12p70, KC/GRO, TNF-α. 
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2.14  Determination of Mito P/B ratio in mouse aortas 
The mitochondria-targeted ratiometric mass spectrometry probe MitoB 
has been developed to allow the measurement of H2O2 in vivo (Cocheme et 
al., 2011) (see Figure 2-1). 25 nmol MitoB in 50 µl 0.9% sterile sodium 
chloride was injected into the tail vein of the mouse. The injection was done 
by Alison Finigan. Mice were sacrificed 3 hours after injection using rising CO2 
concentrations and aortas dissected rapidly with further help from Alison 
Finigan. Aortic samples were snap frozen in liquid N2 until extraction of MitoB 
and MitoP. 
Tissue was homogenised in 60% acetonitrile and 0.1% formic acid at 
4oC in a bullet blender storm (Next Advance, USA), centrifuged at 16,000 x g 
for 10 minutes and the supernatant transferred to a new reaction tube. The 
extraction was repeated and the supernatants were pooled, spiked with 
deuterated d15 internal standards of MitoB and MitoP, filtered, dried in a speed 
vac concentrator and resuspended in 20% acetonitrile and 0.1% formic acid. 
Standards of MitoB (1- 100 µM) and MitoP (0-25 µM) were prepared in 
parallel in untreated rat liver tissue homogenate (gift from Tracy Prime).  
Detection and quantification of MitoP and MitoB were done by Dr 
Angela Logan and Dr Sabine Arndt as previously described (Logan et al., 
2014). In short, MitoP and MitoB were detected using an I-class Acquity liquid 
chromatograph attached to a Xevo TQ-S triple quad mass spectrometer 
(Waters). Data was analysed using MassLynx software, and the amounts of 
MitoP and MitoB in each sample determined relative to a standard curve 




Figure 2-1 Principles of H2O2 assessment using MitoB in mice 
A) Boronic acid linked to tetraphenolphosphonium (TPP), MitoB, reacts with the conjugate bsae of 
H2O2, HOO-, to form the phenol product MitoP. B) Mice receive a tail vein injection of MitoB. MitoB 
is then taken up into cells driven by the plasma membrane potential (ΔΨ p) and further accumulates in 
mitochondrial through the mitochondrial membrane potential (ΔΨ m). The reaction of A) is facilitated 
by high mitochondrial concentrations of MitoB and is further enhanced by the alkaline environment 
such that the reaction primarily occurs within the mitochondrial matrix. The MitoP/MitoB ratio 
determined through LC-MS/MS is therefore an indicator of mitochondrial H2O2 concentrations. Figure 
adapted from (Cocheme et al., 2011). 
 
2.15 Glutathione recycling assay 
The glutathione recycling assay is well established and has been 
described in detail (Rahman, Kode, & Biswas, 2006). The underlying 
to whole organisms by chemical extraction, rather than being
limited to cells or tissue surfaces, as with optical approaches.
To ensure accurate quantification, it is essential to include
deuterated internal standards (ISs) of MitoB andMitoP to correct
for variability during extraction and detection. An important
additional advantage of using TPP is that its inherent positive
charge facilitates sensitive detection by mass spectrometry.
Indeed, erivatization with TPP is used to enhance detection
sensitivity in mass spectrometry (Woo et al., 2009). Finally, TPP
compounds that undergo intramitochondrial reactions rapidly
equilibrate with the external medium (Ros et al., 2008). There-
fore measurement of the MitoP/MitoB ratio in the extracellular
medium may enable minimally invasive measurement of mito-
chondrial ROS production. Here we show that this approach
can be used to assess average mitochondrial matrix H2O2
concentration in vivo within flies. We then apply this method-
ology to demonstrate that although average mitochondrial
matrix H2O2 does increase in flies during aging, interventions
such as dietary restriction (DR) increase life span without altering
mitochondrial H2O2. These findings have significant implications























































Figure 1. Rationale for the Development
of a Mitochondrial H2O2 Probe
(A) Structure of mitochondria-targeted boronic
acid, MitoB, and its phenol product, MitoP, formed
by reaction with HOO– (the conjugate base of
H2O2).
(B) MitoB uptake into mitochondria within tissues.
MitoB is first taken up into cells driven by the
plasma membrane potential (Djp), and then
accumulates inside themitochondrialmatrix driven
by the mitochondrial membrane potential (Djm),
resulting in a several-hundred-fold accumulation,
as predicted by the Nernst equation. Within mito-
chondria, MitoB is converted to MitoP in response
to H2O2. The reaction with H2O2 is further
enhanced by the higher pH of the matrix relative
to the cytoplasm, thus the rate of MitoB to MitoP
conversion is an indicator of the mitochondrial
H2O2 concentration. To measure the MitoP/MitoB
ratio, the tissue is spiked with deuterated ISs,
extracted, and then quantified by LC-MS/MS.
RESULTS
Characterization of the MitoB Mass
Spectrometry Probe
In vitro reaction of MitoB with H2O2 gave
a single product, identified by reverse
phase (RP)-HPLC (Figure 2A) and mass
spectrometry as MitoP (m/z = 369.1).
Addition of excess H2O2 to MitoB gave
a UV absorbance spectrum identical to
that of MitoP (Figure 2B). The conversion
of MitoB toMitoP by H2O2 wasmonitored
using the difference in absorbance at
285 nm (Figure 2B), giving a second-order
rate constant of !9 M–1s–1 at 37"C and
!3.8 M–1s–1 at 25"C, pH 8.0. The reaction
is far slower than that of the dominant
mitochondrial peroxidase, peroxiredoxin III (k !2 3 107 M–1s–1
[Cox et al., 2010]); therefore, MitoB will not affect physiological
levels of H2O2. The reaction of MitoB with H2O2 was !4-fold
faster at the pH of the mitochondrial matrix (8.0) compared to
that of the cytosol (7.2) (Figure 2C), consistent withMitoB detect-
ing the conjugate base of H2O2 and thereby reacting preferen-
tially with mitochondrial H2O2.
Oxidation of MitoB to MitoP was selective for H2O2 over
simple alkylperoxides (Figure 2D), and it did not react with lino-
leic acid peroxide (see Figure S2A available online). MitoB was
not oxidized to MitoP by superoxide (Figures S2B and S2C), by
the NO donor DETA-NONOate (Figure S2D), or by peroxidases
(Figures S2E and S2F). Addition of ONOO– (100–250 mM) to
MitoB (100 mM) led to the rapid formation of MitoP as assessed
by UV spectrophotometry and RP-HPLC (data not shown),
consistent with the fast (k !106 M–1s–1) reaction of phenylboro-
nates with ONOO– (Sikora et al., 2009). Therefore, the conversion
of MitoB to MitoP is selective for H2O2 over other biological ROS
but will also respond to ONOO–.
Both MitoB (Figure S3A) and MitoP (Figure S3C) fragmented
during tandem mass spectrometry by pathways expected for
Cell Metabolism
In Vivo Measurement of Reactive Oxygen Species
Cell Metabolism 13, 340–350, March 2, 2011 ª2011 Elsevier Inc. 341
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reactions are summarised in Figure 2-2. Aortic samples were snap frozen in 
liquid N2 after mouse sacrifice. Samples were kept on dry ice, weighed 
quickly, and lysed in HCL-acidified EtOH (20 µl/mg tissue, pH 1) in CK14 vials 
(Precellys) using a high speed tissue lyser (Precellys24, Bertin Instruments). 
20 µl of sample equivalent to 1 mg of tissue was supplemented with 80 µl 5% 
sulfosalicylic acid to inhibit γ-glutamyl transferase (γ-GT) and centrifuged at 
14,000 rpm for 10 minutes to precipitate proteins and 10 µl of supernatant 
was then used in the assay. Standards of GSH in 5% 5-sulfosalicylic acid 
(SSA) were made up at concentrations of 5, 10, 20, 50, and 100 µM. Samples 
were incubated in a 96-well plate in the presence of 0.5 mM NADPH, 0.5 mM 
5,5’-dithio-bis (2-nitrobenzoic acid) (DTNB) and 4 U/ml glutathione reductase. 
Absorbance of 5’-thio-2-nitrobenzoic acid (TNB) was measured at 412 nm 




Figure 2-2 Principles of the glutathione recycling assay 
Total glutathione concentrations, GSSG and GSH, in mouse aortic samples was determined using the 
glutathione recycling assay. GSSG/GSH: oxidised/reduced glutathione, NADP+/NADPH: 
oxidised/reduced nicotinamide adenine dinucleotide phosphate, DTNB: 5,5’-dithio-bis (2-nitrobenzoic 
acid), also known as Ellman’s reagent, TNB: 5’-thio-2-nitrobenzoic acid. TNB is then quantified by 
absorption at 412 nm.  
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2.16  Determination of ATP/ADP ratio in mouse aortic tissue 
An assay to determine ATP and ADP extracted from tissues based on 
Strehler (1974) has been established in Dr. Murphy’s laboratory and depends 
on the reactions described in Figure 2-3. 
ATP is rapidly degraded in tissues before extraction and snap-frozen 
tissues (1-5 mg) were therefore ground up without thawing using a pestle and 
mortar kept on dry ice. ATP and ADP were extracted using 1 ml ice-cold 
perchloric acid extractant  (3% v/v HClO4, 2 mM Na2EDTA, 0.5% Triton X-
100). The pH of 400 µl sample was neutralised (pH 7-7.5) using ice-cold 
potassium hydroxide buffer (2 M KOH, 2mM Na2EDTA, 50 mM MOPS), the 
precipitate was pelleted and the supernatant used in the assay. Standard 
curves of ATP (0-20 µM) and ADP (0-5 µM) were prepared and neutralised as 
above. For measurement of ATP, 100 µl of neutralised sample or standard 
was added to 400 µl Tris-acetate buffer (100 mM Tris, 2 mM Na2EDTA, 50 
mM MgCl2, pH 7.75 with glacial acetic acid). For measurement of ADP, 250 µl 
neutralised sample was first incubated with 250 µl ATP sulfurylase buffer [5 
mM 5’GMP, 20 mM Na2MoO4, 0.2 U ATP sulfurylase (New England Biolabs, 
0394L), in Tris-HCL buffer (100 mM Tris-HCl, 10 mM MgCl2, pH 8)], shaken at 
30oC for 20 minutes and then boiled at 100oC for 5 minutes to deactivate the 
sulfurylase. 200 µl of this ATP depleted sample was added to 400 µl Tris-
acetate buffer. Samples and standards of ATP and ADP were then incubated 
with 10 µl pyruvate kinase (PK)/phosphoenoylpyruvate (PEP) solution [1.25 µl 
PK suspension (Sigma P1506), 100 mM PEP] for 30 minutes at 25oC. To test 
for complete degradation of ATP in the ATP sulfurylase reaction, a sample 
without addition of PK/PEP solution was incubated in parallel. All standards 
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and samples were then analysed in an AutoLumat plus (Berthold) 
luminometer after injection of 100 µl luciferin/luciferase solution [120 µM 
luciferin (L6882),1.92 µg luciferase protein/ml (Sigma, L9506), 0.4 mg/ml 





Figure 2-3 Principles of ATP/ADP ratio assay 
To measure ATP concentrations D-luciferin reacts, catalysed by luciferase and Mg2+, in the presence of 
adenosine triphosphate (ATP) and O2 to Oxyluciferin, adenosine monophosphate, pyrophosphate anion 
P2O74− (PPi) and CO2, thereby emitting light. This light emission can be detected using a luminometer. 
To allow for the measurement of ADP, the ATP in the sample is degraded through the ATP sulfurylase 
reaction forming PPi and adenosine 5’-phosphosulfate (APS). The remaining ADP is then converted to 








Different stimuli including exposure to OxLDL or inflammatory 
mediators as well as the altered expression of proteins such as sirtuins 
involved in mitochondrial function may all lead to the disruption of 
mitochondrial performance in atherosclerosis. In this chapter I aim to identify 
stimuli relevant to atherosclerosis that induce mitochondrial dysfunction in 
cultured VSMCs using rat VSMCs (RVSMCs) overexpressing sirtuin-1, 
deacetylase-deficient sirtuin-1, or empty vector that have previously been 
developed in our laboratory (Gorenne et al., 2013) (section 3.2). In a first set 
of experiments the uptake of DiI-labelled OxLDL was assessed using flow 
cytometry (section 3.3). The effects of LDL, OxLDL and LPS on mitochondrial 
respiration and extracellular acidification of RVSMCs was then examined 
using a Seahorse extracellular flux analysis assay (section 3.4). The 
expression of ETC complexes (section 3.5) and mtDNA copy number (section 
3.6) were determined after OxLDL treatment. 
 
3.2 Sirtuin-1 expression in rat vascular smooth muscle cell lines 
RVSMCs were previously generated by Dr Isabelle Gorenne using 
retroviruses encoding either the empty vector, human sirtuin-1 or a 
deacetylase-deficient mutant of human sirtuin-1 in which histidine substitutes 
tyrosine 365 (sirtuin-1H365Y) (Gorenne et al., 2013). In the following these 
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RVSMCs are denoted EV, SIRT+ and SIRT-, respectively. To confirm that 
these cells overexpress sirtuin-1 and that other sirtuins such as sirtuin-6 are 
not dysregulated, Western blotting was performed. Figure 3-1 demonstrates 
that expression of human sirtuin-1 is detected in SIRT+ and SIRT- RVSMCs 
but not in EV RVSMCs. Expression was assessed in whole cell lysates and 
subcellular localisation of sirtuin-1 was not determined. Endogenous levels of 
rat sirtuin-1 and sirtuin-6 were not affected by the overexpression of the 




Figure 3-1 Sirtuin-1 and sirtuin-6 expression in RVSMCs 
EV, SIRT- and SIRT+ whole cell lysates were subjected to SDS gel electrophoresis using pre-cast 8-
12% gradients gels. Membranes were probed for sirtuin-1 and sirtuin-6. Top band of upper panel 
corresponds to human sirtuin-1 and lower band to rat sirtuin-1. See also Appendix 8.1. 
 
3.3 Uptake of DiI-OxLDL into rat VSMCs 
Previous studies in endothelial cells reported that inflammatory 
cytokines and OxLDL can upregulate the scavenger receptor SR-E1 (LOX-1) 












siRNA-treated cells (Ma et al., 2013). OxLDL uptake in RVSMCs with or 
without overexpression of sirtuin-1 was therefore examined. RVSMCs were 
cultured in 24-well plates prior to treatment with various concentrations of DiI-
OxLDL for 24 hours. Cells were trypsinised, fixed and DiI-OxLDL uptake 
examined by flow cytometry. DiI-OxLDL was taken up in a dose-dependent 
manner, but was significantly lower in SIRT+, and SIRT- cells compared to EV 
(Figure 3-2).  
 
 
Figure 3-2 DiI-OxLDL uptake in RVSMCs 
EV, SIRT- and SIRT+ RVSMCs were treated with varying concentrations of DiI-labelled OxLDL 
(DiI-OxLDL) for 24 hours, trypsinised and subjected to flow cytometry analysis. The peak 
fluorescence value (FL2-H) was determined using a BD Accuri flow cytometer. Data are means± 
SEM of N=3 independent experiments. * P<0.05, **** P<0.0001 for EV compared to SIRT- and 
SIRT+ using two-way ANOVA with Bonferroni’s correction for multiple comparisons. 
 


















3.4 Extracellular flux analysis 
A Seahorse bioscience 96-well extracellular flux analyser (XF96) was 
used to examine the effects of OxLDL on mitochondrial respiration. The XF96 
simultaneously measures the oxygen tension and pH, therefore allowing 
calculation of the oxygen consumption rate (OCR) and extracellular 
acidification rate, a measure of glycolysis flux. Through sequential injection of 
mitochondrial inhibitors (oligomycin, rotenone and antimycin) and the 
uncoupler FCCP, the OCR for mitochondrial ATP generation can be 
differentiated from OCR due to proton leak and non-mitochondrial OCR. 
Uncoupling with FCCP needs to be titrated as uncoupling increases dose-
dependently, before plateauing at optimal concentrations and decreasing at 
supra-optimal concentrations (manufacturer’s instructions, 
www.seahorsebio.com).  
As very few studies have been published on mitochondrial function in 
cultured RVSMCs, the optimal seeding density and FCCP concentrations 
were determined. RVSMCs were plated at 5000 cells/well in 96-well Seahorse 
culture plates, incubated for 48 hours, washed once with sterile assay 
medium, and analysed in the XF96. 2 µg/ml oligomycin and 1 µM each of 
rotenone/antimycin A were used. The ideal FCCP concentration based on 
maximal uncoupling for each well was found to be 1 µM and was therefore 
used in all future experiments (Figure 3-3). At an initial seeding density of 
5000 cells/well, baseline OCR prior to injection of any inhibitors was around 
200 pmol/min. A baseline OCR of 100 pmol/min aids measurement of oxygen 
consumption within the dynamic range of the flux analyser (Dr Hannah 
Bridges, Mitochondrial Biology Unit, Cambridge, personal communication), so 
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2500 RVSMCs were plated per well in all subsequent experiments. This 
plating density results in approximately 90-95% confluence after 48 hours.  
Subsequently, 2500 EV, SIRT- or SIRT+ RVSMCs were seeded into 
96-well plates and incubated for 24 hours prior to treatment with varying 
doses of LDL, OxLDL and LPS for a further 24 hours. As the mitochondrial 
inhibitors can be toxic and therefore affect protein concentrations after the 
assay, a parallel 96-well plate was used to determine protein concentrations 
after all treatments. All OCR and ECAR values were then normalised to µg 
protein to allow adjustment for potential differences in cellular density during 
the run. For assessment of the effects of various treatments, data was 
expressed as % change from untreated. The resulting data is presented as a 
comparison of EV, SIRT- and SIRT+ RVSMCs (Figure 3-4) and effects of the 




Figure 3-3 Optimisation of FCCP concentration 
5000 EV RVSMCs were plated into a 96-well Seahorse culture plate and incubated for 48 hours prior 
to addition of inhibitors and extracellular flux analysis. Oligomycin (2 µg/ml final concentration), 
FCCP at various concentrations, and a combination of rotenone (Rot) 1 µM final concentration and 
antimycin A (Ant) 1 µM final concentration were injected sequentially. Data represent means ± SEM 
of technical triplicates in one experiment.  Each cycle consists of 3 minutes of waiting, 2 minutes of 
mixing and 3 minutes of O2 and pH measurement.  
 
FCCP titration

































Figure 3-4 OCR and ECAR of EV, SIRT- and SIRT+ RVSMCs 
RVSMC lines EV, SIRT- and SIRT+ were analysed using a 96-well plate Seahorse extracellular flux 
analyser (XF96). Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were 
determined after serial injection of oligomycin (2 µg/ml final concentration), FCCP (1 µM), and a 
combination of rotenone and antimycin A (1 µM final concentration each) and normalised to amount of 



































































































significant differences between the cell lines using one-way ANOVA analysis with Bonferroni’s 
correction for multiple comparisons. 
 
 
Figure 3-5 OCR and ECAR of EV RVSMCs 
EV RVSMCs were analysed using a 96-well plate Seahorse extracellular flux analyser (XF96). Oxygen 
consumption rate (OCR) and extracellular acidification rate (ECAR) were determined after serial 
injection of oligomycin (2 µg/ml final concentration), FCCP (1 µM), and a combination of rotenone 
and antimycin A (1 µM final concentration each) and normalised to amount of protein. Data presented 
as % baseline (mean ± SEM) from N=3 experiments per treatment group. * P<0.05, ** P<0.01 using 
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Figure 3-6 OCR and ECAR of SIRT- RVSMCs 
SIRT- RVSMCs were analysed using a 96-well plate Seahorse extracellular flux analyser (XF96). 
Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were determined after 
serial injection of oligomycin (2 µg/ml final concentration), FCCP (1 µM), and a combination of 
rotenone and antimycin A (1 µM final concentration each) and normalised to amount of protein. Data 
presented as % baseline (mean ± SEM) from N=3 experiments per treatment group. ** P<0.01, *** 
























5 10 50 100 
10 50 
0.1 
- - - - 
- - - - 


























5 10 50 100 
10 50 
0.1 
- - - - 
- - - - 

























5 10 50 100 
10 50 
0.1 
- - - - 
- - - - 
























5 10 50 100 
10 50 
0.1 
- - - - 
- - - - 
























5 10 50 100 
10 50 
0.1 
- - - - 
- - - - 


























5 10 50 100 
10 50 
0.1 
- - - - 
- - - - 





Figure 3-7 OCR and ECAR of SIRT+ RVSMCs 
SIRT+ RVSMCs were analysed using a 96-well plate Seahorse extracellular flux analyser (XF96). 
Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were determined after 
serial injection of oligomycin (2 µg/ml final concentration), FCCP (1 µM), and a combination of 
rotenone and antimycin A (1 µM final concentration each) and normalised to amount of protein. Data 
presented as % baseline (mean ± SEM) from N=3 experiments per treatment group. * P<0.05, ** 
P<0.01 using one-way ANOVA with Bonferroni’s correction for multiple comparisons. 
 
 
There was no difference in the OCR at baseline and following serial 
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A between EV, SIRT- and SIRT+ RVSMCs (Figure 3-4). Similarly ECAR did 
not differ across the cell lines (Figure 3-4). In EV cells, OxLDL, but not LDL, 
dose-dependently decreased cellular respiration both at baseline and 
following uncoupling with FCCP (Figure 3-5). LPS (1000 ng/ml) significantly 
increased ECAR. The pattern of response of SIRT- (Figure 3-6) and SIRT+ 
(Figure 3-7) was similar. A significant increase in ECAR was also observed 
with 10 µg/ml LDL. This is surprising and was not observed with 50 µg/ml 
raising the possibility of an erroneous result, particularly as this effect was not 
observed across all three cell lines.  
 
3.4.1 RVSMC viability and density after treatment with OxLDL 
Although the OCR and ECAR values derived from the extracellular flux 
analysis were normalised to protein concentrations as a surrogate for cell 
number, it was important to determine whether the effects of OxLDL were due 
to effects on overall cell viability or density. The 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT) assay was used to detect cell growth 
and survival (Mosmann, 1983), where yellow MTT is reduced to a dark blue 
formazan detected by a 96-well plate reader. The reduction, however, is 
dependent on NADH/NADPH and a significant proportion of MTT reduction 
depends on mitochondrial electron transport (Berridge & Tan, 1993). This 
assay would therefore only be useful if no differences in MTT conversion were 
observed. As demonstrated in Figure 3-8 OxLDL markedly reduced 
absorbance in EV, SIRT- and SIRT+ cells. Furthermore, the effects observed 
after incubation with OxLDL solution may have been due to remnant copper 
 92 
ions rather than the OxLDL itself, further limiting the use of this assay in the 





Figure 3-8 MTT assay in RVSMCs treated with atherogenic lipids and LPS 
RVSMCs were plated in triplicate wells of 96-well plates, allowed to adhere and treated with varying 
concentrations of OxLDL, MTT reduction was assessed by absorbance at 590 nm. Data represents 
mean ± SEM of technical triplicates in one experiment. a.u.: arbitrary unit 
 
Because there were no differences in respiration of SIRT+ and SIRT- 
compared to EV cells and the responses to OxLDL were similar in both the 
Seahorse extracellular flux analysis and the MTT assay, SIRT+ and SIRT- 
RVSMCs were not studied further. 
To clarify whether the effects seen during extracellular flux analysis are 
due to effects on cellularity rather than mitochondrial function, an Incucyte HD 
live cell imager (Essen Bioscience) was used to directly assess cell density 
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confluence measured every four hours. Although confluence as an outcome 
measure cannot differentiate between effects on proliferation, cell death and 
cell shape, it should provide an approximation of total cell number. In 
preliminary experiments plating densities of 50,000 RVSMCs per well led to 
near confluence at 72 hours. EV RVSMCs were therefore plated at this 
density and treated with 5-100 µg/ml OxLDL or vehicle. OxLDL at the 
concentrations used in the extracellular flux analysis did not decrease cell 
density (Figure 3-9), suggesting that the reduced respiration observed in 
previous experiments is due to reduced mitochondrial respiration rather than 
decreased cell number.  
 
Figure 3-9 Effects of OxLDL on confluence of RVSMCs 
EV RVSMCs were seeded into 6-well plates at 50,000 cells per well, and treated with varying doses of 
OxLDL as indicated of vehicle control (PBS). Confluency was assessed using an Incucyte HD live cell 
imager placed in a cell culture incubator. Data represents mean % confluence ± SD of N=3 biological 
replicates with technical duplicates.  
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3.5 Effects of OxLDL on electron transfer chain complex 
expression 
Section 3.4 has demonstrated that OxLDL decreases OCR in RVSMCs 
but the mechanism of this effect is not known. One possibility is that OxLDL 
affects the expression of proteins in the electron transfer chain (ETC), either 
through damage and subsequent degradation or reduced synthesis. Western 
blot was therefore used to examine expression of each ETC complex subunit 
with citrate synthase as a loading control. Administration of the pro-oxidant 
tert-butyl hydroperoxide (t-BHP), an oxidative damage-causing agent, was 
used as a positive control. OxLDL did not affect the expression of any of the 
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Figure 3-10 Western blots of electron transfer chain complexes in RVSMCs 
A) – D) Western blot of whole cell lysates after treatment with OxLDL or t-BHP. I-V corresponds to 
subunits of electron transport chain complexes and ATP synthase. CS: citrate synthase. Intensity of 
bands in Western blots varied across different complexes and different exposure times were therefore 
used. Note different loading order in Western blot C. E) Densitometry analysis of N=4 Western blots 
normalised to citrate synthase. Results expressed as mean ± SEM. * P<0.05 using one-way ANOVA. 
See also Appendix 8.1. 
 
3.6 Effects of OxLDL on mitochondrial DNA copy number 
mtDNA copy number is highly correlated to mitochondrial gene 
expression levels and mitochondrial mass across different tissues (D'Erchia et 
al., 2015), such that reduced mtDNA copy number may be an alternative 
explanation for the reduced respiration rate after OxLDL treatment. mtDNA 
copy number was determined by amplification of a short segment of mtDNA 
normalised to a short segment of nuclear DNA. The qPCR was first validated 
demonstrating comparable reaction efficiencies for the nuclear and 
mitochondrial amplicon and satisfactory melt curve analysis (Figure 3-11). No 
statistically significant differences of mtDNA copy number were observed after 
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Figure 3-11 Validation of qPCR for rat mitochondrial DNA copy number  
Rat DNA was serially diluted (1:2) ranging from 20-0.625 ng and qPCR reactions were run in triplicate 
on a Corbett Rotor-Gene™ 6000 QPCR thermocycler. A) There is linearity of the nuclear amplification 
over a wide DNA input range. The efficiency of the reaction was 0.98. B) Melt curve analysis suggests 
amplification of a single product. C) Linearity of the mitochondrial reaction is demonstrated over a 
wide DNA input range and the amplification had a comparable efficiency (1.19). D) Melt curve 
analysis of the mitochondrial reaction suggests amplification of a single product. dF/dT: the derivative 
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Figure 3-12 Mitochondrial DNA copy number in RVSMCs 
EV RVSMCs were treated with varying doses of OxLDL or t-BHP for 24 hours as indicated and DNA 
was isolated using the GenElute mammalian genomic DNA isolation kit (Sigma). MtDNA copy 
number relative to nuclear DNA was determined by qPCR in N=3 independent experiments. No 
statistically significant differences were observed using one-way ANOVA.  
 
3.7 Discussion 
MtDNA damage has been described in human atherosclerosis, and 
previous studies have shown that mtDNA damage in both vessel wall and 
haematopoietic cells can promote atherosclerosis and/or changes in plaque 
composition (E. Yu et al., 2013). However, it is currently unclear which of the 
mediators of atherosclerosis lead to mitochondrial damage during 
atherogenesis, and whether any of them reduce mitochondrial function. The 
effects of several known atherogenic factors on RVSMCs were therefore 
studied including sirtuin-1, which regulates PGC-1α, inflammatory mediators 
(represented by LPS), and lipids or oxidised lipids. 
Treatment of EV, SIRT- and SIRT+ RVSMCs with OxLDL dose-
dependently decreased OCR whereas LDL and LPS did not have similar 
effects. The effects of OxLDL on OCR and MTT reduction in EV RVSMCs 
were not due to changes in cell density, further suggesting that they may be 
due to direct effects on mitochondrial function. However, OxLDL did not 
reduce ETC complex expression or mtDNA copy number. Although mtDNA 
copy number correlates to mitochondrial mass (D'Erchia et al., 2015) other 
techniques such as electron microscopy or citrate synthase activity assays 
could have been used to help determine mitochondrial density in VSMCs 
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upon OxLDL treatment. This would have helped to clarify whether changes in 
OCR after OxLDL treatment were due to altered mitochondrial function or due 
to overall reduced mitochondrial density.  
A previous study has shown that OxLDL reduces respiration of VSMCs 
both at baseline and following uncoupling (Ahn et al., 2010). In this study, 
reduced respiration was also associated with reduced intracellular ATP 
content, although ADP levels were not reported making interpretation of the 
bioenergetics consequences of this decrease difficult. The study also does not 
investigate whether LDL itself exerts effects on respiration (Ahn et al., 2010), 
although LDL did not cause significant reduction in respiration in the current 
study, suggesting that it is the oxidation of the lipid rather than the lipid itself 
that exerts an effect.  
OxLDL induces ROS production (Guo et al., 2014), which in turn could 
lead to mitochondrial dysfunction through damage of mitochondrial proteins or 
mtDNA. However, OxLDL did not affect ETC proteins as determined by 
Western blot, whereas the positive control t-BHP caused a significant 
reduction in complex I expression. Similarly, mtDNA copy number was not 
altered after OxLDL treatment. Another possibility is that ROS cause 
posttranslational modifications of mitochondrial proteins thereby affecting their 
function. For example, the ND3 subunit of complex I contains a redox-
sensitive cysteine (Cys39) which can alter the activity of complex I 
(Chouchani et al., 2013). An alternative explanation for reduced mitochondrial 
respiration could be the induction of mitochondrial damage and subsequent 
mitophagy. This hypothesis is evaluated in chapter 6.  
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A limitation of the present study is that the oxidation state of the OxLDL 
solution has not been assessed. The solution used was copper oxidised and 
therefore a highly oxidised LDL form rather than a minimally oxidised LDL. 
However, because OxLDL is not a pure chemical additional batch control- and 
quality control experiments could have been considered.  
In the present study overexpression of either sirtuin-1 or the 
deacetylase deficient isoform of sirtuin-1 did not significantly affect respiration 
in RVSMCs. However, the present study is limited in that the activity of sirtuin-
1 in overexpressing cell lines has not been assessed. Furthermore, the 
subcellular localisation of the overexpressed sirtuin-1 has not been assessed 
and it is unclear whether the overexpressed sirtuin-1 fulfils its physiological 
role. Without such assessment it remains to be determined whether sirtuin-1 
overexpression affects cellular or mitochondrial metabolism and the data from 
the Seahorse extracellular flux analysis therefore needs to be interpreted with 
caution. A previous study suggested that overexpression of sirtuin-1 reduces 
oxygen consumption rate in PC12 cells by approximately 25% (Nemoto et al., 
2005). Sirtuin-1 binds to p53, Foxo3a and importantly PGC-1α and 
deacetylates these proteins. Sirtuin-1 may therefore lead to decreased PGC-
1α activity and reduced respiratory complex expression (Nemoto et al., 2005). 
However, the mechanisms by which sirtuin-1 could affect metabolism may not 
only depend on the deacetylation of PGC-1α. For example, a mutation in 
sirtuin-1, sirtuin-1G261A, which abrogates its ADP-ribosyltransferase activity but 
leaves its deacetylation activity intact, does not affect the oxygen consumption 
rate (Nemoto et al., 2005). This suggests that sirtuin-1 may not act through 
deacetylation of PGC-1α alone (Nemoto et al., 2005).  
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Sirtuin-1 may also alter mitochondrial physiology through effects on 
mitophagy, as overexpression of sirtuin-1 increases whereas knockout of 
sirtuin-1 decreases autophagy (I. H. Lee et al., 2008). Mechanistically, sirtuin-
1 deacetylates autophagy components ATG5, ATG7 and ATG8 and sirtuin-1 -
/- mice have similar phenotypes as ATG5-/- mice (I. H. Lee et al., 2008).  
Another interesting observation from the current study is that SIRT- 
and SIRT+ have significantly diminished OxLDL uptake. Again, this data 
needs to be interpreted with caution, as sirtuin-1 activity has not been 
assessed. From previous studies we know that inhibition of sirtuin-1 using 
siRNA can increase SR-E1 (LOX-1) expression (Ma et al., 2013). The 
differences in uptake in this study may be consistent with sirtuin-1-induced 
downregulation of SR-E1 leading to decreased uptake of OxLDL. As the effect 
on OxLDL uptake is also present in the SIRT- cells this process appears to be 
independent of the deacetylation activity of sirtuin-1. Despite the decreased 
OxLDL uptake observed in SIRT+ and SIRT- cells, the functional 
consequences of OxLDL treatment in the extracellular flux analysis and the 
MTT assay are comparable to EV cells. Endogenous rat sirtuin-1 expression 
has not been altered in our SIRT+ and SIRT- cell lines. Thus the endogenous 
sirtuin-1 present in EV RVSMCs may be entirely sufficient for cellular function 
and additional expression of human SIRT+ or SIRT- may not exert large 
effects. Ideally endogenous sirtuin-1 should be knocked-out, for example 
through use of a CRISPR-cas 9 system or temporarily downregulated by the 
use of siRNA to draw conclusions on the effects of sirtuin-1 in RVSMCs. 
Only LPS consistently increased the ECAR as a measure of glycolysis 
in all three cell lines tested. LPS as a pro-inflammatory mediator has 
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previously been shown to upregulate glycolytic pathways in monocytes, and 
at least partly acts through succinate-mediated stabilisation of HIF-1α  
(Tannahill et al., 2013). 
In summary, the findings in this chapter indicate that OxLDL and LPS 
can affect mitochondrial function and VSMC metabolism through effects on 
respiration and glycolysis, respectively. However, the results obtained in rat 
VSMCs may not necessarily apply to atherosclerosis, a complex disease 
involving potentially multiple DAMPs acting simultaneously on various cell 
types within the plaque. It is therefore important to determine whether 
mitochondrial dysfunction occurs in atherosclerosis and VSMCs derived from 
atherosclerotic plaques as described in the following chapters. 
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4 Effects of fat-feeding on ApoE-/- mice 
 
4.1 Introduction 
The previous chapter described experiments using OxLDL to reduce 
mitochondrial oxygen consumption rate in cultured RVSMCs. To investigate 
whether hyperlipidaemia can also induce mitochondrial dysfunction in the 
development of atherosclerosis I next tested the effects of fat-feeding on 
mitochondrial function in aortas of ApoE-/- mice. These mice are frequently 
used as a model of atherosclerosis, as discussed in section 1.1.6. When 
ApoE-/- mice were fat a high-fat diet for up to 8 weeks, their cholesterol and 
triglyceride levels increased, but the serum cytokine levels remained largely 
unaffected (section 4.2). Previous work in our laboratory has demonstrated 
that fat-feeding of ApoE-/- mice leads to mtDNA damage in aortas that occurs 
prior to the development of atherosclerosis (E. Yu et al., 2013). However, this 
study did not investigate whether the mtDNA damage observed had any 
functional consequences on mitochondria. I hypothesised that mitochondrial 
damage and dysfunction may be early events in atherogenesis prior to the 
development of advanced atherosclerotic lesions. To investigate the 
functional effects of fat-feeding on mouse aortas I therefore adapted the 
Seahorse extracellular flux assay for use of aortic tissue samples (section 
4.3). Fat-feeding did not significantly affect mitochondrial respiration in ApoE-
/- mouse aortas at up to 8 weeks of fat-feeding (section 4.4). 
Immunohistochemistry of aortic tissue in these mice confirmed the absence of 
atherosclerosis at these early time points (section 4.5). However, in 
accordance with previous findings of increased mtDNA damage (E. Yu et al., 
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2013), mtDNA copy number relative to nuclear DNA was reduced (section 
4.6). The ATP/ADP ratio did not change in ApoE-/- mouse aortas after fat-
feeding (section 4.7). Similarly, mitochondrial ROS and glutathione levels 
were not affected (section 4.8). To test whether I missed effects of fat-feeding 
on mitochondrial function developing at later time points I then repeated the 
Seahorse extracellular flux analysis assay in aortas from ApoE-/- mice on 
high-fat diet for 14 weeks (section 4.9) but there was no difference between 
the groups.  
 
4.2 Serum lipid and cytokine levels of ApoE-/- mice after fat-
feeding 
Female ApoE-/- mice were fat a high-fat diet for up to 8 weeks. Serum 
samples were obtained from ApoE-/- mice, fat-fed ad libitum, i.e. not fasted, in 
the morning by cardiac puncture and analysed for serum cholesterol, HDL 
and triglyceride levels by the central biochemistry service at Addenbrooke’s 
Hospital. Fat-feeding primarily increased cholesterol concentrations (Figure 
4-1) rather than triglyceride concentrations consistent with published findings 
in our laboratory (E. Yu et al., 2013). However, previously reported cholesterol 
concentrations after fat-feeding were considerably higher (Nakashima et al., 
1994; Plump et al., 1992). Plump et al. (1992) originally reported total 
cholesterol concentrations after fat-feeding of 1821 ± 395 mg/dl (~ 47 ± 10 
mmol/l) when sampled in the afternoon, whilst Nakashima et al. (1994) 
reported values ranging from 1085 mg/dl to 4402 mg/dl (~ 28 mmol/l to 114 
mmol/l). Whilst minor differences in cholesterol concentrations could be due to 
diurnal variation (Ferrell & Chiang, 2015) and slightly different diets used, the 
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concentrations observed in this study and in previous studies from our 
laboratory (E. Yu et al., 2013) are considerably lower than previously 
reported.  
In parallel, serum cytokine levels were assayed by the central 
biochemistry service (Figure 4-2). Only TNF-α was significantly increased 
after fat-feeding, whereas other cytokines were not altered or large variations 
existed between mice precluding meaningful interpretation given the relatively 
small sample sizes. The variability in IL-6 and CXCL1 cytokine concentrations 
was largely due to one mouse in the 2-week fat-feeding group and one mouse 
in the 8-week fat-feeding group. In the case of IL-6 for example the 
concentration of cytokine in the 8-week fat feeding group were 2564.7 pg/ml, 
26.0 pg/ml, 29.2 pg/ml and 23.6 pg/ml. The mouse with very high cytokine 
levels may have carried another pathology affecting cytokine levels such as 
an infection or cancer, which was not investigated in the present study. Due to 
the small sample size formal outlier analysis was not conducted.  
In the present study fat-feeding increased TNF-α to between 15-36 
pg/ml compared to baseline levels of 7-13 pg/ml. Together the increased 
cholesterol and cytokine concentrations observed after fat-feeding suggest 




Figure 4-1 Serum cholesterol and triglyceride concentrations in ApoE-/- mice 
with or without fat-feeding 
Blood of littermate ApoE-/- mice fed a ‘western’ high-fat diet for 0, 2, 4, or 8 weeks was obtained 
through cardiac puncture directly after sacrifice. Serum of N=4 animals per group was analysed. Data 






































































Figure 4-2 Serum cytokine concentrations in ApoE-/- mice with or without fat-
feeding 
Blood of littermate ApoE-/- mice fed a ‘western’ high-fat diet for 0, 2, 4, or 8 weeks was obtained 
through cardiac puncture directly after sacrifice. Serum concentrations of tumour necrosis factor 1α 
(TNF-α), interleukin (IL) 1β (IL1β), IL2, IL5, IL6, IL10, interferon γ (IFNγ), The chemokine (CXC 
motif) ligand 1 (CXCL1, also known as KC/GRO) were assessed by the core biochemical assay 








































































































































































mean ±SEM. **P<0.01 using one-way ANOVA with Bonferroni’s correction for multiple 
comparisons. 
 
4.3 Optimisation of extracellular flux analysis of mouse aortic 
tissues 
Although mtDNA damage has been demonstrated in atherosclerosis, to 
my knowledge, the functional consequences of such damage have not yet 
been assessed in whole tissue. My aim was therefore to establish an assay 
that provides information on mitochondrial function in aortic tissues. Indeed, 
the extracellular flux assay described in section (3.4) has recently been 
adapted to study tissues aiming to get a better understanding of mitochondrial 
function than could be achieved through study of cells in culture (Dunham-
Snary et al., 2014; Feeley et al., 2014; Fried, Moffat, Seifert, & Oshinsky, 
2014).  
Pancreatic islet capture plates have been developed which contain a 
0.25 mm deep and 3.17 mm wide depression in each well which can 
subsequently be covered by a custom mesh mounted on a plastic ring. 
Although developed to measure mitochondrial bioenergetics of pancreatic 
islets, these custom culture plates have been adapted to study the 
mitochondrial bioenergetics of whole fat tissue (Dunham-Snary et al., 2014) 
and subsequently also brain tissue (Fried et al., 2014). During this project a 
method describing extracellular flux analysis in mouse aortic tissue (Feeley et 
al., 2014) has also become available. The inhibitor concentrations of 
oligomycin (10 µg/ml), antimycin A (10 µM) and FCCP (1 µM) were adapted 
from the latter study (Feeley et al., 2014). Similarly, rotenone was used at 10 
µM in combination with antimycin. 
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Initial experiments were conducted to determine how best to prepare 
the aortic tissue for the assay. In a first experiment I compared sample 
preparation in warm (37oC) DMEM compared to cold (4oC) PBS. Less 
variation between tissue samples and a higher respiratory reserve capacity 
(RRC) were observed when the aorta was prepared in warm DMEM 
compared to cold PBS (Figure 4-3). In the following, tissue samples were 
therefore prepared in warm DMEM. In a further optimisation step, dissected 
aortas were either left as aortic rings or opened longitudinally to form aortic 
sheets. Aortic rings resulted in less intra-experimental variation (Figure 4-4) 
and in subsequent experiments aortic rings were therefore left intact.  
 
Figure 4-3 Aortic preparation for extracellular flux analysis 
Mouse aortas were dissected in either DMEM at 37oC or PBS at 4oC and cut open longitudinally to 
form aortic sheets. Tissue pieces were then analysed using an islet capture plate and capture rings in a 
Seahorse XF24e extracellular flux analyser. Oligomycin (10 µg/ml final assay concentration), FCCP (1 
µM) and a combination of rotenone (Rot, 10 µM) and antimycin A (ant, 10 µM) were injected using 
ports A-C of the assay plate as indicated. Four measurement cycles were completed before and after 
each of the inhibitors. Data represents mean ± SEM of technical replicates of one experiment.  









































Figure 4-4 Aortic sheets and aortic rings in extracellular flux analysis 
Mouse aortas were dissected in DMEM at 37oC and either left as intact rings, or cut open 
longitudinally to form aortic sheets. Tissue pieces were then analysed using an islet capture plate and 
capture rings in a Seahorse XF24e extracellular flux analyser. Oligomycin (10 µg/ml final assay 
concentration), FCCP (1 µM) and a combination of rotenone (Rot, 10 µM) and antimycin A (ant, 10 
µM) were injected using ports A-C of the assay plate as indicated. Four measurement cycles were 
completed before and after each of the inhibitors. Data represents mean ± SEM of technical replicates 
of one experiment.  
 
4.4 Extracellular flux analysis of ApoE-/- mouse aortas 
Next, extracellular flux analysis of aortic tissues derived from ApoE-/- 
mice was performed. Mice were fed a ‘western’ high-fat diet for 2, 4, or 8 
weeks or alternatively left on normal chow (0 weeks of high-fat diet). The 
starting point of fat-feeding was staggered so that littermates were all 
sacrificed on the same day of an experiment aged 15 weeks. Rising CO2 
concentrations with subsequent cervical dislocation and cardiac puncture 
were used to kill the animals. After snap freezing liver and heart samples the 
aortas were quickly dissected in pre-warmed DMEM (37oC) and run in the 
extracellular flux assay. There was no significant difference in the OCR in 
these mice at any time point (Figure 4-5). Similarly, there was no significant 





































B) Oligomycin FCCP Rot/Ant
 
 110 
difference in the ECAR at baseline and after injection of oligomycin and FCCP 
(Figure 4-5). However, following injection of rotenone and antimycin ECAR 
was significantly lower in mice without fat-feeding (0 weeks) compared to fat-
fed mice (Figure 4-5). This result needs to be interpreted with caution as the 
assay was designed to mainly detect differences in OCR and injection of 
rotenone and antimycin is not normally used in assays designed to evaluate 





Figure 4-5 Extracellular flux analysis of ApoE-/- mouse aortas after fat-feeding 
Aortas were dissected in pre-warmed DMEM after sacrifice of ApoE-/- mice with or without fat-
feeding. Aortic tissue samples from aortic arch to proximal abdominal aorta were secured in 24-well 
islet capture wells using the mesh provided with the kit. Oligomycin (10 µg/ml final assay 
concentration), FCCP (1 µM) and a combination of rotenone and antimycin A(Rot/Ant, 10 µM each) 
were injected through ports A-C of a 24-well extracellular flux analyser (Seahorse 24XFe) and the 
oxygen consumption rate (OCR) and the extracellular acidification rate (ECAR) were determined. 
After completion of the run the tissue pieces were retrieved and weighed to allow normalisation of the 
data. A) OCR normalised to tissue wet weight (mmol/min/µg wet weight). B) ECAR normalised to 
tissue wet weight (mpH/min/µg wet weight), **P<0.01 0 weeks vs 4 weeks and 8 weeks, ***P<0.001 
0 weeks v 4 weeks, two-way ANOVA with Tukey correction for multiple comparisons.  
 
4.5 Immunohistochemistry of mouse aortas after fat-feeding 
To confirm that ApoE-/- mice have not developed significant 
atherosclerosis after fat-feeding for up to 8 weeks tissue pieces were retrieved 
from the Seahorse extracellular flux analysis plates after completion of the 
run, weighed, fixed in formalin and immunohistochemistry was performed. 
From the aortic tissue pieces that were used in extracellular flux analysis 
(aortic arch to proximal abdominal aorta) the aortic arch is the area most 
prone to develop atherosclerosis (Nakashima et al., 1994) and was therefore 
analysed. As demonstrated in representative images in Figure 4-6 no 





 Figure 4-6 Immunohistochemistry of ApoE-/- mouse aortas after high-fat diet 
After completion of the Seahorse extracellular flux analysis run, aortic arch tissue pieces were fixed in 
formalin and immunohistochemistry was performed. Haematoxylin and eosin stain (H&E): nuclei 
(blue) and eosinophilic structures such as cytoplasm (red). MAC3: immunohistochemistry against 
surface macrophage marker. SMA: immunohistochemistry against smooth muscle cell actin. Masson’s 
trichrome stain: smooth muscle cells/cytoplasm (red), collagen (blue) and nuclei (brown). 
Representative images are shown. No atherosclerotic plaques were visualised in aortic arches of N=4 
animals per group.  
 
4.6 mtDNA copy number 
In section 3.6 I described that mtDNA copy number correlates well with 
mitochondrial mass across different tissues (D'Erchia et al., 2015). I therefore 
tested whether prolonged fat-feeding, known to induce mtDNA damage (E. Yu 
et al., 2013), also affects mtDNA copy number. qPCR was used to determine 
the amplification of a short mitochondrial segment relative to a nuclear DNA 
segment. First, serial dilutions of DNA were run to determine the reaction 
efficiency of the mitochondrial and nuclear PCR reactions (Figure 4-7). To 
confirm amplification of a single product of the right size, the PCR product 
250 µm 







was run on a 1% Agarose gel, and DNA visualised using UV light after 
staining with GelRed (Figure 4-8). After validation of the qPCR assay for 
mtDNA copy number, DNA samples from aortas after fat-feeding were 
analysed. Fat-feeding for 4 or 8 weeks significantly reduced mtDNA copy 
number in mouse aortas compared to no fat-feeding (Figure 4-9). 
 
 
Figure 4-7 Validation of qPCR efficiency for mouse nuclear and mitochondrial 
DNA reactions 
Mouse DNA was serially diluted (1:2) and qPCR reactions were run in triplicate on a Corbett Rotor-
Gene™ 6000 QPCR thermocycler. A) The nuclear reaction was linear with an efficiency of 1.17 in the 
DNA range 20-0.625 ng. B) Melt curve analysis suggests amplification of a single product. The 
mitochondrial reaction (C) was linear and had a comparable efficiency (1.29) in the DNA loading 
range 10-0.0625 ng. D) Melt curve analysis of the mitochondrial reaction suggests amplification of a 
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Figure 4-8 Confirmation of single PCR product from mouse nuclear and 
mitochondrial reactions 
10 µl of PCR product from nuclear DNA reaction and mitochondrial DNA reaction were run on a 1% 
agarose gel, stained with GelRed and visualised by UV light. Nuclear amplicon is expected to be 155 
bp, mitochondrial amplicon is expected to be 127 bp. Expected molecular weight of 2-log ladder 













































Figure 4-9 Effects of fat-feeding on mtDNA copy number in ApoE-/- mouse 
aortas 
DNA was isolated from aortas of ApoE-/- mice after fat-feeding or from littermate control ApoE-/- 
mice kept on standard chow. qPCR is used to amplify a short mtDNA segment (127 bp) and a short 
nuclear DNA segment (β-globin, 155 bp product). MtDNA copy number is calculated as 2x2Δct, where 
ΔCt=Ct(mtDNA)-Ct(nuclearDNA). This formula contains a correction by the factor 2 to account for 2 
copies of the β-globin gene in the genome. N=5 mice per group, one-way ANOVA (Fisher’s test) was 
used for statistical analysis. 
 
4.7 ATP/ADP ratio 
To get an alternative readout of mitochondrial function the ATP/ADP 
ratio was measured in aortas from ApoE-/- with and without fat-feeding. I used 
an assay where ATP is required for a luciferase/luciferin reaction creating light 
emission, which is quantified by a luminometer. ADP is quantified after 
degradation of ATP in the sample, conversion of ADP to ATP, and 
quantification of ATP. Standard curves for ATP and ADP were used for 
normalisation and the ratio ATP/ADP was formed. ATP and ADP were 
isolated from snap frozen aortic samples. Variability was great between 
samples but the data was not suggestive of large changes in the ATP/ADP 




Figure 4-10 ATP/ADP ratio in aortas from ApoE-/- mice after fat-feeding 
Aortic tissues were snap frozen and ATP and ADP were extracted in perchloric acid to avoid 
degradation. ATP concentrations were determined using a luciferase/luciferin assay. ADP 
concentrations were determined following ATP degradation and conversion of ADP to ATP and 
subsequent ATP measurement by luciferase/luciferin assay. N=3 per group (N=2 for 8 weeks of fat-
feeding due to sample loss). Data are mean ± range. There were no statistical differences between 0, 2 
and 4 weeks of fat-feeding using one-way ANOVA (Fisher’s test). 8 weeks was excluded from 
statistical analysis due to sample loss. 
 
4.8 MitoP/B ratio and glutathione levels in tissues from ApoE-/- 
mice after fat-feeding 
Previous studies have demonstrated that increased concentrations of 
ROS can be detected during atherosclerosis in mouse aortas (M. Ekstrand et 
al., 2015). However, the source of ROS remains unclear. To measure 
mitochondrial ROS production the mitochondrially targeted probe, MitoB, has 






















to from MitoP. Our laboratory has recently demonstrated that fat-feeding of 
ApoE-/- mice for 14 weeks induces mitochondrial ROS production as 
determined by quantification of the MitoP/B ratio using mass spectroscopy (E. 
P. K. Yu et al., 2017). However, it remained unclear whether ROS increase 
prior to the development of atherosclerotic lesion, i.e. after short-term fat-
feeding of ApoE-/- mice. I therefore determined the MitoP/B ratio of ApoE-/- 
mice fat-fed for 8 weeks in comparison to littermate control mice kept on 
normal chow. Figure 4-11 demonstrates that ROS production in aortas is not 
affected in ApoE-/- mice after 8 weeks of fat-feeding (see also Appendix 8.4). 
Unexpectedly, mitochondrial ROS production was significantly reduced in 
livers of fat-fed mice. Previous studies have shown that MitoP/B ratios can 
vary across tissues (Logan et al., 2014; E. Yu et al., 2013), a potential 
explanation for the higher ratios observed in aortas is the longer exposure to 
atmospheric oxygen concentrations due to longer dissection times. Although 
not formally assessed, mouse hearts and liver were snap-frozen faster than 
mouse aortas for which dissection took several minutes. Such differences 





Figure 4-11 MitoB/P ratio in aorta, liver and heart of ApoE-/- mice 
After weaning ApoE-/- mice were fat-fed for 8 weeks or kept on normal chow. 25 nmol MitoB was 
injected into the tail-vein and mice were sacrificed 3 hours later. Aortic, liver and heart tissue was snap 
frozen until extraction of MitoB and MitoP in acetonitrile and formic acid. Concentrations of MitoB 
and MitoP were determined using mass spectroscopy with deuterated d15 internal standards. Black 
circles: normal chow, blue circles: fat-feeding for 8 weeks. N=6-8 mice for each group. Unpaired two-
tailed t-test assuming equal variation was used for statistical analysis for each tissue type.   
 
To get further evidence of effects of fat-feeding on ROS production in 
mouse aortas I also determined total glutathione levels. 8 weeks of fat-feeding 
did not affect total glutathione levels in ApoE-/- mouse aortas  (Figure 4-12) 
supporting the observation of unaffected mitochondrial ROS concentrations. 
This data needs to be interpreted with caution as the dissection of mouse 
aortas took several minutes after mouse sacrifice which may have affected 



















Figure 4-12 Total glutathione levels in ApoE-/- mice after fat-feeding 
Total glutathione was extracted from snap frozen aorta samples of ApoE-/- mice fed a high-fat diet for 
8 weeks or kept on normal chow. Total glutathione levels were determined using a recycling assay, 
thus measuring both GSH and GSSG. Standards of GSH were used to determine quantities of total 
glutathione in the tissue. N=6 aortas in each group. No statistical significant differences were observed 
using unpaired two-tailed t-test with equal variation.  
 
4.9 Extracellular flux analysis of ApoE-/- mouse aortas after 14 
weeks of fat-feeding 
Because fat-feeding of ApoE-/- mice for up to 8 weeks induced very 
few changes I repeated the Seahorse extracellular flux analysis in ApoE-/- 
mice after 14 weeks of fat-feeding. This duration of fat-feeding is expected to 
induce atherosclerosis in ApoE-/- mouse aortas (E. Yu et al., 2013). Because 
of the longer period of fat-feeding, mice studied in this set of experiments 
were 21 weeks old, whereas mice in the experiments described in section 4.4 
were 15 weeks old. Again, there was no significant change in the OCR or 
ECAR of aortas from ApoE-/- mice after 14 weeks of fat-feeding compared to 
littermate control mice on standard chow. 
 























Figure 4-13 Extracellular flux analysis of aortic tissues from ApoE-/- mice after 
fat-feeding for 14 weeks 
Aortas were dissected in pre-warmed DMEM after sacrifice of ApoE-/- mice with or without fat-
feeding for 14 weeks. Aortic tissue samples from aortic arch to proximal abdominal aorta were secured 
in 24-well islet capture wells using the mesh provided with the kit. Oligomycin (10 µg/ml final assay 
concentration), FCCP (1 µM) and a combination of rotenone and antimycin A(Rot/Ant, 10 µM each) 
were injected through ports A-C of a 24-well extracellular flux analyser (Seahorse 24XFe) and the 
oxygen consumption rate (OCR) and the extracellular acidification rate (ECAR) were determined. 
After completion of the run the tissue pieces were retrieved and weighed to allow normalisation of the 
data. A) OCR normalised to tissue wet weight (mmol/min/µg wet weight). B) ECAR normalised to 
tissue wet weight (mpH/min/µg wet weight). N=4 animals per group, no statistical significant 






















































differences between groups were observed using serial unpaired two-tailed t-tests with Holm-Sidak 
correction for multiple comparisons.  
 
4.10 Discussion 
Previous work in our laboratory has shown that fat-feeding of ApoE-/- 
mice induces mtDNA damage prior to the development of atherosclerotic 
lesions (E. Yu et al., 2013). However, the functional consequences of such 
damage were not known. In this part of the project I adapted the Seahorse 
extracellular flux analysis assay to assess the OCR and ECAR in aortic tissue 
from ApoE-/- after fat-feeding.  
First I confirmed that fat-feeding of ApoE-/- mice had the desired pro-
atherogenic effects. Serum concentrations of cholesterol significantly 
increased with fat-feeding as expected from previous studies in our laboratory 
(E. Yu et al., 2013), although the effect size of fat-feeding was smaller than 
previously reported (Plump et al., 1992). The discrepancies may in part be 
explained by different sampling times of blood with effects of the circadian 
rhythm and fasting state of mice as well as slight variations in the diet 
provided. However, the ‘western’ diet chosen for the present study (Special 
Diets Services 829100, ~21% Fat, ~20% Protein) should resemble the diet 
used by Plump et al. (1992) relatively closely. Future studies in our laboratory 
should aim to investigate the reasons for these differences in cholesterol 
levels in greater detail to allow better comparability of our studies using ApoE-
/- mice on high-fat diet to studies by other research groups.  
There was also an increase in serum TNF-α cytokine levels after fat-
feeding, but other inflammatory cytokines such as IL1β were not changed. In 
the present study fat-feeding increased TNF-α to between 15-36 pg/ml 
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compared to baseline levels of 7-13 pg/ml. For comparison, LPS treatment of 
mice increases serum TNF-α to above 103 pg/ml (Mills et al., 2016), however, 
fat-feeding of ApoE-/- mice, even for prolonged periods of over one year, only 
increases TNF-α concentrations to approximately three times baseline levels 
(Dinh et al., 2017). Thus the effects of fat-feeding on serum cytokine levels 
are expected to be relatively small, consistent with the findings in the present 
study.  
To assess the respiration of aortic tissue of fat-fed ApoE-/- mice I 
adapted the Seahorse extracellular flux assay for the measurement of tissue 
samples. This assay has previously been used for the measurement of fat 
(Dunham-Snary et al., 2014), brain (Fried et al., 2014) and aortic (Feeley et 
al., 2014) tissues. The final assay inhibitory concentrations were adapted from 
Feeley et al. (2014) as their technique analysed the same tissue as the 
present study. In a first set of experiments I further optimised the handling of 
aortic tissue after sacrifice of the mice. Preparation in warm DMEM led to less 
intra-experimental variation compared to preparation in ice-cold PBS and was 
therefore used in subsequent experiments. Similarly, keeping mouse aortic 
rings intact rather than cutting them longitudinally to form aortic sheets led to 
more consistent measurements. This may be due to additional tissue damage 
introduced by the scissors in the aortic sheet group. Consequently, aortic 
rings were left intact in the following experiments.  
After optimisation, Seahorse extracellular flux analysis was performed 
on aortas derived from ApoE-/- mice with or without fat-feeding. No 
differences in OCR or ECAR were observed between groups. There is limited 
data available to compare the results of the present study against. In a 
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description of the Seahorse method on mouse aortic tissues, the authors 
reported on a single experiment comparing fat-fed ApoE-/- mice with ApoE-/- 
mice on a normal chow (Feeley et al., 2014). There were numerical 
differences in the OCR between the groups, with the OCR being higher in the 
fat-fed group, but the analysis was based on two mice per group and 
therefore no statistical analysis was provided. In isolated rat hearts, increased 
availability of fatty acids as metabolites leads to increased OCR, probably in 
part due to increased uncoupling of mitochondria (Cole et al., 2011). 
However, oxidation of lipid species and formation of OxLDL may also 
decrease OCR of VSMCs as demonstrated in a previous study (Ahn et al., 
2010) and the present study (see chapter 3). There are at least two 
explanations for not observing any differences in OCR in aortas after fat-
feeding in the present study. The stimulatory effects of lipids on respiration in 
mouse aortas may be less pronounced than in cardiac tissues, as the energy 
requirements are considerably lower. Furthermore, the assay was performed 
in the presence of glucose such that changes in β-oxidation of fatty acids 
would not be adequately captured. Mouse aortas were also assessed at a 
time point where no significant atherosclerotic lesions have developed. A 
detailed analysis of lesion development, their timing and location has 
previously been performed by Nakashima et al. (1994). This study suggests 
that foam cell lesions and at least intermediate lesions should have been 
visible after 8 weeks of fat-feeding. Similarly, a previous study from our lab 
suggests that although lesion development at this stage is small (E. Yu et al., 
2013) it can be detected with H&E staining as early as 7 weeks after fat-
feeding. A possible explanation for the relatively small lesion sizes in our 
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laboratory could be the weaker effects of our western diet on total cholesterol 
concentrations compared to previous studies (Nakashima et al., 1994; Plump 
et al., 1992) and in the present study also the area of aorta that was sampled, 
i.e. excluding the aortic root which develops atherosclerotic lesions first.  
In a further experiment mice were therefore fat-fed for 14 weeks at 
which point atherosclerotic lesions are expected to be well established. 
However, no changes in OCR and ECAR were observed in these experiments 
either. The method may not be sensitive enough to detect subtle changes in 
metabolism or oxygen consumption. Even after 14 weeks of fat-feeding the 
proportion of aorta affected by atherosclerosis is less than 10% once the 
aortic root is excluded (E. Yu et al., 2013); thus the OCR in this assay will 
mainly be determined by healthy tissue. 
Another limitation of the present technique is the sacrifice of animals 
through the use of rising CO2 concentrations. It is well established that 
hypoxia can decrease metabolic rates of mammals but the effects of CO2 
have generally been less studied (Saiki & Mortola, 1996). Although CO2 
concentrations up to 5% do not affect metabolism of rats (Saiki & Mortola, 
1996), it is currently unclear whether higher concentrations used in the 
present study to sacrifice the animals could affect metabolism. Tissues were 
dissected in atmospheric CO2 concentrations but I cannot exclude an effect of 
prior high CO2 exposure on metabolism or viability of mitochondria. Future 
experiments should use alternative means of sacrifice such as cervical 
dislocation to study metabolism of tissues. 
In line with the results of the Seahorse extracellular flux analysis there 
were no obvious effects of fat-feeding on the ATP/ADP ratio, with the caveat 
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that the dataset was small. Similarly, fat-feeding did not affect the production 
of mitochondrial ROS as determined by the MitoP/B ratio, nor did it affect total 
glutathione levels. The redox state or the presence of redox stress could 
additionally have been investigated by other techniques, for example using 
2’,7’ –dichlorofluorescin diacetate (DCFDA) dye (E. Yu et al., 2013), however 
this would not have been able to differentiate between mitochondrial 
generated ROS or ROS generated from other cellular sites. The only 
significant difference induced by fat-feeding was a reduction in mtDNA copy 
number. This is consistent with previous work in our laboratory demonstrating 
increased aortic mtDNA damage after fat-feeding of ApoE-/- mice. Thus, 
mtDNA damage and a reduction in mtDNA copy number may occur prior to 
the development of functional consequences.  
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In this chapter I investigate whether the mtDNA damage that is present 
in advanced human atherosclerosis (E. Yu et al., 2013) has functional 
consequences. For this, the Seahorse extracellular flux assay was used to 
measure the OCR and ECAR of tissues derived from carotid 
endarterectomies (section 5.2). The respiratory reserve capacity of the 
diseased cap and core regions were significantly lower compared to relatively 
unaffected media. Similar to mouse tissue exposed to high lipids (section 4.6) 
a reduced mtDNA copy number was found in tissue derived from carotid 
endarterectomies (section 5.3). Consistent with these findings the expression 
of complexes I and II of the ETC were reduced in VSMCs cultured from 
carotid endarterectomies (section 5.4). However, Seahorse extracellular flux 
analysis of VSMCs derived from plaque or aorta did not recapitulate the 
findings from whole tissues (section 5.5).  
 
5.2 Human atherosclerotic plaque tissue extracellular flux 
analysis 
Tissues derived from carotid endarterectomies were obtained from 
surgical theatres at Addenbrooke’s Hospital, Cambridge. All specimens were 
from male patients. The average age of the donors was 69.4 years ± 8.47 
years (standard deviation). Four distinct areas corresponding to normal 
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carotid medial wall, the shoulder region of the atherosclerotic plaque as well 
as the cap region and the necrotic core were identified (for an illustration of 
the definitions of medial wall, shoulder region, cap region and necrotic core 
region see Figure 5-1).  
 
Figure 5-1 Illustration of sample areas for Seahorse extracellular flux 
experiments of carotid endarterectomies.  
Hematoxylin and eosin stain of human carotid endarterectomy sample. Top right: lumen. Sample areas 
used for Seahorse experiments and scale bar are depicted for illustration.  
 
Five sections of approximately 1 mg each were dissected from each of 
these areas and analysed in a Seahorse extracellular flux analyser. To 
confirm that the appropriate regions were sampled and to allow for 
normalisation against cellular density in addition to wet weight, the tissue 
pieces were retrieved and subjected to standard immunohistochemistry. 











shoulder regions are relatively similar, there are clear differences in the 
staining pattern of the cap and core regions compared to the media. Whilst 
the media and the shoulder region stain for smooth muscle actin, less staining 
is observed in the cap and the core areas. Masson’s trichrome stain reveals 
collagen staining, particularly in the cap and the core regions. CD68 as a 
marker of macrophages is found in the core region, but also in the cap and 
shoulder region. The mean cellular density across different plaque regions is 
depicted in Figure 5-3. For normalisation of Seahorse data, each OCR and 
ECAR value was therefore normalised to the wet weight and nuclei count of 
the corresponding tissue sample.  
The results of the Seahorse extracellular flux analysis of tissues from 
carotid endarterectomies are shown in Figure 5-4. Only the healthy wall and 
the shoulder region of the plaque responded significantly to FCCP uncoupling 
by increasing oxygen consumption. Accordingly, the RRC of the media was 





Figure 5-2 Immunohistochemistry of human tissue from carotid 
endarterectomies 
After completion of the Seahorse extracellular flux analysis run, tissue pieces were fixed in formalin 
and immunohistochemistry was performed. Haematoxylin and eosin stain (H&E): nuclei (blue) and 
eosinophilic structures such as cytoplasm (red). Masson’s trichrome stain: smooth muscle 
cells/cytoplasm (red), collagen (blue) and nuclei (brown). SMA: immunohistochemistry against smooth 
muscle cell actin. CD68: immunohistochemistry against surface macrophage marker. Representative 












Figure 5-3 Cellular density in carotid atherosclerotic plaque regions 
Cellular density was determined by counting nuclei in representative visual fields in 5 independent 
experiments. Five tissue pieces per region were counted in each experiment. There were no statistically 
significant differences in cellularity between the groups using one-way ANOVA with Bonferroni’s 






























Figure 5-4 Seahorse extracellular flux analysis of tissues derived from carotid 
endarterectomies 
Seahorse extracellular flux analysis was performed on tissue samples derived from human carotid 
endarterectomy specimens. The media, shoulder, cap and core regions were identified and samples 
weighing approximately 1 mg were dissected and analysed in Seahorse islet capture plates on a XF24e 
platform. Data was normalised to individual tissue wet weights and nuclear density. A) Oxygen 
consumption rate (OCR) at baseline and after serial injection of oligomycin (10 µg/ml final assay 
concentration), FCCP (1 µM) and a combination of rotenone and antimycin A (Rot/Ant, 10 µM each). 
N=5 carotid endarterectomy samples B) OCR expressed as % baseline (i.e. last measurement before 
oligomycin injection). N=6 carotid endarterectomy samples. Unpaired two-tailed t-tests with Holm-
Sidak method for correction of multiple comparisons. C) Respiratory reserve capacity (RRC) of 
different regions of the plaque. N=5 carotid endarterectomy samples, ANOVA with Bonferroni’s 
correction for multiple comparisons. D) Extracellular acidification rate (ECAR) at baseline and after 
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5.3 Mitochondrial DNA copy number in plaque and healthy 
tissues 
mtDNA copy number is highly correlated to mitochondrial gene 
expression levels and mitochondrial mass across different tissues (D'Erchia et 
al., 2015), such that a reduction in mtDNA copy number may be a possible 
explanation for the reduced respiratory reserve capacity in cap and core 
regions. mtDNA copy number was therefore determined using the qPCR 
method comparing the amplification of two short mitochondrial DNA segments 
(mt3211 and mt9827) to the amplification of a short nuclear segment (β2 
microglobulin). The reaction efficiency of the nuclear amplification was similar 
to the mitochondrial segments using DNA in the range of 50-0.2 ng (Figure 
5-5). Amplification of a single product in each reaction was confirmed by 
electrophoresis on a 1% agarose gel (Figure 5-6).  
Age- and sex- matched samples of carotid endarterectomies and 
healthy aortas were derived from our internal tissue bank. The average age of 
donors for aortic tissue was 71.7 years ± 8.3 years (SD) and that of carotid 
tissue was 70.6 years ± 11.1 years (SD). 66% of both aortic tissue donors and 
carotid tissue donors were male. mtDNA copy number was significantly 
reduced in tissues derived from plaques compared to healthy aortas (Figure 
5-7).  
 
5.4 Expression of electron transfer complexes in plaque and 
aortic VSMCs 
A reduced RRC of plaque tissue may be explained by changes in the 
expression of complexes of the ETC. To test this hypothesis, Western blot 
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was performed on cell lysates from plaque and aortic VSMCs. The average 
age of donors for aortic VSMCs was 48.6 years ± 26.0 years (SD), the 
average age of plaque VSMC donors was 65.2 years ± 3.9 years (SD). All 
donors of aortic VSMCs were male, but only 40% of plaque VSMC donors 
were male. Figure 5-8 demonstrates that the expression of complexes I and II 
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Human DNA was serially diluted (50 ng, 10 ng, 1 ng and 0.2 ng) and qPCR reactions were run in 
triplicate on a Corbett Rotor-Gene™ 6000 QPCR thermocycler. Linearity of nuclear reaction (A) and 
mitochondrial reactions mt3211 (C) and mt9827 (E) with appropriate reaction efficiencies and 
corresponding melt curve analyses (B, D, F) are shown. dF/dT: the derivative of fluorescence (F) with 




Figure 5-6 Confirmation of single PCR product from human nuclear and 
mitochondrial reactions 
10 µl of PCR product from nuclear DNA reaction (β2 microglobulin) and mitochondrial DNA reactions 
(mt3211 and mt9827) were run on a 1% agarose gel, stained with GelRed and visualised by UV light. 
2-log ladder ranging from 0.1-10 kb is shown in the right lane. Expected amplicon sizes are: β2 
microglobulin – 86 bp, mt3211 – 87 bp, mt9827 – 147 bp.  
 










Figure 5-7 Mitochondrial DNA copy number in carotid atherosclerotic plaques 
and healthy aortas 
DNA was isolated from snap frozen tissues derived from carotid endarterectomies (plaque) and healthy 
aortas. qPCR was performed to amplify two short mtDNA segments and a short nuclear DNA segment 
(β2 microglobulin). The average Ct value for the two short mtDNA segments, Ct(mtDNA), was 
formed. MtDNA copy number was calculated as 2x2Δct, where ΔCt=Ct(mtDNA)-Ct(nuclearDNA). 
This formula contains a correction by the factor 2 to account for 2 copies of the β2 microglobulin gene 
in the genome. Data represents mean ± SEM of N=9 per group. Unpaired two-tailed t-test was used to 




























































































































Figure 5-8 Expression of electron transfer chain complexes in plaque and aortic 
VSMCs 
Whole cell lysates of aortic and plaque VSMCs were run on 8-12% gradient SDS gels. Western blot 
(top) and quantification (bottom) of protein expression of mitochondrial protein complexes within the 
electron transport chain [Complexes I-IV and ATPase (V)] is depicted. Data are mean ± SEM of N=3 
(III-V) or N=5 (I-II) primary cell lines per group relative to citrate synthase (CS). See also Appendix 
8.1. 
 
5.5 Oxygen consumption rate of cultured VSMCs derived from 
atherosclerotic plaques or healthy aortas 
VSMCs are the main cellular component of the media and the fibrous 
cap. To help clarify whether the reduced RRC observed in diseased tissue is 
permanent (and therefore present in cells cultured from the plaque) or 
potentially reversible, I cultured VSMCs derived from carotid endarterectomies 
and aortas under standard conditions and subjected them to Seahorse 
extracellular flux analysis. To do this, FCCP concentrations in the assay were 
optimised for use in human VSMCs  (Figure 5-9) and 1 µM FCCP were used 
in the following. Aortic VSMC donors were 62.4 years ± 6.7 years old and all 
male, plaque VSMC donors were 71.8 years ± 10.8 years old and all male. As 
demonstrated in Figure 5-10 there were no significant differences in the OCR 




Figure 5-9 FCCP titration for Seahorse extracellular flux analysis in HVSMCs 
HVSMCs were plated into a 96-well Seahorse culture plate and allowed to adhere overnight prior to 
extracellular flux analysis. OCR expressed as % baseline is shown for various concentrations of FCCP. 
Data represent means ± SEM of technical replicates in one experiment. 1 µM FCCP induced the 
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Figure 5-10 Seahorse extracellular flux analysis of HVSMCs and plaque VSMCs 
HVSMCs and plaque VSMCs were plated into Seahorse 96 well culture plates and were allowed to 
adhere for at least 16 hours. The oxygen consumption rate (OCR) and extracellular acidification rate 
(ECAR) were determined before and after serial injection of oligomycin (2 µg/ml final assay 












































concentration), FCCP (1 µM) and a combination of rotenone (Rot, 1 µM) and antimycin A (Ant, 1 µM) 
as shown. Data represents mean ± SEM of N=6 experiments. There were no significant differences 




To my knowledge this is the first report demonstrating altered 
mitochondrial respiration in diseased human tissue using the Seahorse 
extracellular flux analysis technique. Despite the data variability, a significant 
reduction in the response to FCCP was observed in the diseased cap and 
core regions of the plaque. This finding was supported by evidence of 
reduced mtDNA copy number in plaque tissue compared to healthy aortic 
tissue. Reduced mitochondrial respiration after uncoupling may relate to 
reduced protein expression of the ETC complexes I and II in plaque VSMCs 
demonstrated in this chapter. Reduced mitochondrial respiration, however, 
was not observed in plaque VSMCs compared to healthy VSMCs. 
Microdissecting atherosclerotic plaques for Seahorse extracellular flux 
analysis is technically challenging. Therefore, the n-numbers of the present 
study are relatively small. It is possible that the areas identified and analysed 
may not completely represent the healthy media, shoulder region or the cap 
and core regions. For example, samples thought to derive from the shoulder 
region, may, to a degree, have included tissue from the neighbouring core 
region. For this reason, immunohistochemistry was performed on tissue 
pieces after completion of the assay, demonstrating different areas of the 
atherosclerotic plaque can be sampled. Furthermore, contamination of 
samples with adjacent areas should lead to a reduced effect size such that 
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this study may have underestimated the true differences present in vivo rather 
than overestimating them. Data was normalised to both the tissue weight and 
cellularity suggesting that the differences observed were not due to tissue 
mass or cellular density. Furthermore, the ECAR increased in all regions after 
serial injections of mitochondrial inhibitors suggesting that all plaque areas 
remained metabolically active. However I cannot rule out that some of the 
differences observed between the regions are driven by differences in cellular 
composition of the sampled areas. For example, the core region may have 
contained more inflammatory cells than the media explaining the different 
Seahorse extracellular flux analysis profile. Since the completion of the 
experimental work for this study Dr Mercer’s group has published a similar 
study examining different areas of human atherosclerotic plaque derived from 
carotid endarterectomies for respiration (Docherty, Carswell, Friel, & Mercer, 
2018). Not only did that study confirm the findings of reduced respiration in 
the cap and core region of human atherosclerosis presented here, but also 
attempted to quantify the cellular composition of the different regions of the 
plaque in more detail. Their work suggests that although the shoulder region 
and the core region have higher proportions of inflammatory cells, the 
composition of the cap region and the healthy media is very similar. The 
present study did not determine viability of cells in the regions sampled and it 
is therefore possible that the differences observed reflect a general decline in 
cellular viability rather than a defect that is specific to mitochondria. 
One of the advantages of the Seahorse assay is that it allows for the 
simultaneous assessment of mitochondrial respiration in up to 20 tissue 
samples. However, the laborious post assay sample validation using 
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immunohistochemistry and determination of cellular density may limit its 
widespread use in the assessment of mitochondrial function in diseased 
tissues.  
In the present work, mtDNA copy number was reduced in plaque tissue 
compared to healthy aortic tissue. This observation fits with a previous report 
from our laboratory demonstrating increased mtDNA damage in plaques 
compared to aortas (E. Yu et al., 2013) and with reduced mitochondrial 
respiration in the present study. Similarly, the reduced expression of ETC 
complexes I and II in plaque VSMCs could offer an explanation of the reduced 
mitochondrial respiration observed in diseased plaque tissue. Complex I is 
particularly prone to oxidative damage due to its size and composition from 
multiple subunits as well as its exposure to high concentrations of ROS 
(Murphy, 2009; J. Zhu, Vinothkumar, & Hirst, 2016). There is evidence that 
reduced activity of ETC complexes I and II are relevant to other human 
diseases. For example, mutations of vacuolar sorting protein 35 (VPS35), 
known to cause Parkinson’s disease, also lead to reduced complex I and II 
assembly and activity and increased mitochondrial fragmentation (W. Wang et 
al., 2016; L. Zhou, Wang, Hoppel, Liu, & Zhu, 2017). 
Using cultured VSMCs from plaques or aortas, however, I did not 
demonstrate any difference in the OCR or ECAR using the Seahorse 
extracellular flux assay. This result was surprising, given the reduced 
expression of complexes I and II in these cells. The disconnection between 
protein expression of ETC complexes and results from the extracellular flux 
analysis is concerning. There was, however, a great variability in the 
extracellular flux analysis of cultured human cells leading to large standard 
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errors. It may therefore be possible that any potential effect of reduced 
expression of complexes I and II was not captured in this assay. The result of 
the present study is also contradicting previous experiments in our laboratory, 
which demonstrated a clear difference in OCR and RRC in plaque VSMCs 
compared to aortic VSMCs (E. P. K. Yu et al., 2017). Of note, the experiments 
that were previously conducted had much lower standard errors.  It may be 
that the differences in the results are due to a slightly different population of 
VSMCs investigated. VSMCs were cultured from plaques containing very 
diseased core areas as well as shoulder, cap and media regions. During cell 
culture a subset of more viable cells originating from the media may become 
selected thus diminishing any differences seen between aortic and plaque 
VSMCs. Discrepancies in experiments using cultured VSMCs underline the 
importance of validating findings in whole tissues as presented in the present 
study, whenever possible.   
Taken together, the results from this chapter add to the growing 
evidence of mitochondrial dysfunction in aging and age-related diseases. For 
example, because approximately 95% of ATP in healthy hearts is formed 
through mitochondrial oxidative phosphorylation (De Jong & Lopaschuk, 
2017) and mtDNA defects can lead to primary cardiomyopathies 
(Casademont & Miro, 2002), mitochondrial dysfunction has also been 
implicated in heart failure. We know that deficiencies in electron transfer chain 
complex I can lead to severe cardiomyopathy (Chouchani, Methner, et al., 
2014) and that impaired cardiac energy reserves, measured as the 
phosphocreatine/ATP ratio, correlate with heart failure symptoms and predict 
mortality in dilated cardiomyopathy in humans (Neubauer et al., 1997; 
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Neubauer et al., 1992). It is frequently assumed that in heart failure there is a 
switch from oxidative phosphorylation of fatty acids and other substrates 
towards increased glycolysis (Lopaschuk, 2017). It has been proposed that 
this metabolic switch is a consequence of reduced mitochondrial oxidative 
capacity and reduced expression of genes required for fatty acid oxidation (De 
Jong & Lopaschuk, 2017). A switch to glycolysis could be an adaptive 
response to preserve ATP stores, however, a mismatch between glycolysis 
and oxidative phosphorylation could lead to lactate production, intracellular 
acidification and functional impairment (Lopaschuk, 2017).  
Mitochondrial dysfunction has also been implicated in a variety of 
neurodegenerative diseases including Alzheimer’s, Parkinson’s and 
Huntington’s diseases. Deprivation of nerve growth factor (NGF) is a well-
characterised model of programmed cell death in neurons offering similarities 
to vulnerable neurons in the ageing brain (McManus et al., 2014). Removal of 
NGF increases mitochondrial ROS production in neurons that can lead to 
caspase-dependent and independent cell death. Two cell lines, 7WD4 and 
7PA2, widely used as models for Alzheimer’s disease, demonstrate reduced 
respiration and increased glycolysis, decreased mitochondrial membrane 
potential and ATP content as well as dysfunctional ETC complexes I and IV 
(Krako et al., 2013). Similarly, ETC complex I impairment and ROS production 
are thought to be key modulators in experimental models of Parkinson’s 
disease (Mounsey & Teismann, 2010). Another mechanism in the disease 
pathology of Parkinson’s may be defective mitophagy. Mutations in the genes 
of PINK1 or parkin, important actors in mitophagy, cause dopaminergic 
neuron degeneration in Drosophila melanogaster (Clark et al., 2006; Park et 
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al., 2006) and cause early-onset Parkinson’s disease (Kitada et al., 1998; 
Valente et al., 2004). The role of mitophagy in VSMCs is further assessed in 
chapter 6. 
In summary, I have demonstrated that mitochondrial respiration is 
reduced in the cap and the core region of human atherosclerotic plaques. This 
reduction may partly be explained by reduced expression of ETC complexes I 
and II in VSMCs derived from such plaques. mtDNA copy number is also 
reduced in human atherosclerotic plaques supporting previous findings of 
increased mtDNA damage.  
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6 Assessment of mitochondrial turnover in human 
VSMCs derived from atherosclerotic plaques and 
healthy aortas  
 
6.1 Introduction 
The previous chapter has determined that there is mitochondrial 
dysfunction in human atherosclerosis manifest as reduced respiration and 
reduced mtDNA copy number as well as reduced expression of complexes I 
and II of the ETC in plaque VSMCs. To maintain mitochondrial homeostasis, 
various mechanisms have been identified, that allow cells to address 
mitochondrial damage. One of the key mechanisms for the degradation of 
dysfunctional mitochondria is mitophagy (section 1.2.3.1). After discussing 
and validating the use of the mitochondrially targeted mitophagy probe Keima 
(sections 6.2-6.3) I demonstrate that OxLDL but not LDL or LPS induce 
mitophagy in healthy human VSMCs (section 6.4) without effects on 
mitochondrial shape. I further demonstrate increased mitophagy and altered 
mitochondrial shape in plaque VSMCs compared to healthy aortic VSMCs 
(section 6.5). Expression of genes involved in mitochondrial fission and fusion 
(section 6.6) and biogenesis and repair (section 6.7), was assessed in plaque 




6.2 Approaches to mitophagy 
Mitophagy in mammalian cell can be assessed through a variety of 
techniques, each with their own advantages and limitations. Up to now no 
consensus has emerged as to which method is superior (Klionsky et al., 
2012). A direct way to detect mitophagy is through use of electron microscopy 
with identification of mitochondria within autophagosomes (Chu, 2010). 
However, electron microscopy is time-consuming and expensive and can 
potentially be subjective. Another method that is frequently used relies on the 
demonstration of colocalisation of mitochondria or mitochondrial proteins with 
lysosomes. For example, labelling of mitochondria can be achieved with 
MitoTracker Green FM and lysosomes can be labelled with LysoTracker Red. 
A positive colocalisation then leads to a yellow signal in the merged channels 
(Klionsky et al., 2012). Alternatively, colocalisation of autophagy markers such 
as LC3 with mitochondrial proteins such as LAMP1 or FUNDC1 has been 
used in the detection of mitophagy (L. Liu et al., 2012). However, this 
approach may cause artefacts as LC3 can also be incorporated into protein 
aggregates independently of autophagy (Kuma, Matsui, & Mizushima, 2007). 
Another way to quantify mitophagy is through the assessment of loss of 
mitochondrial mass using flow cytometry, immunocytochemistry and Western 
blot of mitochondrial proteins (Klionsky et al., 2012). Electron microscopy can 
further help identify loss of mitochondria, or qPCR as described in this thesis 
can be used to quantify mtDNA which is closely related to mitochondrial mass 
(see section 2.9). Further evidence of mitophagy has also been sought by 
confirming involvement of the PINK1/Parkin pathway. As PINK1 degradation 
is inhibited after inner mitochondrial membrane depolarisation (see section 
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1.2.3.1) increased PINK1 protein levels are supportive of mitophagy. 
Alternatively, Parkin translocation to the mitochondria can indicate mitophagy 
(Swiader et al., 2016), although both of these approaches on their own are not 
sufficient to prove mitophagy.  
A novel method to quantify mitophagy uses a fluorescent variant of the 
coral-derived protein Keima (Kogure et al., 2006). When targeted to 
mitochondria, Keima allows for the detection of mitophagy based on a pH-
dependent shift in the excitation spectrum once mitochondria are delivered to 
the lysosome (Katayama et al., 2011). Keima can be excited at 440 nm at the 
physiological mitochondrial matrix pH ~8, but the excitation spectrum shifts to 
allow excitation at 586 nm once mitochondria are targeted to the lysosome 
with an acidic pH (Figure 6-1).  
 
 
Figure 6-1 pH-dependent excitation spectrum of keima  
was completely degraded by lysosomal proteases at acidic pH,
mKeima and dKeima were resistant to acid proteases (Figures
S2A and S2B). Thus, transfection of mKeima or dKeima into
mammalian cells results in the formation of bright punctate struc-
tures with a high ratio of excitation at 550/438 nm. Because
dKeima matures slightly faster than mKeima (data not shown),
we chose dKeima to characterize these punctate structures
further. We examined the appearance ofmouse embryonic fibro-
blast (MEF) cells transfected with dKeima under different culture
conditions (Figure 3A). Fluorescent structures appeared when
cells were treated with 200 nM rapamycin or underwent starva-
tion by culture in Hank’s balanced salt solution (HBSS). The star-
vation-induced appearance of these structures was blocked by
treatment with PI3 kinase inhibitors (10 mM 3-methyladenine
[3-MA] or 100 nM Wortmannin), inhibitors of V-type H+-ATPase
(100 nM Bafilomycin A1), or H+-ionophores (30 mM NH4Cl).
These results indicate that a high ratio of excitation at 550/
438 nm for intracellular dKeima reflects autolysosome formation.
Use of Keima-Based Probes with Other Green-Emitting
Fluorophores
Because it possesses a long wavelength emission that peaks at
620 nm, Keima can be simultaneously imaged with green-emit-
ting fluorophores within the same cell without serious concern
for cross-excitation, cross-detection, and resonance transfer
(Figure S3). We cotransfected dKeima and iR-pHluorin into
MEF cells. Dual-excitation ratio imaging using dKeima, but not
iR-pHluorin, revealed punctate structures with high ratio values
and were sensitive to NH4Cl treatment (Figure 3B).
Althoughdual-excitation ratiometric dyesareexcitedalternately
at two different wavelengths, fluorophore emission is collected at
a single fixedwavelength; thepair of intensitymeasurementsmust
be collected sequentially. This limitation makes dual-excitation
ratiometric imaging generally inadequate to follow rapid events
in highly motile structures. In this regard, the observation of auto-
lysosome formation using dKeima may be limited by the poor
spatiotemporal resolution of conventional wide-field microscopy.
To confirm that the punctate structures were lysosomes, we
examined costaining with a lysosomal marker. To distinguish
these intracellular structures, we had to increase z axis resolu-
tion. In addition, because lysosomes are often motile, we sought
to increase the rapidity of production and collection of excitation
peak ratios. Although we had previously established a special
laser-scanning confocal microscopy (LSCM) system in which
two laser beams alternately scanned every line to achieve
dual-excitation ratiometric imaging (Shimozono et al., 2002; Fu-
kano et al., 2008), the same function is now available on certain
commercial LSCM systems. In this study, we examined dKeima-
expressing MEF cells by confocal imaging using a Zeiss LSM
510 META system equipped with a multi-argon laser (458, 488,
and 514.5 nm) and a He/Ne laser (543 nm) (Figure S4). Prior to
imaging, we treated cells with an Alexa 488-conjugated dextran
for 6 hr to identify lysosomes. Cells were then scanned on each
line sequentially by the 458 and 543 nm lasers and the 488 nm
laser to detect red emissions, providing the confocal ratio (543/
458) images for dKeima, and green emissions, generating
confocal images of lysosomes (Figure 3C). In a separate exper-
iment using this microscopy system, we generated a pH titration
curve using a dKeima-containing solution (Figure 3D). The ratio
(543/458) reflecting an acidic environment (pH <6.0) was
1.5–3.0. We then determined that the ratio (543/458) for pH <6.0
(Figure 3C, red) corresponded to the signals for lysosomal
staining using the fluorescent dextran (Figure 3C, green).
Detection of Autolysosome and Autophagosome
Formation by a Keima-Based Probe
and EGFP-LC3, Respectively
We transfected dKeima into MEF cells stably expressing EGFP-
LC3, then monitored the resultant fluorescence to observe auto-
phagic events (Figure 4). After starving for 1 hr in HBSS, trans-
fected cells developed cytoplasmic punctate structures with
high ratio (550/438) signals derived from dKeima fluorescence.
These signals, indicating autolysosome formation, increased
cumulatively over time. After replacement of HBSS with fresh
growth medium, dKeima-derived fluorescence persisted in
almost all transfected cells. In contrast, EGFP-LC3 fluorescence
increased during starvation but quickly decreased to normal
levels after substitution of rich medium, confirming the detection
of autophagosome formation by LC3-based probes.
Visualizing Parkin-Dependent Delivery of Impaired
Mitochondria to Lysosomes
Although autophagy was originally thought to be a nonspecific










































































Figure 2. pH-Dependent Spectral Properties of dKeima, mKeima, and iR-pHluorin
(A–C)Wemeasured the fluorescence excitation and emission spectra of purified recombinant proteins to determine the pH dependence of the excitation spectra
of dKeima (A), mKeima (B), and iR-pHluorin (C). (D) pH titration curves of the excitation peak ratio of dKeima (586/440), mKeima (586/440), and iR-pHluorin (481/
390). F. I., fluorescence intensity.
Chemistry & Biology
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Excitation spectra of keima at pH 4-8 and fixed emission spectrum is illustrated. F.I. fluorescence 
intensity. Reproduced from Katayama et al. (2011). 
 
Since Keima is resistant to lysosomal degradation, the Keima signal 
can be used to infer cumulative mitophagy (Sun et al., 2015). Keima-based 
assessment of mitophagy has been validated against parkin translocation as 
well as colocalisation with lysosomes (Katayama et al., 2011; Sun et al., 
2015). The method has already been used to demonstrate increased 
mitophagy in PolG mice, which have high levels of mtDNA damage, during 
hypoxia, and in a mouse model of B16 melanoma cell injection (Sun et al., 
2015). Decreased mitophagy was observed with ageing in WT mice and in 
mice expressing the transgene for human Huntingtin’s protein, which has 
deleterious effects on mitochondrial function (Sun et al., 2015). 
 
6.3 Use of Keima-expressing lentiviral particles 
Because of the limited availability of plaque VSMCs I considered the 
approach using Keima to assess mitophagy to be most promising. A lentiviral 
strategy was chosen as this would lead to stable expression of Keima and 
infection can also occur in non-dividing cells (Naldini et al., 1996). Lentiviral 
particles were generated in HEK-293T cells, harvested, and concentrated. 
qPCR was performed to determine lentiviral copy number. Lentiviral particles 
were then used to infect target HeLa cells to validate the method. As 
demonstrated in Figure 6-2 lentiviral infection of HeLa cells resulted in protein 
expression of Keima. The expression of Keima was then assessed using a 
SP5 confocal microscope (Leica) after plating HeLa cells into glass-bottom 
culture dishes for live cell imaging. Structures resembling mitochondrial 
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networks could be visualised but there was variability in the Keima signal 
across cells (Figure 6-3). Areas of Keima signal corresponding to normal pH 
(green Keima in the following) and acidic pH (red Keima in the following) were 
visible in cells. 
 
 
Figure 6-2 Keima expression in HeLa cells after lentiviral infection 
Western blot confirmed expression of Keima protein in HeLa cells infected with Keima lentiviral 
particles (Keima LV). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as loading 




Figure 6-3 Keima expression in HeLa cells assessed by confocal microscopy 
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HeLa cells were infected with Keima -expressing lentiviral particles and selected with puromycin. 
Cells were then plated in MatTek glass bottom culture dishes and allowed to adhere. Nuclei were 
stained with Hoechst 33342 and cells were imaged using a SP5 confocal microscope (Leica). A 10x/0.3 
PL Fluotar lens was used and three channels were acquired after serial excitation with UV (nuclei, 
coded blue), an argon laser at 458 nm (Keima at normal pH, coded green) and a yellow laser at 561 nm 
(acidic mitochondria, coded red). A composite image of the maximum projection of an imaging z-stack 
is shown on the left. The magnified area on the right demonstrates areas of red Keima signal (arrows). 
The magnified area appears pixelated due to the limit of resolution at this magnification 
 
Next, human VSMCs were infected with Keima lentiviral particles and 
selected with puromycin before plating on glass bottom culture dishes for 
Hoechst 33342 staining and live cell imaging. The three donors for aortic 
VSMCs were 69.7 years ± 18.1 years (SD) and all male, the three donors of 
plaque VSMCs were 66.0 years ± 5.3 years (SD) and 66.7% were male. 
Although proliferation and viability of human VSMCs was not assessed in the 
present study there is evidence that plaque VSMCs have reduced 
proliferation, increased cell death and earlier cell senescence compared to 
healthy VSMCs (Bennett, Macdonald, Chan, Boyle, & Weissberg, 1998). 
Infection with Keima lentiviral particles was therefore conducted as early as 
possible, between passage 3 and 9 for all VSMC lines. Cells were imaged on 
a SP5 confocal microscope using a 63x/1.4-0.6 Oil lens and serial excitation 
to visualise nuclei as well as green and red Keima. Figure 6-4 illustrates 
mitochondrial networks in untreated cells (A) and rounded mitochondrial 




Figure 6-4 Keima confocal imaging in human VSMCs 
Human VSMCs were infected with Keima-expressing lentiviral particles and selected with puromycin. 




stained with Hoechst 33342 and cells were imaged using a SP5 confocal microscope (Leica). A 
63x/1.4-0.6 PL Apo oil lens was used and three channels were acquired after serial excitation with UV 
(nuclei, coded blue), an argon laser at 458 nm (Keima at normal pH, coded green) and a yellow laser at 
561 nm (acidic mitochondria, coded red). Representative composite images of the maximum projection 
of z-stacks are shown in A) untreated HVSMCs and B) following treatment with 5 µM FCCP for 24 
hours. FCCP appeared to induce fragmentation of mitochondria and induce mitophagy with a shift 
towards red Keima signal. 
 
To investigate the effects of atherogenic lipids on mitophagy and to 
determine whether plaque VSMCs have altered mitophagy, cells were 
subjected to confocal microscopy assessment of Keima as described above. 
The consistency of labelling of either human VSMCs or plaque VSMCs was 
not formally assessed; instead confocal microscopy focused on cells with 
intense keima signal to generate images with sufficient resolution. At least 20 
z-stacks were acquired in at least three independent experiments from three 
different primary cell cultures per group. These experiments were conducted 
in parallel but for clarity of data presentation the results are divided into the 
effects of atherogenic lipids, LPS and bafilomycin on healthy VSMCs (section 
6.4) and the comparison of plaque VSMCs with and without treatment with 
OxLDL and FCCP compared to aortic VSMCs (section 6.5). 
 
6.4 Effects of OxLDL and FCCP on mitophagy and mitochondrial 
shape of human VSMCs 
Figure 6-5 depicts representative images of aortic VSMCs with and 
without treatment with OxLDL, LDL, LPS, Bafilomycin and FCCP. To 
objectively assess changes in mitochondrial shape and Keima signal an 
image J plug-in was designed by Richard Butler (the Gurdon Institute, 
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University of Cambridge). This plug-in is based on the published MitoLoc 
plug-in (Vowinckel et al., 2015) but allows for the assessment of green, red or 
the combined Keima signal. Using the combined red and green Keima signal 
and an Otsu thresholding method, the programme uses the resulting 3D mask 
to calculate the outputs surface area/volume (SA:V) and compactness as 
previously derscribed for MitoLoc. The ratio SA:V is expected to be higher in 
rounded fragmented mitochondria compared to mitochondrial networks and 
has therefore been used as measure of mitochondrial fragmentation. 
Compactness describes the variance of the radial distance/volume and offers 
an estimate of the tubularity of the mitochondrial network. The means of 
signal intensity derived from the voxels of red and green Keima were used to 
calculate the mitophagy index (red/green).  
OxLDL significantly increased mitophagy in HVSMCs after 24 hours, as 
did the positive control FCCP (Figure 6-6). The results from 4 hours and 16 
hours of treatment with OxLDL are inconclusive at the sample size. LDL did 
not exert an effect on mitophagy, nor did LPS. Bafilomycin, an inhibitor of the 
vacuolar type H+-ATPase responsible for lysosomal acidification, also 
increased the red/green ratio probably reflecting slower Keima degradation in 
the lysosomes rather than increased mitophagy. The data from mitochondrial 
shape assessment was more variable (Figure 6-6). FCCP treatment 
decreased the SA:V ratio suggesting increased mitochondrial fragmentation; 
however there were no significant differences after OxLDL, LDL, LPS or 
bafilomycin treatment. The measure of compactness showed even higher 




Figure 6-5 Representative confocal microscopy images of mitophagy in HVSMCs 
Human VSMCs were infected with Keima-expressing lentiviral particles and selected with puromycin. 
Cells were then plated in MatTek glass bottom culture dishes and allowed to adhere before treatment. 
Nuclei were stained with Hoechst 33342 and cells were imaged using a SP5 confocal microscope 
(Leica). A 63x/1.4-0.6 PL Apo oil lens was used and three channels were acquired after serial 
excitation with UV (nuclei, coded blue), an argon laser at 458 nm (Keima at normal pH, coded green) 
and a yellow laser at 561 nm (acidic mitochondria, coded red). Control: Vehicle (PBS) treatment for 24 
hours, OxLDL: 100 µg/ml for 24 hours, LDL: 100 µg/ml for 24 hours, LPS: 1000 ng/ml, FCCP (5 µM 
for 24 hours), Baf: bafilomycin (30 nM for 6 hours). Representative composite images of the maximum 
projection of z-stacks are shown. High magnification field (box) demonstrates red Keima signal in 
OxLDL (100 µg/ml for 24 hours) and FCCP (5 µM for 24 hours) treated cells.  
 
Control OxLDL LDL 









Figure 6-6 Mitophagy and mitochondrial shape in human VSMCs 
Human VSMCs were infected with Keima expressing lentiviral particles and selected with puromycin. 
Cells were then plated in MatTek glass bottom culture dishes and allowed to adhere before treatment. 
Nuclear were stained with Hoechst 33342 and cells were imaged using a SP5 confocal microscope 
(Leica). A 63x/1.4-0.6 PL Apo oil lens was used and three channels were acquired after serial 
excitation with UV (nuclei, coded blue), an argon laser at 458 nm (Keima at normal pH, coded green) 
and a yellow laser at 561 nm (acidic mitochondria, coded red). Control: Vehicle (PBS) treatment for 24 
hours, OxLDL: 100 µg/ml for 24 hours, LDL: 100 µg/ml for 24 hours, LPS: 1000 ng/ml, FCCP (5 µM 
for 24 hours), bafilomycin (30nM for 6 hours). Quantification of the mitophagy index (A), SA:V (B) 
and compactness (C) from at least 20 z-stacks from at least three independent experiments from three 
different primary cell cultures per group were analysed using ImageJ and the mitochondrial 
























































































































discovery rate of 0.1% (the most stringent setting in Prism 6). 2 outliers from a total of 229 data points 
were identified and removed prior to analysis. One-way ANOVA with Bonferroni’s correction for 
multiple comparison was performed. 
 
 
6.5  Mitophagy and mitochondrial shape in plaque VSMCs 
compared to healthy VSMCs 
Previous chapters have shown that mtDNA copy number is reduced in 
plaques compared to healthy aortas, RRC is impaired in the diseased cap 
region of human plaques, and VSMCs derived from carotid endarterectomies 
have decreased expression of complexes I and II of the ETC. Such 
mitochondrial dysfunction may have effects on mitochondrial shape and 
mitophagy and was therefore assessed in plaque VSMCs with and without 
treatment with OxLDL and FCCP in comparison to healthy VSMCs. 
Representative images are shown in Figure 6-7. Plaque VSMCs had 
increased mitophagy and increased mitochondrial fragmentation whilst the 
interpretation of data on the tubularity (compactness) was hindered by large 
variations (Figure 6-8). Mitophagy in plaque VSMCs could not be further 






Figure 6-7 Representative confocal microscopy images of mitophagy in plaque 
and healthy HVSMCs 
Human VSMCs were infected with Keima expressing lentiviral particles and selected with puromycin. 
Cells were then plated in MatTek glass bottom culture dishes and allowed to adhere before treatment. 
Nuclei were stained with Hoechst 33342 and cells were imaged using a SP5 confocal microscope 
(Leica). A 63x/1.4-0.6 PL Apo oil lens was used and three channels were acquired after serial 
excitation with UV (nuclei, coded blue), an argon laser at 458 nm (Keima at normal pH, coded green) 
and a yellow laser at 561 nm (acidic mitochondria, coded red). Control: Vehicle (PBS) treatment of 
aortic VSMCs, plaque: vehicle (PBS) treated HVSMCs derived from carotid endarterectomies ± 
OxLDL (100 µg/ml for 24 hours) or FCCP (5 µM for 24 hours) treatment. Representative composite 
images of the maximum projection of z-stacks are shown. High magnification field (box) for each 















Figure 6-8 Mitophagy and mitochondrial shape in plaque VSMCs compared to 
healthy VSMCs 
Human VSMCs and plaque VSMCs were infected with Keima expressing lentiviral particles and 
selected with puromycin. Cells were then plated in MatTek glass bottom culture dishes and allowed to 
adhere before treatment. Nuclei were stained with Hoechst 33342 and cells were imaged using a SP5 
confocal microscope (Leica). A 63x/1.4-0.6 PL Apo oil lens was used and three channels were 































































































normal pH, coded green) and a yellow laser at 561 nm (acidic mitochondria, coded red). Control: 
Vehicle (PBS) treatment, plaque: vehicle (PBS) treated HVSMCs derived from carotid 
endarterectomies ± OxLDL (100 µg/ml for 24 hours) and FCCP (5 µM for 24 hours) treatment. 
Quantification of the mitophagy index (A), SA:V (B) and compactness (C) from at least 28 z-stacks 
from at least three independent experiments from three different primary cell cultures per group were 
analysed using ImageJ and the mitochondrial morphology plug-in. One-way ANOVA with 
Bonferroni’s correction for multiple comparison was performed. 
 
To get supporting evidence of increased mitophagy in plaque VSMCs 
compared to healthy aortic VSMCs, expression of PINK1, a key mediator of 
mitophagy, was performed. Mitochondrial inner membrane depolarisation 
inhibits uqiquitination and degradation of PINK1 thereby facilitating the 
recruitment of parkin to mitochondria inducing the targeting of dysfunctional 
mitochondria to the autophagolysosome (see section 1.2.3.1). Western 
blotting of PINK1 has previously been used as evidence of mitophagy in 
VSMCs exposed to OxLDL (Swiader et al., 2016).  
Although mRNA levels of PINK1, determined by reverse transcription 
PCR (RT-PCR), did not differ between plaque VSMCs [donor age 67.3 years 
± 5 years (SD)] and healthy aortic VSMCs [donor age 70.7 years ± 11.9 years 
(SD)], plaque VSMCs [donor age 66 years ± 5.3 years (SD), 66.7% male] had 
higher protein expression of PINK1 compared to aortic VSMCs [donor age 62 
years ± 23.8 years (SD), 100% male] supporting the finding of increased 
mitophagy in these cells (Figure 6-9). 
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Figure 6-9 PINK1 expression in Plaque and healthy aortic VSMCs 
A) RT PCR of PINK1 normalised to 18S. RNA was extracted from plaque and healthy aortic VSMCs 
and converted to cDNA. qPCR of cDNA was performed for PINK1 and 18S as an internal control. 
Relative expression was calculated according to the ΔCt method. N=6 healthy aortic VSMC lines, N=4 
plaque VSMC lines. No significant differences were observed using unpaired two-tailed t-test 
assuming equal variation. B) Western blot of PINK1 expression in plaque and healthy aortic VSMCs. 
Whole cell lysates of aortic VSMC and plaque VSMC-lines were run on 8-12% gradient gels and 
membranes were probed with anti-PINK1 and anti-actin antibodies. Densitometry was performed using 
ImageJ. Relative expression of PINK1 compared to actin expressed as mean ± SEM of N=3 is 
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6.6 Mitochondrial fission genes in atherosclerotic plaques vs 
healthy aortas. 
Because plaque VSMCs demonstrated an altered shape of the 
mitochondrial network with increased fragmentation compared to healthy 
aortic VSMCs, I next investigated whether the genes involved in mitochondrial 
shape dynamics were also differentially expressed. RT-PCR of RNA extracted 
from four plaque VSMC lines [donor age 67.3 years ± 5 years (SD), 75% 
male] and six aortic VSMC lines [donor age 70.7 years ± 11.9 years (SD), 
100% male] did not demonstrate differences in gene expression of mitofusin-1 
(mfn-1), mitofusin-2 (mfn-2), mitochondrial fusion protein opa-1, mitochondrial 
fission-1 protein (fis-1) and dynamin-related protein-1 (drp-1) (Figure 6-10).  
Western blot was performed to determine protein expression of these 
genes, however, this was not successful due to non-specific binding of the 
antibodies used and the low expression of the protein (see Appendix 8.1). As 
there were no changes in expression levels of genes involved in mitochondrial 
shape dynamics at least at mRNA level, and as protein levels could not be 
determined by Western blot I did not investigate changes in mitochondrial 






Figure 6-10 mRNA expression of genes involved in mitochondrial shape 
dynamics 
RNA was extracted from plaque and healthy aortic VSMCs and converted to cDNA. RT PCR of A) 
mitofusin-1 (mfn-1), B) mitofusin-2 (mfn-2), C) mitochondrial fusion protein opa-1, D) mitochondrial 
fission-1 protein (fis-1), E) dynamin-related protein-1 (drp-1) normalised to 18S. Relative expression 
was calculated according to the ΔCt method. N=6 healthy aortic VSMC lines, N=4 plaque VSMC 
lines. Data are means ± SEM. No significant differences were observed using unpaired two-tailed t-test 
with equal variation. 



























































































6.7 Expression of genes involved in mitochondrial biogenesis 
Mitophagy and mitochondrial biogenesis are processes that are highly 
regulated and linked (see 1.2.3.1 and 1.2.3.2). Mitophagy, not balanced by 
mitochondrial biogenesis, may therefore lead to reduced mitochondrial mass 
or mtDNA content. To test whether genes involved in mtDNA replication and 
repair are upregulated in plaque VSMCs I first used RT-PCR. As 
demonstrated in Figure 6-11 the expression of Twinkle, TFAM and PolG were 
not altered in plaque VSMCs [donor age 67.3 years ± 5 years (SD), 75% 
male] compared to healthy aortic VSMCs [donor age 70.7 years ± 11.9 years 
(SD), 100% male]. However, in the case of PolG there is the possibility of a 
type II error as the statistical analysis presented uses the assumption of 
normal distribution (unpaired two-tailed t-test). However, a test of normality 
could not be performed due to sample size. 
Next, Western blot was used to test for differential protein expression 
of PGC-1α, Twinkle, TFAM and PolG in plaque [donor age 66 years ± 5.3 
years (SD), 66.7% male] and healthy aortic VSMCs [donor age 62 years ± 
23.8 years (SD), 100% male] (Figure 6-12). The expression pattern was 
variable within groups and no significant differences were observed. 
Interestingly, whilst the analysis of mRNA suggested that PolG is either 
unchanged or possibly upregulated in plaque VSMCs there was no such trend 
of increased PolG expression at protein level in plaque VSMCs.  
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Figure 6-11 mRNA expression of Twinkle, TFAM and PolG in plaque and 
healthy aortic VSMCs 
RT PCR of A) Twinkle, B) TFAM and C) PolG normalised to 18S. RNA was extracted from plaque 
and healthy aortic VSMCs and converted to cDNA. Relative expression was calculated according to 
the ΔCt method. N=6 healthy aortic VSMC lines, N=4 plaque VSMC lines. Data are means ± SEM. No 
significant differences were observed using unpaired two-tailed t-test with equal variation. 



























































Figure 6-12 Protein expression of Twinkle, TFAM and PolG in plaque and 
healthy aortic VSMCs 
Whole cell lysates of aortic VSMC and plaque VSMC-lines were run on 8-12% gradient gels and 
membranes were probed with anti-PGC-1α, anti-Twinkle, anti-TFAM, anti-PolG or anti-actin 
antibodies as indicated. Densitometry was performed using ImageJ. Relative expression of proteins of 
interest compared to actin is expressed as mean ± SEM of N=3 cell lines each. No statistically 




In this chapter I have demonstrated the feasibility of lentiviral-mediated 






































subsequently HVSMCs were infected resulting in stable expression of Keima, 
and changes in Keima fluorescence could be used to detect changes in 
mitophagy in human VSMCs. For example, FCCP, a mitochondrial uncoupler 
known to induce mitophagy caused changes in mitochondrial organisation 
resulting in a more fragmented appearance of mitochondria. In accordance 
with previous findings, FCCP induced mitophagy in this study.  
OxLDL but not LDL or LPS induced mitophagy in HVSMCs but 
interestingly mitochondrial fragmentation was not significantly affected. There 
are a number of possible explanations for this. First, the resolution achieved 
using the technique presented here may not be sufficient to conclusively map 
the mitochondrial network and fragmented mitochondria within the cell, such 
that more subtle changes in mitochondrial fragmentation may have been 
missed. Second, mitochondria that have been damaged by OxLDL exposure 
and subsequently fragmented may have been diverted to 
autophagolysosomes, such that the overall number of fragmented 
mitochondria remains unchanged. Increased fragmentation induced by 
OxLDL could also be balanced by areas of mitochondrial hyperfusion allowing 
for the exchange of proteins and RNAs between polarised and depolarised 
mitochondria. In contrast, the effects of FCCP may be more severe, causing 
depolarisation and fragmentation of large areas of the mitochondrial network. 
During this project Dr Vindis’ group (Toulouse University, France) investigated 
the effects of OxLDL on mitophagy in immortalised human VSMC-lines in 
greater detail. They demonstrated that OxLDL induces DRP-1 dependent 
mitochondrial fragmentation in human VSMCs (Swiader et al., 2016), which 
was accompanied by increased ROS production assessed by MitoSOX red 
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dye and a decrease in the inner mitochondrial membrane potential measured 
with the JC-1 dye. Following OxLDL treatment PINK1 was stabilised and 
Parkin translocated to mitochondria. 
However, the finding that mitophagy is increased and that mitochondria 
are more fragmented in plaque VSMCs has not been described before. PINK1 
protein stabilisation in plaque VSMCs further supports the finding of increased 
mitophagy in plaque VSMCs, with no changes in RNA levels or expression of 
proteins mediating mitochondrial fission and fusion. Mitophagy in VSMCs has 
been proposed to be a protective mechanism against apoptosis induced by 
atherogenic lipids (Swiader et al., 2016). This theory was supported by data 
demonstrating that inhibition of mitophagy using siRNA targeting PINK1 or 
Parkin increased OxLDL induced apoptosis of VSMCs. 
Because Keima is, to a degree, resistant to lysosomal degradation, the 
red Keima signal has been interpreted as mitophagy occurring over time, and 
therefore representing mitophagy flux (Sun et al., 2015). However, an 
alternative explanation for the increased red Keima signal in plaque VSMCs in 
this study could be dysfunctional and therefore delayed lysosomal 
degradation of the Keima protein. Methods to determine autophagic flux 
include the quantification of the degradation of proteins involved in the 
formation of autophagosomes such as LC3 (Bauvy, Meijer, & Codogno, 
2009). Indeed, Western blot analysis of LC3-I and LC3-II in samples from 
human carotid endarterectomies and from healthy mammary arteries suggest 
that autophagy is increased in human atherosclerosis (Martinet & De Meyer, 
2009). A previous study has reported reduced autophagic flux in mouse 
atherosclerosis (Razani et al., 2012). P62, a chaperone shuttling proteins for 
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lysosomal degradation that is inversely related to autophagic flux, was 
increased in atherosclerotic arteries of mice. However, p62 was mainly 
detected in plaque macrophages rather than VSMCs (Razani et al., 2012). 
Assessment of human atherosclerotic lesions using electron microscopy 
suggests that autophagy occurs in both the fibrous cap and the 
atherosclerotic core and indeed in all main cell types involved in 
atherosclerosis (Perrotta, 2013). Although the possibility of decreased 
lysosomal activity in plaque VSMCs has not been excluded in this study, 
increased PINK1 stabilisation and changes in mitochondrial shape point 
towards increased mitophagy as an explanation for the increased red Keima 
signal in the present study.  
Mitophagy and mitochondrial biogenesis are closely regulated. One of 
the key regulators of mitochondrial biogenesis in humans is PGC-1α, a 
member of the PCG-1 family of co-activators, which acts as a sensor of the 
energy status of cells such as NAD+/NADH and AMP/ATP ratios (Friedman & 
Nunnari, 2014). PGC-1α activation leads to the expression of mitochondrial 
proteins including TFAM (Picca & Lezza, 2015), an important regulator of 
mtDNA copy number (M. I. Ekstrand et al., 2004). The expression of PGC-1α 
was not altered in plaque VSMCs compared to healthy VSMCs. Modulation of 
PGC-1α activity through acetylation or phosphorylation, however, were not 
assessed in this study. Nevertheless, the expression of the downstream target 
TFAM, was not affected either. Furthermore, other factors involved in the 
regulation of mtDNA copy number and repair such as Twinkle and PolG were 
also not dysregulated in plaque VSMCs. The results of increased mitophagy 
without compensatory upregulation of mitochondrial biogenesis and repair 
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further support the finding of decreased mtDNA copy number in carotid 
atherosclerotic plaques compared to healthy aortas described in chapter 5.3. 
The results of this chapter add to the growing evidence that modulation 
of mitophagy could be a target in the treatment of atherosclerosis. 
Rapamycin, also known as sirolimus, is a strong inhibitor of mTOR complex 1 
(mTORC1) and inducer of autophagy and has been successfully used in drug-
eluting vascular stents to inhibit re-occlusion (De Meyer et al., 2015). Its 
effects were long thought to be mediated through inhibition of VSMCs 
proliferation, although other inhibitors of VSMCs proliferation, such as 
paclitaxel, have been less successful and the effects of rapamycin and its 
derivatives may in part be mediated through effects on autophagy (De Meyer 
et al., 2015). Although systemic administration of rapamycin has been shown 
to exert protective effects on atherosclerosis in animal models (Chen et al., 
2009; Waksman et al., 2003), systemic administration has also 
proatherogenic side effects such as dyslipidaemia and hyperglycaemia (De 
Meyer et al., 2015). Nevertheless, there are several other drugs that have the 
potential to induce autophagy including acid sphingomyelinase, calcium 
channel blockers, metformin, resveratrol, spermidine, trehalose and valproic 
acid [reviewed in (De Meyer et al., 2015)]. Through better understanding of 
mitophagy the development of specific modulators of this process may 
become possible. For example, the activity of PINK1 can be enhanced 
through the ATP analogue kinetin triphosphate (KTP), thereby increasing 
parkin recruitment to depolarised mitochondria (Hertz et al., 2013). 
Interestingly, kinetin, the precursor to KTP, has already been used in human 
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clinical trials of an unrelated disorder (familial dysautonomia) (Hertz et al., 
2013). 
Targeting mitochondrial biogenesis could also be a therapeutic target 
in atherosclerosis. For example, resveratrol an activator of the sirtuin-1-PGC-
1α pathway, has received attention due to its promising preclinical effects on 
ageing and age-related diseases (de Oliveira et al., 2016). The mechanism of 
action, however, is not limited to induction of mitochondrial biogenesis and its 
effects in humans have not been rigorously tested (de Oliveira et al., 2016; 
Tome-Carneiro et al., 2013; Zordoky et al., 2015). The development of 
specific inducers of mitochondrial biogenesis is therefore a promising area 




Mitochondria regulate various processes within cells that determine cell 
fate, proliferation and senescence as well as inflammation. Because of the 
importance of these processes in a variety of diseases and ageing, several 
research groups have focused on the role of mitochondria and metabolism in 
neurodegenerative disease, cancer and cardiovascular disease. However, 
despite the increasing interest in the role of mitochondria in atherosclerosis, 
much of the data available to date is correlative and a causative role of 
mitochondrial dysfunction in atherogenesis has not been firmly established. 
The present study adds to the growing evidence of the importance of 
mitochondrial biology in atherosclerosis.  
To my knowledge, mitochondrial respiration has not been assessed in 
human atherosclerotic tissues, yet. Because mitochondrial respiration can 
currently not be assessed in atherosclerotic tissue in vivo, I have adapted the 
Seahorse extracellular flux analysis assay to study human tissues 
immediately after carotid endarterectomy. This ex vivo approach should 
reflect in vivo conditions as closely as technically possible at present. Indeed, 
due to limitations in studying cultured cells as a proxy for disease processes 
several other groups have recently adapted this assay to study freshly 
prepared tissue samples. Thus far the Seahorse extracellular flux assay has 
been used to study brain tissue as well as fat tissue and more recently aortic 
tissue (Dunham-Snary et al., 2014; Feeley et al., 2014; Fried et al., 2014). 
However, the current study is the first to investigate different areas of human 
atherosclerotic arterial tissue. The data presented in this study is normalised 
to both tissue mass and cellular density allowing for comparison of respiration 
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across different areas of the human atherosclerotic plaque. Using this novel 
method, I have demonstrated that the cap and the core regions of the human 
atherosclerotic plaque have reduced mitochondrial respiration.  
I investigated the reasons for such reduced respiration in the 
atherosclerotic plaques first through determination of the protein expression of 
complexes of the ETC. The expression of complexes I and II was reduced in 
VSMCs cultured from human atherosclerotic plaques compared to healthy 
arteries and this may in part explain the reduced respiration observed in 
atherosclerotic plaques.  
From the present study it remains unclear whether energy stores such 
as the ATP/ADP ratio are affected in human atherosclerotic plaques or 
whether ATP generation through alternative pathways can compensate for the 
reduced mitochondrial respiration. For example, high-energy phosphate store 
depletion, i.e. phosphocreatine, has been implicated in reduced contractility of 
cardiomyocytes in heart failure [reviewed in Doenst, Nguyen, and Abel 
(2013)]. Reduced energy availability in VSMCs of the atherosclerotic cap 
could potentially affect plaque stability, however this is an area that has not 
been investigated, yet.  
It has long been known that in atherosclerosis there is increased 
mtDNA damage, however until now it was unclear whether such damage has 
functional consequences on mitochondrial biology. Respiration and the 
generation of ATP are key roles of mitochondria. Further studies should 
investigate whether the decreased respiration observed in this study leads to 
a metabolic shift with higher reliance on other sources of energy generation 
such as glycolysis. A metabolic switch with reliance on aerobic glycolysis 
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rather than oxidative phosphorylation (Warburg metabolism) is well described 
in cancer cells, but is also observed in immune cells, such as dendritic cells, 
upon activation (Mills et al., 2016; Tannahill et al., 2013). Further studies 
should seek to determine whether such a metabolic switch also occurs in 
atherosclerosis and whether modulation of cellular and mitochondrial 
metabolism could be a target in atherosclerosis.  
The current study did not investigate other aspects of mitochondrial 
biology and signalling in human atherosclerotic plaques. Altered mitochondrial 
biology may affect cellular signalling through effects on cell proliferation, cell 
survival or cell death and future studies should aim to establish whether 
altered mitochondrial biology in human atherosclerosis affects these 
processes. 
Importantly, I have not demonstrated causality of mitochondrial 
dysfunction in atherosclerosis. However, we know from previous studies that 
mtDNA damage can accelerate atherogenesis. ApoE-/- mice with defective 
polymerase γ proofreading capacity (ApoE-/- PolG-/-) have markedly 
increased mtDNA damage and show signs of accelerated ageing including 
premature greying of the fur, kyphosis and weight loss (E. Yu et al., 2013). 
When fat a high-fat diet, these mice develop increased atherosclerotic 
plaques compared to ApoE-/- prior to the development of other age related 
degenerative diseases. ApoE-/- PolG-/- mice also have decreased complex I 
expression and reduced mitochondrial respiration of aortic tissue, similarly to 
the observation of reduced expression of the electron transfer chain complex I 
and II in human atherosclerotic plaques in the present study. Thus, causing 
artificial mtDNA damage as in the ApoE-/- PolG-/- model can perpetuate 
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atherogenesis but it remains to be established whether the relatively mild 
mtDNA damage and mitochondrial dysfunction observed in human 
atherosclerosis are sufficient to affect disease progression.  
Recently, several attempts have been made to modulate mitochondrial 
function with the aim of changing disease progression. For example, MitoQ, 
an anti-oxidant targeted to mitochondria, reverses some of the ageing related 
loss of endothelium-dependent vasodilation in mice (Gioscia-Ryan et al., 
2014). Chronic administration of MitoQ in ApoE-/-ATM-/- mice did not 
significantly reduce atherosclerotic plaque development but decreased 
macrophage content in the plaque suggesting effects at least on plaque 
composition and stability (J. R. Mercer et al., 2012). Similarly, in animal 
models of neurodegenerative diseases such as spinocerebellar ataxia type 1 
(Stucki et al., 2016) and Parkinson’s disease (Ghosh et al., 2010) MitoQ 
elicited protective effects. However, a randomised, placebo-controlled clinical 
trial of MitoQ failed to elicit protective effects in humans with Parkinson’s 
disease (Snow et al., 2010). Such discrepancies underline the importance of 
studying human disease rather than relying on inference from animal models 
alone. Understanding the role of mitochondrial dysfunction in human disease 
may help identify further targets for manipulation of mitochondrial function. It 
may not be the amount of ROS generated by mitochondria and the resulting 
oxidative damage per se that is responsible for disease progression but rather 
other aspects of mitochondrial signalling that affects cellular function.  
Mitochondrial fission and fusion and mitophagy have emerged as key 
processes of mitochondrial homeostasis. Through fission and mitophagy 
dysfunctional mitochondria can be degraded to preserve a pool of functioning 
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mitochondria. Fusion of mitochondria is thought to facilitate communication 
between mitochondria and thereby access to proteins only encoded in the 
mitochondrion, and to buffer transient mitochondrial defects [reviewed in 
Friedman and Nunnari (2014)]. To study mitophagy in VSMCs from healthy 
aortas and human atherosclerotic plaques I have used a novel fluorescent 
reporter, Keima. This acid-stable protein is targeted to mitochondria and its 
excitation spectrum is pH dependent such that mitochondria that have been 
delivered to autophagolysosomes can be differentiated from healthy 
mitochondria. Using a lentiviral infection strategy allowed for this probe to be 
expressed in human VSMCs derived from aortas and atherosclerotic plaques. 
To my knowledge, this is the first study using lentivirus-mediated Keima 
infection of diseased primary human cell lines to study mitophagy. I have 
shown that mitophagy is stimulated by OxLDL in human primary VSMCs and 
that increased basal levels of mitophagy are a feature of VSMCs derived from 
atherosclerotic plaques. Mitophagy has been found to be protective in 
cultured VSMCs cell lines exposed to OxLDL at least partly by decreasing 
apoptosis (Swiader et al., 2016). Targeting this pathway therefore holds 
promise in the treatment of human atherosclerosis. At least in animal models 
of atherosclerosis, the induction of mitophagy through rapamycin 
administration has been encouraging (Chen et al., 2009; Waksman et al., 
2003). However, to be clinical useful in human disease, induction of 
mitophagy would have to be targeted more specifically to the vascular tissue 
to avert the systemic side effects observed with systemic rapamycin 
administration. 
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Changes in mitochondrial shape, mitophagy and mitochondrial 
biogenesis are closely linked processes. In the present study, mitochondrial 
shape and mitophagy were found to be altered in human VSMCs derived from 
atherosclerotic plaques and in aortic VSMCs treated with the uncoupler FCCP 
as a control. Furthermore, PINK1 expression as a marker of mitophagy was 
also elevated in plaque VSMCs further supporting the observation of 
increased mitophagy in plaque VSMCs 
Despite increased mitophagy in plaque VSMCs compared to healthy 
aortic VSMCs there was no compensatory upregulation of mitochondrial 
biogenesis or mitochondrial DNA repair both at RNA and protein level. This is 
an interesting observation that warrants further studies and is another 
plausible explanation for the decreased mitochondrial respiration observed in 
diseased human atherosclerotic plaques. Indeed, in the present study mtDNA 
copy number was significantly reduced in plaque tissues compared to healthy 
aortic tissues. Further studies in our laboratory have demonstrated that 
increasing mitochondrial DNA copy number in ApoE-/- mice through 
transgenic overexpression of twinkle helicase leads to plaques with increased 
cap/core ratios suggestive of higher stability after fat-feeding (E. P. K. Yu et 
al., 2017). Twinkle overexpression preserved electron transfer chain complex 
I expression and was associated with increased mitochondrial respiration. 
Although targeting of twinkle in human atherosclerosis itself is unlikely to be a 
useful clinical target, increasing mitochondrial biogenesis may be more 
promising. Inducers of mitochondrial biogenesis including resveratrol and their 
effects on atherosclerosis need to be rigorously studied at molecular level and 
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in diseases associated with mitochondrial dysfunction such as 
atherosclerosis.  
The present study also confirms findings of previous studies 
demonstrating reduced mitochondrial respiration of VSMC after OxLDL 
stimulation (Ahn et al., 2010). LDL, that has not been altered through 
oxidation, however, does not elicit similar effects. Similarly, a high-fat diet 
alone, in the absence of established atherosclerosis, does not alter aortic 
respiration in ApoE-/- mice. However, the latter findings need to be interpreted 
with caution as the assay was conducted ex vivo in the presence of glucose 
and any effects on beta-oxidation of fatty acids would not have been captured 
adequately. Future studies should therefore study aortic tissue metabolism 
using various metabolites including fatty acids. 
Together the data from the current study support a model where 
OxLDL induces acute damage to mitochondria in VSMCs thereby causing 
reduced mitochondrial respiration and activation of mitophagy to help 
preserve mitochondrial homeostasis. Plaque VSMCs, chronically exposed to 
oxidised lipid species, show increased mitophagy without compensatory up-
regulation of genes involved in mitochondrial biogenesis. Consequently, 
mtDNA copy number is reduced in atherosclerotic plaques compared to 
healthy arteries. Mitochondrial dysfunction in atherosclerotic plaques could 
then perpetuate disease progression through effects on cell viability, 
senescence and pro-inflammatory signalling. Mitochondrial function in the cap 
region of the atherosclerotic plaque could be an important determinant of cap 





8.1 Full scans of Western blots 
 
Figure 8-1 Western blots corresponding to Figure 3-1 




Figure 8-2 Western blots corresponding to Figure 3-10 
All Western blots correspond to Figure 3-10 A. Top panel: example of short exposure (left) and long 
exposure (right) of ETC complexes in RVSMCs. Various exposure lengths were required to capture 
individual complexes. Bottom: longer exposure of Western blot for citrate synthase. Note reversed 





Figure 8-3 Western blots corresponding to Figure 5-8 
ETC complexes in HVSMCs. Left: complex V (top), complex III (middle) and complexes IV, II and I 






Figure 8-4 Western blots corresponding to Figure 6-2 
Left: Keima expression, right: GAPDH expression in HeLa cells with (right lane) and without (left 














Figure 8-5 Western blots corresponding to Figure 6-9 B 
Western blot for PINK1 (top) and actin (bottom). First three lanes derived from aortic HVSMCs and 






Figure 8-6 Western blots corresponding to Figure 6-12 
Twinkle 
Previous probing (trial of HIF1α) 
  Previous probing (actin) 
PGC-1α actin for PGC-1α and 
Twinkle 
Trial of HIF1α 
 Previous probing (actin) 
TFAM 
Actin for TFAM 
PolG 







A) Western blot probing for PGC-1α, B) reprobing of membrane for actin, C) trial of Western blot for 
HIF1α (using antibody NB100-105, Novus Biologicals, 1:500 in 5% BSA PBST, secondary 1:1000 
anti-mouse, Cell Signaling Technology, 7076, in 0.25% milk PBST). Bands do not match expected 
molecular weight, however these bands were still visible when re-probing the membrane for Twinkle 
(D). Western blot for TFAM (E) and corresponding actin (F). Western blot for PolG and corresponding 
actin (H).  
 
8.2 Unsuccessful Western blots of proteins involved in 
mitochondrial shape dynamics 
 
 
Figure 8-7 Unsuccessful Western blots of proteins involved in mitochondrial 
shape dynamics 
Representative unsuccessful Western blots of proteins involved in mitochondrial shape dynamics are 
shown. The antibodies were tested under various conditions but no clear bands representing the protein 
of interest alone were detected. A) OPA1: Santa Cruz sc-393296 mouse monoclonal antibody; B) Fis1: 
Santa Cruz sc-376337 mouse monoclonal antibody; C) MFN2 : Santa Cruz sc-515647 mouse 
monoclonal antibody; D) DRP1: Santa Cruz sc-32898 rabbit polyclonal antibody; E) MFN1: Santa 





8.3 Vector map of pLESIP vector 
 
 
Figure 8-8 Vector map of pLESIP vector 
Vector map of pLESIP vector. Keima has been inserted between Sfi I A (2877) and Sfi I B (2908) 








Figure 8-9 Examples of LC-MS/MS chromatograms used for quantification of 
MitoB and MitoP 
Multiple reaction monitoring (MRM) for the analysis of d15MitoB, MitoB, d15MitoP and MitoP and 
total ion chromatogram (TIC). ES+ electrospray positive. Area under the curve was formed for peaks 
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 412.277 > 191.071 (d15MitoB)
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